{"meta":{"query_hash":"e12ef9ce158e","filters":{"venue":"Expert Opinion on Biological Therapy"},"cohort_total":145,"direct_labels_cover":1,"predictions_cover":145,"exported":145,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/e12ef9ce158e","api":"https://metacan.xera.ac/api/v1/cohort?venue=Expert+Opinion+on+Biological+Therapy"},"results":[{"id":"W1596505224","doi":"10.1517/14712598.2015.1057564","title":"Cell therapy in muscular dystrophies: many promises in mice and dogs, few facts in patients","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Wilfrid Laurier University; Centre hospitalier de l'Université Laval","funders":"","keywords":"Myocyte; Clinical trial; Medicine; Cell therapy; Transplantation; Cell; Skeletal muscle; Bioinformatics; Stem cell; Pathology; Immunology; Internal medicine; Biology; Genetics","score_opus":0.07396828387614951,"score_gpt":0.34510738124797535,"score_spread":0.27113909737182584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1596505224","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000091123096,0.99727315,0.00016596515,0.0009635083,0.00044948875,0.0000055393825,0.00002092871,0.0000075881803,0.0010226874],"genre_scores_gemma":[0.00064535404,0.9972584,0.0002748143,0.0007612803,0.00023532982,0.000011147453,0.000032815224,0.000003277817,0.00077748625],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997514,0.000051992498,0.000035468787,0.00004192122,0.00010003997,0.000019240711],"domain_scores_gemma":[0.9995503,0.0002639624,0.000042360196,0.000012197549,0.00010425652,0.000026893187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094828237,0.0005901176,0.0010877552,0.0011166316,0.00022794634,0.00084439333,0.0008488889,0.001546722,0.0036235359],"category_scores_gemma":[0.0010266702,0.00019327269,0.0005549676,0.00079390383,0.000659592,0.0012974426,0.00051698973,0.0025388882,0.002288695],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009132604,0.00004370707,0.00011932592,0.013181261,0.00006646177,0.00020562965,0.00007172393,0.00025295,0.0024186487,0.007696727,0.050763942,0.9250883],"study_design_scores_gemma":[0.000017725584,0.00006903759,0.00032536878,0.0037391637,0.000053064567,0.0008920536,0.00003952332,0.000049462556,0.0004708648,0.0021219857,0.9922092,0.000012582826],"about_ca_topic_score_codex":0.0006738305,"about_ca_topic_score_gemma":0.0013744045,"teacher_disagreement_score":0.0036235359,"about_ca_system_score_codex":0.0005166725,"about_ca_system_score_gemma":0.0006253634,"threshold_uncertainty_score":0.012121975},"labels":[],"label_agreement":null},{"id":"W1827097600","doi":"10.1517/14712598.2015.1065248","title":"Subcutaneous abatacept in rheumatoid arthritis: current update","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Abatacept; Medicine; Rheumatoid arthritis; Clinical trial; Immunogenicity; Biologic Agents; Adverse effect; Safety profile; Intensive care medicine; Internal medicine; Oncology; Immunology; Antigen; Antibody","score_opus":0.15672135775429896,"score_gpt":0.42064719267581663,"score_spread":0.26392583492151767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1827097600","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006364181,0.99881554,0.00005214524,0.00023506515,0.00019202392,0.000005059233,0.000018438943,0.000004753856,0.000613436],"genre_scores_gemma":[0.000510683,0.99852115,0.00009859941,0.0003131481,0.00021981534,0.0000073774795,0.000032559383,0.0000012345417,0.00029549925],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997329,0.000049781618,0.000048948496,0.00004871583,0.00009778637,0.000021767672],"domain_scores_gemma":[0.99938977,0.00029598878,0.00010714168,0.000011430777,0.00016259747,0.00003304764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007076285,0.00073250406,0.0013751875,0.0018142868,0.0002034514,0.0010291238,0.0009630119,0.0012140735,0.007220926],"category_scores_gemma":[0.0010829,0.00028346552,0.00076448574,0.0016822554,0.00040773247,0.00114815,0.00045861682,0.0016750259,0.00295658],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011055411,0.000046769248,0.00011403257,0.026729695,0.00009261062,0.00011706565,0.00003556592,0.00015621228,0.00062651327,0.0010546979,0.032462407,0.938454],"study_design_scores_gemma":[0.00008207521,0.00016837995,0.0009226675,0.01452018,0.00041886888,0.002009409,0.000067864064,0.000110101326,0.00031290168,0.0014615081,0.97990257,0.000023457178],"about_ca_topic_score_codex":0.0011720669,"about_ca_topic_score_gemma":0.0020154065,"teacher_disagreement_score":0.007220926,"about_ca_system_score_codex":0.0005417446,"about_ca_system_score_gemma":0.0009669537,"threshold_uncertainty_score":0.024156392},"labels":[],"label_agreement":null},{"id":"W1917425892","doi":"10.1517/14712598.2015.1065249","title":"Combination therapy for the treatment of Crohn’s disease","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"UCB Pharma","keywords":"Crohn's disease; Medicine; Disease; Inflammatory bowel disease; Intensive care medicine; Gastrointestinal tract; Drug; Infliximab; Pharmacotherapy; Immunology; Internal medicine; Pharmacology","score_opus":0.14270470312422884,"score_gpt":0.4020402889959434,"score_spread":0.25933558587171457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1917425892","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006381316,0.9992694,0.0000350412,0.000112248046,0.0000940525,0.000009053384,0.000013483613,0.0000017832408,0.00040118542],"genre_scores_gemma":[0.0010675295,0.9982926,0.00012887534,0.00018399586,0.00010310086,0.000012959628,0.000022750692,8.000487e-7,0.000187362],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99930215,0.00022558887,0.00013304898,0.000078139405,0.00022658739,0.00003445659],"domain_scores_gemma":[0.9993345,0.00036663722,0.00017869647,0.000012285042,0.00008284946,0.0000250471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007596724,0.0007025392,0.0021499014,0.0028734829,0.00022398689,0.00091914856,0.0008468409,0.0011205081,0.0069272825],"category_scores_gemma":[0.0015606781,0.00017950333,0.0010623113,0.0022411325,0.00042707394,0.0008399016,0.0005631853,0.0012053123,0.0015808458],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019889671,0.00006207118,0.00015687326,0.17274143,0.0006500607,0.00029059054,0.000079523,0.00015593565,0.0012049082,0.0014079063,0.020337708,0.8027141],"study_design_scores_gemma":[0.00027499968,0.00035013305,0.0020568112,0.116635755,0.0027165709,0.0044201873,0.00016332895,0.00013137561,0.0008614353,0.0019402871,0.87040776,0.000041280946],"about_ca_topic_score_codex":0.00077798846,"about_ca_topic_score_gemma":0.0017928974,"teacher_disagreement_score":0.0069272825,"about_ca_system_score_codex":0.000512148,"about_ca_system_score_gemma":0.00085051096,"threshold_uncertainty_score":0.023174047},"labels":[],"label_agreement":null},{"id":"W1963526807","doi":"10.1517/14712598.3.1.187","title":"AACR Special Conference in cancer research: ubiquitination in normal and cancer cells","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ubiquitin; Cancer; Proteasome; Cancer cell; Cancer research; Biology; Medicine; Cell biology; Biochemistry; Genetics; Gene","score_opus":0.18081447936761028,"score_gpt":0.4022481292485984,"score_spread":0.2214336498809881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963526807","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019647495,0.52854735,0.0060874852,0.07960361,0.27733478,0.0006134133,0.0007324759,0.00076286116,0.104353294],"genre_scores_gemma":[0.016928913,0.38697556,0.005139994,0.023723744,0.09007201,0.00081550307,0.002400635,0.00045716358,0.47348645],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967583,0.0006015918,0.00019053646,0.00036636367,0.001429941,0.0006532982],"domain_scores_gemma":[0.996636,0.0002822489,0.00023792549,0.00019872139,0.0012180187,0.0014270697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004821979,0.0030736614,0.0022631665,0.0040630214,0.002138718,0.004614736,0.0028498608,0.0069699255,0.02969194],"category_scores_gemma":[0.0024411876,0.0009481735,0.0012997623,0.0032539757,0.001544313,0.0023325046,0.0029310572,0.007837513,0.021634411],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017330653,0.000068797206,0.00011476524,0.0005738325,0.000024844187,0.00014154098,0.00003431353,0.00012429868,0.0021440233,0.00242892,0.9059021,0.08826931],"study_design_scores_gemma":[0.000018554014,0.000056764395,0.00037578776,0.00012219949,0.000015511832,0.00023385377,0.000017862136,0.0000782852,0.00061863585,0.0006127133,0.9978362,0.000013753657],"about_ca_topic_score_codex":0.0054774894,"about_ca_topic_score_gemma":0.014011648,"teacher_disagreement_score":0.02969194,"about_ca_system_score_codex":0.0050293705,"about_ca_system_score_gemma":0.004911962,"threshold_uncertainty_score":0.09932941},"labels":[],"label_agreement":null},{"id":"W1967641319","doi":"10.1517/14712598.2.5.483","title":"New developments in immunosuppressive therapy in renal transplantation","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heritage Medical Research Clinic; University of Alberta","funders":"","keywords":"Medicine; Calcineurin; Alemtuzumab; Rituximab; Tacrolimus; Adverse effect; Transplantation; Pharmacology; Monoclonal antibody; Belatacept; Monoclonal; Immunosuppression; Immunology; Internal medicine; Kidney transplantation; Antibody","score_opus":0.19644409638056642,"score_gpt":0.4155422922459468,"score_spread":0.21909819586538037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967641319","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053562715,0.998409,0.00010199334,0.00035396768,0.00038784367,0.0000023076736,0.000003351375,0.000004296763,0.0006838302],"genre_scores_gemma":[0.0003428233,0.99800783,0.00019118548,0.00038130546,0.00056296383,0.0000037750035,0.0000093600975,8.821256e-7,0.00049984874],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99951756,0.000108567896,0.0000771809,0.00006064299,0.00020947616,0.00002658709],"domain_scores_gemma":[0.9994387,0.0002861426,0.00006887322,0.000019348852,0.00014334015,0.000043635926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012022983,0.0010515829,0.001656492,0.0024172352,0.00033255355,0.0010330697,0.0009258602,0.0013001789,0.003865023],"category_scores_gemma":[0.0009394667,0.00025149353,0.0005690682,0.0029070557,0.0006470115,0.0018799002,0.00055633194,0.0021908695,0.0025893496],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080541504,0.00008724798,0.00015452728,0.011154495,0.00007805122,0.0003179757,0.00005439051,0.00029650866,0.001011801,0.002653362,0.030030033,0.95408106],"study_design_scores_gemma":[0.000040651998,0.00010959785,0.00083347555,0.0031550052,0.000096957665,0.001935245,0.00006223989,0.00008060956,0.0002829628,0.0025477246,0.99083894,0.000016622973],"about_ca_topic_score_codex":0.00093624357,"about_ca_topic_score_gemma":0.0019737254,"teacher_disagreement_score":0.003865023,"about_ca_system_score_codex":0.0008197352,"about_ca_system_score_gemma":0.0011086779,"threshold_uncertainty_score":0.012929797},"labels":[],"label_agreement":null},{"id":"W1968763049","doi":"10.1517/14712598.1.3.359","title":"Anticytokine gene therapy of autoimmune diseases","year":2001,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Viral Infectious Diseases and Gene Expression in Insects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute on Aging; National Institutes of Health","keywords":"Genetic enhancement; Immunology; Biology; Naked DNA; DNA vaccination; Autoimmunity; Immune system; Cytokine; Medicine; Gene; Genetics","score_opus":0.10684949923676214,"score_gpt":0.390288394400051,"score_spread":0.28343889516328885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968763049","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5734581,0.30291274,0.08725783,0.0023882133,0.002084553,0.0004441394,0.00064651435,0.0010847691,0.029723074],"genre_scores_gemma":[0.8541867,0.094624594,0.024513897,0.00090518873,0.0005356817,0.00037985865,0.000890093,0.00015024788,0.0238137],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997539,0.00006722176,0.000021745842,0.000039773295,0.00007334415,0.000044158445],"domain_scores_gemma":[0.99989283,0.000025207575,0.00003095001,0.000014938099,0.000018799363,0.000017211694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029921782,0.00047006697,0.0003564488,0.00049596926,0.00012922147,0.00041115846,0.0002726686,0.00051431597,0.001808776],"category_scores_gemma":[0.0002060025,0.00010024413,0.00027495858,0.00032134034,0.0003692885,0.00027522375,0.00035500684,0.0007826974,0.00076468906],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038783756,0.00017586621,0.00042749985,0.0007614477,0.00003757866,0.000656878,0.000097064214,0.0004036274,0.9073416,0.0039098216,0.0016376823,0.08416304],"study_design_scores_gemma":[0.00043976042,0.002657816,0.0028537915,0.00018289039,0.00017110407,0.005656438,0.000036458034,0.002024618,0.84485173,0.001521882,0.13958064,0.000022921497],"about_ca_topic_score_codex":0.00026763152,"about_ca_topic_score_gemma":0.00027657236,"teacher_disagreement_score":0.001808776,"about_ca_system_score_codex":0.00033962962,"about_ca_system_score_gemma":0.00029899372,"threshold_uncertainty_score":0.0060508847},"labels":[],"label_agreement":null},{"id":"W1970421649","doi":"10.1517/14712590903130558","title":"Fate and manipulations of endogenous neural stem cells following brain ischemia","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Neurogenesis and neuroplasticity mechanisms","field":"Neuroscience","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"L'Alliance Boviteq","funders":"","keywords":"Subgranular zone; Subventricular zone; Neural stem cell; Neuroscience; Stem cell; Neurogenesis; Biology; Endogeny; Hippocampus; Cell biology; Endocrinology","score_opus":0.3729883159791388,"score_gpt":0.38326063814457023,"score_spread":0.010272322165431447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970421649","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016441665,0.99218,0.0019443628,0.00025125418,0.00028297043,0.000019582749,0.000030298728,0.000026965701,0.0036204313],"genre_scores_gemma":[0.005816171,0.990617,0.0010877826,0.00017325618,0.00012770577,0.00002961162,0.000058262576,0.0000048470606,0.002085343],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985623,0.000022276552,0.000014152737,0.000027624013,0.00006299767,0.000016566752],"domain_scores_gemma":[0.9999219,0.000026169557,0.000019705574,0.0000049192668,0.00002015936,0.0000071832574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039947254,0.00085352216,0.0012380837,0.0008134747,0.00016265326,0.00053069263,0.0008102043,0.0008672151,0.0016843894],"category_scores_gemma":[0.000233902,0.00015441343,0.0002894963,0.0006179473,0.00063335657,0.00070184295,0.0004618105,0.00080943154,0.0020774603],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008662314,0.00008169301,0.00015207866,0.010231108,0.000044724096,0.00064083404,0.0000828318,0.0006843742,0.08073514,0.0062094918,0.0077858777,0.8932652],"study_design_scores_gemma":[0.0000332433,0.00027784842,0.001691459,0.002159267,0.000110859415,0.0030808265,0.000137533,0.0003034492,0.05375744,0.006184501,0.9322241,0.000039471524],"about_ca_topic_score_codex":0.00039228404,"about_ca_topic_score_gemma":0.00081032555,"teacher_disagreement_score":0.0016843894,"about_ca_system_score_codex":0.00042053353,"about_ca_system_score_gemma":0.00036012664,"threshold_uncertainty_score":0.0056348443},"labels":[],"label_agreement":null},{"id":"W1971211783","doi":"10.1517/14712598.2015.993375","title":"Glycoconjugate vaccines: an update","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Child, Adolescent and Family Mental Health","funders":"","keywords":"Glycoconjugate; Vaccination; Neisseria meningitidis; Medicine; Meningococcal vaccine; Streptococcus pneumoniae; Haemophilus influenzae; Immunology; Virology; Immunization; Intensive care medicine; Biology; Microbiology; Antibiotics; Immune system; Bacteria; Bioinformatics","score_opus":0.12243014228357499,"score_gpt":0.3900100634619948,"score_spread":0.2675799211784198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971211783","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010951078,0.9967193,0.00013088487,0.00064223533,0.0009339266,0.000010953975,0.00004740372,0.000011217968,0.0013945843],"genre_scores_gemma":[0.000435107,0.9975923,0.00017579024,0.0005065287,0.0003384352,0.000010472481,0.00006934829,0.0000019335819,0.0008700975],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999694,0.00005238308,0.000041094114,0.00004418592,0.00013624963,0.000032095824],"domain_scores_gemma":[0.99958783,0.00016804115,0.00005889187,0.000011055013,0.00013594312,0.00003827123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006856047,0.0009908278,0.0013738705,0.0018793377,0.00022473262,0.0011479361,0.0009734835,0.0016292646,0.006319261],"category_scores_gemma":[0.0010453336,0.00032103353,0.00071985327,0.0017377994,0.00037510876,0.0015441166,0.00063387956,0.002449495,0.0038788805],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008166411,0.00006681574,0.000108155284,0.019447135,0.00010155813,0.00021843637,0.000050530685,0.00027545769,0.0017109243,0.0024986537,0.09200209,0.88343865],"study_design_scores_gemma":[0.000012769133,0.00004913308,0.00017960671,0.0024812748,0.0000623501,0.00064040907,0.000017206228,0.00003907731,0.00020707688,0.00052400277,0.99577904,0.000008122656],"about_ca_topic_score_codex":0.0011794672,"about_ca_topic_score_gemma":0.0019343043,"teacher_disagreement_score":0.006319261,"about_ca_system_score_codex":0.0008032863,"about_ca_system_score_gemma":0.0011293241,"threshold_uncertainty_score":0.021140039},"labels":[],"label_agreement":null},{"id":"W1972122842","doi":"10.1517/14712590903307370","title":"Modification of mammalian reoviruses for use as oncolytic agents","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Kom op tegen Kanker","keywords":"Oncolytic virus; Reoviridae; Biology; Virology; Genome; RNA; Gene; Capsid; Reverse genetics; Virus; RNA virus; Genetic enhancement; Genetics; Rotavirus","score_opus":0.3425493463956565,"score_gpt":0.4841111118754819,"score_spread":0.1415617654798254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972122842","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013233258,0.98896515,0.002578241,0.00024758655,0.00044872364,0.00003440487,0.000042355125,0.000049012157,0.0063111424],"genre_scores_gemma":[0.0045938366,0.9879546,0.002516756,0.0002757206,0.00014444655,0.000040588122,0.00010054081,0.000008983994,0.0043644942],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998301,0.00002497004,0.000012178528,0.000030364186,0.00008622147,0.000016184165],"domain_scores_gemma":[0.9999435,0.000016556258,0.0000138561645,0.0000041212015,0.000015587615,0.0000063527145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027303802,0.0008160438,0.00095567585,0.0009551024,0.00016138077,0.0004840398,0.0006703492,0.0008916516,0.0018828687],"category_scores_gemma":[0.00020610269,0.0002838414,0.00038595984,0.000889415,0.00030259986,0.00084601576,0.00036760533,0.0011725812,0.003466468],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009055112,0.00012165965,0.000111389345,0.010869498,0.0000627465,0.0005952056,0.000093644965,0.0009327752,0.1305289,0.006479904,0.0182723,0.8318415],"study_design_scores_gemma":[0.000021448035,0.00012916085,0.0003310048,0.00042003373,0.00003118041,0.001717052,0.000020878231,0.00015955839,0.021928843,0.0010389596,0.9741823,0.000019514471],"about_ca_topic_score_codex":0.00045373553,"about_ca_topic_score_gemma":0.000667407,"teacher_disagreement_score":0.0018828687,"about_ca_system_score_codex":0.00046405641,"about_ca_system_score_gemma":0.0003130751,"threshold_uncertainty_score":0.00629884},"labels":[],"label_agreement":null},{"id":"W1975813747","doi":"10.1517/14712598.6.3.301","title":"Fluarix™, inactivated split-virus influenza vaccine","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Reactogenicity; Immunogenicity; Vaccination; Live attenuated influenza vaccine; Virology; Influenza vaccine; Virus; Public health; Medicine; Cornerstone; Immunology; Immune system","score_opus":0.42480656718496224,"score_gpt":0.51788247967576,"score_spread":0.09307591249079772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975813747","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026434546,0.9964367,0.00023208842,0.00026455024,0.0003252035,0.000011512918,0.00002542451,0.000011443888,0.002428774],"genre_scores_gemma":[0.0023273483,0.99279046,0.0005057752,0.00035777295,0.00019117708,0.000018137995,0.00007310218,0.0000020675566,0.0037342785],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998216,0.00003167014,0.00001784445,0.000027769598,0.0000877371,0.000013378443],"domain_scores_gemma":[0.9998846,0.00003980487,0.000031295385,0.0000040417303,0.000028508117,0.000011703369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004450506,0.00063191366,0.001116938,0.001133461,0.00014125866,0.00047900196,0.0007289696,0.0009642936,0.0049188635],"category_scores_gemma":[0.00050325645,0.00015487865,0.00035545538,0.0009085931,0.00024189633,0.00072420645,0.00027057974,0.0008760151,0.0048140273],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013786407,0.00006066485,0.0000853048,0.011166118,0.000067452944,0.00018518639,0.00003297794,0.0001562391,0.007005177,0.0014097982,0.023530794,0.95616245],"study_design_scores_gemma":[0.000047626014,0.000219774,0.00078824465,0.0027376732,0.00008828889,0.0014597644,0.000034733093,0.000050430866,0.0020290825,0.0007635169,0.9917704,0.000010495434],"about_ca_topic_score_codex":0.0006182121,"about_ca_topic_score_gemma":0.0009287453,"teacher_disagreement_score":0.0049188635,"about_ca_system_score_codex":0.00036105938,"about_ca_system_score_gemma":0.0005036216,"threshold_uncertainty_score":0.016455293},"labels":[],"label_agreement":null},{"id":"W1979151040","doi":"10.1517/14712598.2.1.75","title":"The efficacy of genetic vaccination is dependent upon the nature of the vector system and antigen","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Immune system; Antigen; Vaccinia; Biology; Vaccination; Immunology; Virology; Vector (molecular biology); Viral vector; Virus; Immunogenicity; DNA vaccination; Immunization; Genetics; Gene; Recombinant DNA","score_opus":0.06521455261899517,"score_gpt":0.3762826085574467,"score_spread":0.31106805593845155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979151040","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047160005,0.970676,0.007487819,0.0014985309,0.00060828554,0.00004336178,0.000062779756,0.000062209394,0.014845031],"genre_scores_gemma":[0.015409805,0.97426784,0.00420818,0.00057181437,0.00023978652,0.000059260943,0.00007099347,0.000015978794,0.005156292],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996784,0.00006393469,0.000022469292,0.00005906956,0.00014640883,0.000029621024],"domain_scores_gemma":[0.99953854,0.0003061841,0.000044221793,0.000023381763,0.000068066845,0.000019714538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007835847,0.00071523275,0.0015334651,0.0006901632,0.00018464366,0.00095499237,0.00062086,0.0012375012,0.0029677546],"category_scores_gemma":[0.0007121881,0.0001746947,0.00032065331,0.0005750525,0.0007388189,0.0009137304,0.00033603227,0.0009391892,0.0032493977],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010765166,0.00007205869,0.00028227377,0.005534047,0.00005854611,0.00021971893,0.00004446407,0.0006663574,0.1005241,0.0081348205,0.0051175635,0.8792384],"study_design_scores_gemma":[0.000034130913,0.0010266614,0.003178052,0.0023278869,0.00019525827,0.0046124486,0.00021862469,0.00075309654,0.09278891,0.010399305,0.8843976,0.00006797498],"about_ca_topic_score_codex":0.00033083392,"about_ca_topic_score_gemma":0.0004969292,"teacher_disagreement_score":0.0029677546,"about_ca_system_score_codex":0.00054720487,"about_ca_system_score_gemma":0.00049855275,"threshold_uncertainty_score":0.009928107},"labels":[],"label_agreement":null},{"id":"W1981785099","doi":"10.1517/14712590902841924","title":"Oligonucleotide based-strategies for allergy with special reference to siRNA","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital; Western University","funders":"","keywords":"Oligonucleotide; Allergy; Immunotherapy; Immunology; Medicine; Small interfering RNA; CpG Oligodeoxynucleotide; Disease; Immune system; Computational biology; Biology; RNA; DNA; DNA methylation; Gene; Internal medicine; Genetics","score_opus":0.1423333869808301,"score_gpt":0.3848982618277775,"score_spread":0.2425648748469474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981785099","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000559865,0.9854246,0.0054883836,0.00085310417,0.0015298136,0.000050210794,0.000042690466,0.00008723227,0.0059641413],"genre_scores_gemma":[0.0042388835,0.97618026,0.006140861,0.001346257,0.00075606385,0.0001365463,0.00016249905,0.000022584793,0.011016028],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997905,0.000036892714,0.000024676221,0.000038762104,0.00009206021,0.000017233682],"domain_scores_gemma":[0.9998722,0.00005109126,0.000025653211,0.0000066212187,0.000031223775,0.000013197372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004474681,0.0014872433,0.0012002285,0.0015190374,0.00027802752,0.00059215206,0.00093340053,0.0016528937,0.0056989347],"category_scores_gemma":[0.0003070766,0.0003384118,0.00056747923,0.00095932954,0.0005490227,0.001048786,0.00056368345,0.0019796914,0.0058409134],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053776075,0.00015518964,0.00009580809,0.008958028,0.00006865404,0.00078228326,0.00008625167,0.00071972184,0.06749852,0.009460823,0.040938787,0.8711822],"study_design_scores_gemma":[0.00002775565,0.00019644602,0.00028077108,0.00064811367,0.00005226387,0.0027271332,0.000028810653,0.00038195352,0.01567769,0.003029134,0.97692454,0.000025374204],"about_ca_topic_score_codex":0.00048509665,"about_ca_topic_score_gemma":0.0008711573,"teacher_disagreement_score":0.0056989347,"about_ca_system_score_codex":0.0006377307,"about_ca_system_score_gemma":0.00037661596,"threshold_uncertainty_score":0.019064903},"labels":[],"label_agreement":null},{"id":"W1983200035","doi":"10.1517/14712598.2013.748739","title":"Cell-based vasculogenic studies in preclinical models of chronic myocardial ischaemia and hibernation","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Congenital heart defects research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cardiology; Ischemia; Coronary artery disease; Internal medicine; Hibernation (computing); Population; Hibernating myocardium; Myocardial infarction; Revascularization; Computer science","score_opus":0.3619906621239243,"score_gpt":0.48590582635454393,"score_spread":0.12391516423061966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983200035","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00081586797,0.9930648,0.0014843126,0.0006713029,0.0005681566,0.000033757595,0.00004908634,0.000024020066,0.0032886378],"genre_scores_gemma":[0.00443924,0.9909253,0.0015900796,0.0004752693,0.00036151806,0.000043572458,0.0000953167,0.0000061419687,0.0020635219],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999729,0.000059839596,0.000026407391,0.000037297188,0.00012452081,0.000022862565],"domain_scores_gemma":[0.99961156,0.00018381195,0.00005748842,0.000013795221,0.000103973674,0.000029341332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001037909,0.00070198276,0.0010266209,0.0012850588,0.00015589419,0.0006567298,0.0005749735,0.0010331209,0.002291181],"category_scores_gemma":[0.0005932554,0.00016647633,0.00044330233,0.000746424,0.00046328935,0.00072948664,0.00034754092,0.0013772091,0.0016255218],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021953537,0.00018549428,0.00030587852,0.021173406,0.00008311758,0.0006622652,0.000108296554,0.00046660437,0.06021176,0.007075692,0.02537771,0.88413024],"study_design_scores_gemma":[0.00006863416,0.00051290635,0.001616396,0.0036072037,0.00015005138,0.003547522,0.00009516694,0.00021740222,0.02275877,0.0024765187,0.9649044,0.000045051707],"about_ca_topic_score_codex":0.00039521145,"about_ca_topic_score_gemma":0.00078572205,"teacher_disagreement_score":0.002291181,"about_ca_system_score_codex":0.00045079662,"about_ca_system_score_gemma":0.00047342607,"threshold_uncertainty_score":0.00766474},"labels":[],"label_agreement":null},{"id":"W1983435477","doi":"10.1517/14712598.2.2.211","title":"Becaplermin: recombinant platelet derived growth factor, a new treatment for healing diabetic foot ulcers","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Wound Healing and Treatments","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Wound healing; Medicine; Growth factor; Diabetic foot; Platelet-derived growth factor; Platelet-derived growth factor receptor; Surgery; Diabetes mellitus; Internal medicine; Receptor; Endocrinology","score_opus":0.34834058749933167,"score_gpt":0.43390506992427375,"score_spread":0.08556448242494208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983435477","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26424155,0.68221354,0.008498376,0.004759884,0.0026492467,0.00067321904,0.0008319205,0.0010271583,0.03510516],"genre_scores_gemma":[0.5814699,0.3422748,0.019286362,0.0056682043,0.001504213,0.00056444394,0.0016540687,0.00010617853,0.047471784],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999471,0.00000691121,0.0000049863206,0.00000834964,0.000024581617,0.000008058784],"domain_scores_gemma":[0.99996877,0.000004916205,0.0000066246944,0.0000014855885,0.000007275526,0.000010857325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014682823,0.0002157825,0.00022561479,0.00062435394,0.00019810694,0.0002193036,0.00021437039,0.0004790887,0.0024130922],"category_scores_gemma":[0.000106068794,0.000068200214,0.00017518009,0.0002888283,0.00014322695,0.00028927007,0.0002459316,0.000740693,0.0007524764],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023119044,0.0011007885,0.0011017884,0.0022253552,0.00007087038,0.0015275321,0.000111152796,0.00020244773,0.15908353,0.0016027837,0.01617996,0.8144819],"study_design_scores_gemma":[0.0034295921,0.013525735,0.033720296,0.0009310767,0.00033593707,0.026242746,0.00015602409,0.0015019687,0.16011658,0.0014593959,0.75849605,0.000084523745],"about_ca_topic_score_codex":0.00044806846,"about_ca_topic_score_gemma":0.0007867058,"teacher_disagreement_score":0.0024130922,"about_ca_system_score_codex":0.00012958115,"about_ca_system_score_gemma":0.000178089,"threshold_uncertainty_score":0.008072615},"labels":[],"label_agreement":null},{"id":"W1988232405","doi":"10.1517/14712598.1.1.67","title":"Heat shock proteins: novel therapeutic tools for HIV-infection?","year":2001,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Heat shock protein; Biology; Cytotoxic T cell; Virology; Biochemistry; In vitro","score_opus":0.24435351674959216,"score_gpt":0.44245787705115386,"score_spread":0.1981043603015617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988232405","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015842287,0.99675757,0.00020526072,0.00089600263,0.0006575557,0.0000075928615,0.000019123383,0.000011773419,0.0012866502],"genre_scores_gemma":[0.0010595219,0.9955317,0.00028170017,0.000766977,0.00049069716,0.000016839022,0.00004660199,0.0000032073197,0.0018026789],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998847,0.00002856048,0.000010389784,0.000019612826,0.00004069674,0.000016016867],"domain_scores_gemma":[0.99990356,0.00003743888,0.000015406778,0.0000044071417,0.000025762602,0.000013480259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039976303,0.000674177,0.0009587959,0.000781648,0.000186375,0.00081674196,0.00073830294,0.0013339409,0.004779035],"category_scores_gemma":[0.0002972123,0.00020157304,0.0003248565,0.0008244644,0.00044926084,0.0014230547,0.0005261891,0.0020428242,0.0035720738],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001254735,0.00008810408,0.00008827599,0.012320586,0.000081069746,0.00020885872,0.00007080638,0.00033299034,0.00687289,0.008694637,0.058749445,0.91236675],"study_design_scores_gemma":[0.000022248016,0.0000842384,0.00020277587,0.0010202257,0.00003261672,0.0005004921,0.000034088403,0.0000547208,0.0005763489,0.00204435,0.9954188,0.000009205515],"about_ca_topic_score_codex":0.00032133606,"about_ca_topic_score_gemma":0.00068015105,"teacher_disagreement_score":0.004779035,"about_ca_system_score_codex":0.00046777326,"about_ca_system_score_gemma":0.00047918689,"threshold_uncertainty_score":0.015987456},"labels":[],"label_agreement":null},{"id":"W1988523217","doi":"10.1517/14712590903002021","title":"Novel application of lentiviral vectors towards treatment of graft-versus-host disease","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto","funders":"","keywords":"Genetic enhancement; Suicide gene; Transplantation; Graft-versus-host disease; Hematopoietic stem cell transplantation; Medicine; Gene delivery; Immunology; Disease; Stem cell; Immunogenicity; Immune system; Biology; Gene; Internal medicine","score_opus":0.16968350474709196,"score_gpt":0.4337459767547498,"score_spread":0.26406247200765787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988523217","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005069265,0.99383587,0.0019256079,0.00032590408,0.0003131261,0.000023212406,0.000027977883,0.000039062845,0.003002186],"genre_scores_gemma":[0.0023021847,0.99382716,0.0017251737,0.00034197664,0.00015502461,0.000024355078,0.00006601395,0.0000056793097,0.0015524416],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998264,0.00002922893,0.000015710726,0.00003080584,0.000083605795,0.000014312365],"domain_scores_gemma":[0.99990404,0.00003172206,0.000016687998,0.000005860429,0.000029776138,0.000011901332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005929625,0.0008819489,0.0010900908,0.0018769356,0.00020869834,0.0008115043,0.0010203817,0.0010640027,0.0022330638],"category_scores_gemma":[0.00032132198,0.00030161138,0.00046073654,0.0015055994,0.0005411808,0.0010113232,0.00050109235,0.0019527356,0.0024963727],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007305917,0.00010578128,0.00013482143,0.0079869535,0.00008638887,0.0005354555,0.00008971498,0.000724551,0.024899164,0.009512484,0.021866478,0.9339851],"study_design_scores_gemma":[0.00004261113,0.00010510861,0.0004328977,0.00078738364,0.00006494187,0.0015432097,0.00002383307,0.00025781113,0.0056785666,0.0024514908,0.9885867,0.000025532772],"about_ca_topic_score_codex":0.00070043444,"about_ca_topic_score_gemma":0.000881028,"teacher_disagreement_score":0.0022330638,"about_ca_system_score_codex":0.00069582934,"about_ca_system_score_gemma":0.00052990305,"threshold_uncertainty_score":0.0074703097},"labels":[],"label_agreement":null},{"id":"W1989944891","doi":"10.1517/14712598.8.7.1011","title":"Adalimumab for the treatment of Crohn's disease","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary General Hospital; University of Calgary","funders":"","keywords":"Adalimumab; Infliximab; Medicine; Crohn's disease; Monoclonal antibody; Disease; Monoclonal; Internal medicine; Inflammatory bowel disease; Clinical trial; Immunology; Antibody","score_opus":0.11658275887418404,"score_gpt":0.3832660486252241,"score_spread":0.26668328975104005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989944891","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000881439,0.99570197,0.00016470559,0.0005394141,0.00096592173,0.000011120432,0.00001991981,0.000014273715,0.0024943983],"genre_scores_gemma":[0.0010160072,0.993049,0.0004433523,0.0011168668,0.00088638125,0.000019499577,0.000073444244,0.0000041172775,0.0033913087],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999689,0.000058962913,0.000036248406,0.00004734804,0.0001414823,0.000027076974],"domain_scores_gemma":[0.999757,0.00007594007,0.00004538517,0.000009631632,0.000076698765,0.000035272496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006941374,0.0012311924,0.0015878909,0.0019408449,0.00034699016,0.00085740135,0.0010979631,0.0016860515,0.0066849813],"category_scores_gemma":[0.00065910723,0.00027653362,0.00064235483,0.0016271964,0.00048395607,0.001060005,0.00070262596,0.0030547061,0.008992739],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012910817,0.00008104912,0.000084754014,0.0068125087,0.000090453475,0.00024788379,0.000032615153,0.00016864401,0.0013854918,0.0017020822,0.07654942,0.91271585],"study_design_scores_gemma":[0.000074882715,0.00006763721,0.00033726767,0.0011952663,0.0000617629,0.0013737247,0.000014897581,0.000052244708,0.00021602893,0.0008748617,0.9957211,0.000010283474],"about_ca_topic_score_codex":0.00090629497,"about_ca_topic_score_gemma":0.0019002878,"teacher_disagreement_score":0.0066849813,"about_ca_system_score_codex":0.000682836,"about_ca_system_score_gemma":0.00077359495,"threshold_uncertainty_score":0.022363544},"labels":[],"label_agreement":null},{"id":"W1991295531","doi":"10.1517/14712598.3.2.319","title":"RETRACTED: Biotherapeutic approaches to pancreatic cancer","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":18,"is_retracted":true,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital","funders":"","keywords":"Pancreatic cancer; Cancer research; Medicine; Metastasis; Immunotherapy; Cancer; Angiogenesis; Monoclonal antibody; Immunology; Internal medicine; Antibody","score_opus":0.6534273310603201,"score_gpt":0.5014126272413248,"score_spread":0.1520147038189953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991295531","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034078298,0.8060421,0.00087952643,0.04160604,0.14166948,0.00005260634,0.00008517072,0.00008488933,0.00923948],"genre_scores_gemma":[0.0033526258,0.77193767,0.0019438347,0.10676279,0.06510884,0.000094152376,0.0002632932,0.000059807524,0.050477043],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987669,0.0002436501,0.0002279779,0.00014375726,0.0005013054,0.00011648925],"domain_scores_gemma":[0.9972677,0.00089466036,0.0002953871,0.00018050228,0.0010699971,0.00029180737],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0025458084,0.001523808,0.0016304642,0.0016689323,0.0009782307,0.0018227971,0.0024893768,0.006094713,0.008621594],"category_scores_gemma":[0.0047714505,0.00042835542,0.0010338958,0.0025523978,0.0023899532,0.0038627966,0.0016932123,0.009935758,0.012185675],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009578964,0.000072557115,0.00013384374,0.0032674565,0.000041963853,0.0005789355,0.00009788007,0.00021927807,0.00096583343,0.0079192,0.58824044,0.39836687],"study_design_scores_gemma":[0.000014868428,0.000034589586,0.00015480585,0.0004670648,0.000009880168,0.0006305176,0.000023864504,0.000030584764,0.000120636985,0.0009812214,0.99752504,0.0000067964684],"about_ca_topic_score_codex":0.002373603,"about_ca_topic_score_gemma":0.004247133,"teacher_disagreement_score":0.9939053,"about_ca_system_score_codex":0.0017769481,"about_ca_system_score_gemma":0.0018347708,"threshold_uncertainty_score":0.028842151},"labels":[],"label_agreement":null},{"id":"W1993434776","doi":"10.1517/14712598.2013.840580","title":"Etanercept (Enbrel) in the treatment of juvenile idiopathic arthritis","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; London Health Sciences Centre; SickKids Foundation; Western University","funders":"","keywords":"Etanercept; Medicine; Clinical trial; Adverse effect; Intensive care medicine; Arthritis; Quality of life (healthcare); Physical therapy; Internal medicine; Rheumatoid arthritis","score_opus":0.19851319863352745,"score_gpt":0.4213451919868079,"score_spread":0.22283199335328047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993434776","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001308506,0.99828076,0.00008042114,0.00032827642,0.00029621352,0.000006861373,0.000025064157,0.000006738178,0.0008448612],"genre_scores_gemma":[0.0013447241,0.9969355,0.0001650917,0.00044832772,0.00021360297,0.000011168291,0.000049164817,0.0000015167287,0.0008309161],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997795,0.000055201,0.000035481422,0.000036423367,0.00007439017,0.000018939421],"domain_scores_gemma":[0.99972886,0.0001242116,0.000061951614,0.00000507752,0.00006246037,0.000017390847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052112987,0.0005201428,0.0008659071,0.0012211406,0.00015576878,0.00073874916,0.00059589784,0.00082756125,0.005507122],"category_scores_gemma":[0.00068380014,0.00013959961,0.00051077694,0.0010631067,0.00019965564,0.00064054615,0.00040559447,0.0012659975,0.0020624697],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012557958,0.000041312152,0.00008492725,0.024097713,0.00012294717,0.00013017267,0.000034704713,0.00024539244,0.0010618463,0.0012800838,0.029090982,0.9436844],"study_design_scores_gemma":[0.00010337634,0.00015707173,0.0007404271,0.011191713,0.00025713435,0.001500201,0.00004880215,0.00011269388,0.00046268158,0.0011973805,0.98421127,0.00001726128],"about_ca_topic_score_codex":0.0007220226,"about_ca_topic_score_gemma":0.001529634,"teacher_disagreement_score":0.005507122,"about_ca_system_score_codex":0.0003995394,"about_ca_system_score_gemma":0.0007639054,"threshold_uncertainty_score":0.01842314},"labels":[],"label_agreement":null},{"id":"W1993924959","doi":"10.1517/14712598.6.7.727","title":"American Association of Anatomists meeting on regenerative medicine","year":2006,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Anatomy and Medical Technology","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Regenerative medicine; Stem cell biology; Stem cell; Tissue engineering; Medicine; Engineering ethics; Regeneration (biology); Mesenchymal stem cell; Neuroscience; Biology; Pathology; Biomedical engineering; Engineering; Cell biology","score_opus":0.024294286003258378,"score_gpt":0.29171280744139344,"score_spread":0.26741852143813505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993924959","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031135597,0.15924515,0.0065573677,0.12004057,0.3412003,0.0003657615,0.0010171656,0.00069445814,0.36776558],"genre_scores_gemma":[0.019272808,0.10342497,0.0055102804,0.03457411,0.10404197,0.00047359304,0.0017472665,0.0002801785,0.7306748],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.999033,0.00014758947,0.000078683304,0.00017140512,0.0003971845,0.00017213407],"domain_scores_gemma":[0.9980598,0.00013893498,0.00011404157,0.000080142134,0.0009714587,0.0006355671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019865797,0.0012681518,0.00037285037,0.0019517044,0.0010321995,0.0025144003,0.0009792215,0.0028767104,0.070660494],"category_scores_gemma":[0.0018663771,0.00029111016,0.00086437963,0.00069189613,0.0006438307,0.0014389594,0.0022547299,0.003642749,0.03888561],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006323167,0.000053807824,0.00026391746,0.00026692,0.000012784854,0.00015268676,0.000042445907,0.00005438055,0.0018264108,0.0054152836,0.90069234,0.09115588],"study_design_scores_gemma":[0.0000050864933,0.000016615768,0.00038957794,0.00012133048,0.000004484172,0.0002079781,0.000013713351,0.00002846688,0.00016712019,0.0006027784,0.9984383,0.0000045005168],"about_ca_topic_score_codex":0.0012591706,"about_ca_topic_score_gemma":0.003476081,"teacher_disagreement_score":0.070660494,"about_ca_system_score_codex":0.0014201123,"about_ca_system_score_gemma":0.0033197245,"threshold_uncertainty_score":0.2363829},"labels":[],"label_agreement":null},{"id":"W1994672627","doi":"10.1517/14712598.4.5.627","title":"Modulation of immune responses – strategies for optimising vaccines","year":2004,"lang":"en","type":"editorial","venue":"Expert Opinion on Biological Therapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc","funders":"","keywords":"Vaccination; Immune system; Effector; Immune modulation; Immunology; Biology; Acquired immune system","score_opus":0.056115720950990954,"score_gpt":0.3477792489681049,"score_spread":0.291663528017114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994672627","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00043919677,0.31523493,0.0020871786,0.06834868,0.60891604,0.00007544968,0.000046743116,0.00013443382,0.00471735],"genre_scores_gemma":[0.0045655607,0.36894542,0.002192989,0.06820556,0.53243876,0.00011120281,0.000088401444,0.00006833923,0.02338388],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.998613,0.00034421944,0.00016981986,0.0001671209,0.00060675276,0.00009903115],"domain_scores_gemma":[0.99768245,0.00087653275,0.00016439166,0.000084211875,0.0008475747,0.0003449205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037234756,0.0021915585,0.0020105927,0.001058698,0.00070343155,0.0021814757,0.0022033784,0.007141159,0.004524998],"category_scores_gemma":[0.0035652183,0.0005879264,0.0011327178,0.00050899567,0.0018110506,0.0038136605,0.0010172306,0.011970225,0.0044842493],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018361096,0.00008499292,0.000047999067,0.0016008763,0.00009493362,0.00043446044,0.00005875329,0.00029793708,0.0041367505,0.0049276752,0.8937083,0.094423726],"study_design_scores_gemma":[0.000085094594,0.000083264364,0.000106022686,0.000260345,0.000039433235,0.00042617106,0.00002381318,0.00018511734,0.000818081,0.0024842946,0.99547464,0.00001373357],"about_ca_topic_score_codex":0.0004012084,"about_ca_topic_score_gemma":0.001110999,"teacher_disagreement_score":0.007141159,"about_ca_system_score_codex":0.0013761276,"about_ca_system_score_gemma":0.0008386896,"threshold_uncertainty_score":0.019691825},"labels":[],"label_agreement":null},{"id":"W1995328364","doi":"10.1517/14712590802666397","title":"Aflibercept (AVE0005): an alternative strategy for inhibiting tumour angiogenesis by vascular endothelial growth factors","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Aflibercept; Angiogenesis; Cancer research; Decoy; Vascular endothelial growth factor; Tyrosine kinase; Receptor tyrosine kinase; Metastasis; Medicine; Cancer; VEGF receptors; Receptor; Internal medicine; Bevacizumab; Chemotherapy","score_opus":0.12813195382551093,"score_gpt":0.38521482393282175,"score_spread":0.2570828701073108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995328364","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002487971,0.9910573,0.0009999172,0.0005852947,0.00038938495,0.000025282548,0.000052459553,0.000033038403,0.004369333],"genre_scores_gemma":[0.01850847,0.9717206,0.001914612,0.0010227022,0.00042816554,0.00004832463,0.00024111236,0.000006400139,0.0061097],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989855,0.00001715722,0.0000099624185,0.000018632529,0.000040637966,0.000014967903],"domain_scores_gemma":[0.9999498,0.000013834849,0.000015285868,0.0000017134084,0.000009702622,0.000009668593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028441378,0.00062558544,0.0007824479,0.001170467,0.00014840002,0.000550259,0.0006450081,0.0009139891,0.00233767],"category_scores_gemma":[0.00016474671,0.0001385007,0.0003714159,0.00077811454,0.00024443222,0.00061683956,0.0002525414,0.001231458,0.0018684416],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029082512,0.00017027408,0.00019346931,0.005194067,0.00008182262,0.0008342807,0.000036852813,0.00041210835,0.018616647,0.0026011334,0.015608923,0.9559596],"study_design_scores_gemma":[0.0003582529,0.0008731217,0.0015541686,0.00091201806,0.00011485262,0.010768344,0.000028818473,0.0003605741,0.010812753,0.0014294506,0.97275263,0.000035072862],"about_ca_topic_score_codex":0.00048352286,"about_ca_topic_score_gemma":0.0010210386,"teacher_disagreement_score":0.00233767,"about_ca_system_score_codex":0.0005606779,"about_ca_system_score_gemma":0.00032687798,"threshold_uncertainty_score":0.007820249},"labels":[],"label_agreement":null},{"id":"W1996102681","doi":"10.1517/14712598.2010.532786","title":"Treatment of diabetes with glucagon-like peptide-1 gene therapy","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Genetic enhancement; Gene delivery; Medicine; Bioinformatics; Computational biology; Biology; Gene; Genetics","score_opus":0.13994077343704872,"score_gpt":0.37369406287708684,"score_spread":0.23375328944003812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996102681","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007263866,0.9781423,0.002051966,0.008380529,0.0042724754,0.000025993933,0.00006919879,0.00004992403,0.0062812525],"genre_scores_gemma":[0.0043848343,0.98453,0.0010804955,0.0038670348,0.0020593852,0.000027125043,0.000090385685,0.00001046444,0.0039503123],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973255,0.00006667038,0.000019289715,0.000043141383,0.00011125699,0.000026974489],"domain_scores_gemma":[0.9998067,0.000067300105,0.000031529027,0.000006952453,0.00006649884,0.000020996973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005497018,0.00041036648,0.0006375144,0.00048289666,0.00013865886,0.00079859863,0.00052146503,0.001305235,0.0044859373],"category_scores_gemma":[0.0005530021,0.000117677926,0.0005252,0.00032033736,0.00041217526,0.0008990647,0.00042494904,0.0023562822,0.0027465103],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018865461,0.00007785833,0.00017283676,0.009744036,0.00011083063,0.00043137226,0.00008652365,0.00046666662,0.014482789,0.010252925,0.11457146,0.849414],"study_design_scores_gemma":[0.000043183187,0.00013632007,0.00033354314,0.0015197191,0.00005905629,0.00087904994,0.00003915783,0.00016564624,0.0022120085,0.0034531842,0.9911446,0.000014473],"about_ca_topic_score_codex":0.0004334972,"about_ca_topic_score_gemma":0.00064032373,"teacher_disagreement_score":0.0044859373,"about_ca_system_score_codex":0.0005130522,"about_ca_system_score_gemma":0.0005426717,"threshold_uncertainty_score":0.015006959},"labels":[],"label_agreement":null},{"id":"W1996623626","doi":"10.1517/14712598.2012.668517","title":"Eculizumab for treatment of asthma","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Eculizumab; Medicine; Asthma; Immunology; Paroxysmal nocturnal hemoglobinuria; Complement system; Exacerbation; Allergy; Monoclonal; Monoclonal antibody; Antibody","score_opus":0.3470602536935998,"score_gpt":0.44179609915047285,"score_spread":0.09473584545687308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996623626","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001297731,0.99664235,0.00013711817,0.0006145447,0.00042925036,0.0000068385716,0.000019788627,0.000011186996,0.0020090684],"genre_scores_gemma":[0.0017947655,0.9936766,0.00032513728,0.0009422777,0.0007197677,0.000015819523,0.00008061193,0.0000032495252,0.0024417362],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983203,0.000036826368,0.00001908096,0.000031715717,0.000062597,0.000017717051],"domain_scores_gemma":[0.99987423,0.000045186676,0.000028496299,0.0000046054024,0.00002964729,0.000017762532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003492784,0.00062209886,0.00096854876,0.0012632458,0.00018457255,0.00053497043,0.00068058644,0.0011181436,0.005615556],"category_scores_gemma":[0.00040137922,0.00013882756,0.00040692632,0.0008120852,0.00029738917,0.0006208032,0.00042559195,0.0017488386,0.003764863],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106916785,0.000054717537,0.000106557665,0.007709437,0.00007417063,0.00040502608,0.000029377483,0.00017033404,0.0020585817,0.0024399434,0.056893174,0.9299517],"study_design_scores_gemma":[0.000066792825,0.000094236915,0.00064142514,0.0026007132,0.00006898644,0.002963819,0.000021304379,0.00008154227,0.00052116823,0.0014342786,0.99149305,0.000012794073],"about_ca_topic_score_codex":0.00055770256,"about_ca_topic_score_gemma":0.0011408428,"teacher_disagreement_score":0.005615556,"about_ca_system_score_codex":0.00049616647,"about_ca_system_score_gemma":0.00045030526,"threshold_uncertainty_score":0.018785954},"labels":[],"label_agreement":null},{"id":"W2000708671","doi":"10.1517/14712598.6.11.1113","title":"Clinical applications of virosomes in cancer immunotherapy","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Immunotherapy; Cancer immunotherapy; Medicine; Cancer; Cancer vaccine; Antigen; Immunology; Melanoma; Immune system; Cancer research; Internal medicine","score_opus":0.1536356745790547,"score_gpt":0.4501499209983945,"score_spread":0.2965142464193398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000708671","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041490345,0.99506783,0.00071775424,0.00072389335,0.0003910931,0.000014785959,0.000011180886,0.00001310462,0.0026454409],"genre_scores_gemma":[0.003150385,0.99270636,0.001109973,0.0006761725,0.0003853841,0.000027695414,0.00003871602,0.0000034419459,0.0019018532],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99967813,0.000078355915,0.000028959195,0.000047351765,0.00013638836,0.000030876094],"domain_scores_gemma":[0.99978846,0.00008709138,0.000026370859,0.000010532195,0.000064137406,0.000023457947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001115445,0.0007889941,0.001228088,0.0013044464,0.00027053436,0.00093288434,0.0008752913,0.0020602155,0.0035596462],"category_scores_gemma":[0.0005725984,0.00026760067,0.00048170413,0.0009000234,0.00060158444,0.0013122002,0.0006477136,0.001690454,0.002961488],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012021997,0.00011238161,0.00018054196,0.006212325,0.000034554047,0.00047118188,0.000072798764,0.00051795715,0.011860676,0.0077110943,0.01845992,0.95424634],"study_design_scores_gemma":[0.000051302726,0.00023320511,0.0004917391,0.0013276316,0.000033790784,0.0022746762,0.000045585875,0.00020583204,0.0028324332,0.0036801693,0.988806,0.000017558235],"about_ca_topic_score_codex":0.00044830854,"about_ca_topic_score_gemma":0.00072642555,"teacher_disagreement_score":0.0035596462,"about_ca_system_score_codex":0.00085172546,"about_ca_system_score_gemma":0.00087870774,"threshold_uncertainty_score":0.011908233},"labels":[],"label_agreement":null},{"id":"W2003909801","doi":"10.1517/14712598.2011.556615","title":"Autologous cell therapy for cardiac repair","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cell therapy; Stem-cell therapy; Regenerative medicine; Stem cell; Intensive care medicine; Myocardial infarction; Expert opinion; Clinical trial; Bioinformatics; Transplantation; Surgery; Cardiology; Internal medicine; Biology","score_opus":0.3644719191005841,"score_gpt":0.4618652028833351,"score_spread":0.09739328378275103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003909801","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001706769,0.9946036,0.000425572,0.00056479254,0.00066433736,0.000015793048,0.000018730116,0.000009804482,0.0035267319],"genre_scores_gemma":[0.0014657853,0.99434114,0.00051625643,0.00047444092,0.00043719323,0.000020412193,0.000042875636,0.000003500013,0.002698374],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976176,0.000038330534,0.000019816896,0.00004144495,0.0001202362,0.000018382967],"domain_scores_gemma":[0.9998011,0.000080329286,0.000030442723,0.000008282204,0.00006297853,0.000016975351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066354364,0.00077802554,0.0010809689,0.0016535714,0.00030187346,0.00089398253,0.00065927336,0.001455038,0.007179111],"category_scores_gemma":[0.00043655303,0.0002037325,0.0004340035,0.0011639273,0.0006690026,0.0010138921,0.00070782076,0.0018740837,0.006120373],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059841677,0.00008651687,0.000088247,0.009308162,0.00004525551,0.0002938866,0.00006479172,0.00030843142,0.00756499,0.008966841,0.038525354,0.9346877],"study_design_scores_gemma":[0.000023232578,0.00010380462,0.00028640497,0.0024834462,0.000034923298,0.0014677409,0.000035447556,0.00010953763,0.001875206,0.0024702183,0.9910938,0.00001623195],"about_ca_topic_score_codex":0.00076873857,"about_ca_topic_score_gemma":0.001357797,"teacher_disagreement_score":0.007179111,"about_ca_system_score_codex":0.00057039835,"about_ca_system_score_gemma":0.000610987,"threshold_uncertainty_score":0.0240165},"labels":[],"label_agreement":null},{"id":"W2006861467","doi":"10.1517/14712598.2012.693469","title":"Exon skipping for nonsense mutations in Duchenne muscular dystrophy: too many mutations, too few patients?","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Muscular Dystrophy Canada; University of Alberta","funders":"","keywords":"Exon skipping; Nonsense mutation; Exon; Duchenne muscular dystrophy; Dystrophin; Genetics; Nonsense; Mutation; Biology; Muscular dystrophy; Bioinformatics; Medicine; Gene; Alternative splicing; Missense mutation","score_opus":0.11032140776613585,"score_gpt":0.3761372437882556,"score_spread":0.2658158360221197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006861467","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012358441,0.9978695,0.00017012656,0.0007988335,0.00024451799,0.0000045028673,0.00001656401,0.000010344606,0.00076209486],"genre_scores_gemma":[0.0009438856,0.9968945,0.00028814995,0.0007830464,0.00026575837,0.0000090846315,0.00003483273,0.000003929681,0.000776945],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997608,0.000056719833,0.000030794425,0.000039299208,0.000094447496,0.000018048531],"domain_scores_gemma":[0.99968255,0.00016170215,0.00005243596,0.000008136212,0.00007179959,0.00002351291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075020426,0.0006107314,0.0016562571,0.0012886972,0.00020639827,0.0006699996,0.0008798481,0.0013219537,0.0026873054],"category_scores_gemma":[0.0009353849,0.00019667485,0.00040383558,0.0011613009,0.00046870057,0.0010723968,0.00036443627,0.0016376185,0.0027495187],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009418769,0.00004316448,0.00015197085,0.01549697,0.00007734557,0.00063230615,0.00006923618,0.00021593236,0.0019267199,0.0031241602,0.065915264,0.91225284],"study_design_scores_gemma":[0.00004547459,0.000111715184,0.00081079284,0.0053317,0.0001264134,0.0052564438,0.00007642947,0.000095573654,0.00062821346,0.0019886387,0.98550445,0.000024175892],"about_ca_topic_score_codex":0.000791579,"about_ca_topic_score_gemma":0.0019032311,"teacher_disagreement_score":0.0026873054,"about_ca_system_score_codex":0.000565829,"about_ca_system_score_gemma":0.00072286703,"threshold_uncertainty_score":0.00898993},"labels":[],"label_agreement":null},{"id":"W2007006020","doi":"10.1517/14712598.2013.758706","title":"Cholesterol lowering with bile salt hydrolase-active probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health applications","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Probiotics and Fermented Foods","field":"Agricultural and Biological Sciences","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Micropharma (Canada); Université du Québec à Montréal","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Probiotic; Bacteria; Medicine; Cholesterol; Bile acid; Pharmacology; Biology; Internal medicine","score_opus":0.19434818295732378,"score_gpt":0.4072012171945446,"score_spread":0.21285303423722082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007006020","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004210426,0.9988255,0.000052517214,0.00068083673,0.00016421863,0.000004376032,0.000014474666,0.0000024754238,0.00021342764],"genre_scores_gemma":[0.00046923797,0.9985607,0.00019771064,0.00040845879,0.00017657127,0.000008514964,0.000017950251,7.787803e-7,0.00015999527],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994746,0.00015539935,0.00009153308,0.000077395904,0.00016139462,0.000039727347],"domain_scores_gemma":[0.9983367,0.00092795404,0.00026589827,0.00002556203,0.00038469868,0.000059307185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018600355,0.0009800737,0.0026750802,0.0020956236,0.00027419027,0.0013437606,0.0010686814,0.0022284354,0.0072176936],"category_scores_gemma":[0.002821828,0.000283318,0.0014959609,0.002471285,0.000550417,0.0016522998,0.00054898945,0.0022238693,0.0016132755],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022778727,0.00008910729,0.000195685,0.11906947,0.00042530257,0.00021767101,0.000060107974,0.0002508357,0.0018375674,0.0029655604,0.03016365,0.84449714],"study_design_scores_gemma":[0.00019447453,0.00038775816,0.0021140927,0.09918248,0.0020910075,0.0014131198,0.00025996976,0.00034386737,0.00084615214,0.005846127,0.8872603,0.000060602557],"about_ca_topic_score_codex":0.0016460371,"about_ca_topic_score_gemma":0.0032232623,"teacher_disagreement_score":0.0072176936,"about_ca_system_score_codex":0.0010047638,"about_ca_system_score_gemma":0.0030516188,"threshold_uncertainty_score":0.024145603},"labels":[],"label_agreement":null},{"id":"W2009801310","doi":"10.1517/14712598.4.1.107","title":"18th Annual Scientific Meeting of the International Society for Biological Therapy of Cancer","year":2004,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Government (linguistics); Library science; Gerontology; Medicine; Political science; Environmental ethics; Family medicine; Philosophy","score_opus":0.0865523282519976,"score_gpt":0.39436392432464834,"score_spread":0.30781159607265074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009801310","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062913727,0.36415496,0.0092047015,0.08162593,0.2291519,0.00085648545,0.0026353044,0.0007156221,0.30536383],"genre_scores_gemma":[0.018435283,0.14477827,0.004526154,0.012135227,0.04742286,0.0005753405,0.0041204817,0.0002481125,0.76775825],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991391,0.00013940231,0.000051157807,0.00014702491,0.0003987175,0.00012443546],"domain_scores_gemma":[0.99890053,0.00004419407,0.00008208944,0.000042109878,0.0005651618,0.00036594432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001254573,0.0010334353,0.0009551771,0.0014044405,0.0006534144,0.0022883508,0.0009797753,0.0023016152,0.057170823],"category_scores_gemma":[0.0013078725,0.000221439,0.0006462141,0.00069596065,0.00047915702,0.0009479112,0.001368845,0.0028303985,0.03402551],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018985345,0.00008166453,0.00041016858,0.00045163592,0.00003580646,0.00012914646,0.00004342336,0.00013350256,0.004250748,0.0031555851,0.79833984,0.19277863],"study_design_scores_gemma":[0.000010435693,0.000041078685,0.00044894128,0.00008213813,0.000007773379,0.00015858775,0.000011634154,0.000054703272,0.0004098655,0.00038153437,0.9983889,0.0000043633404],"about_ca_topic_score_codex":0.0012220435,"about_ca_topic_score_gemma":0.002332721,"teacher_disagreement_score":0.057170823,"about_ca_system_score_codex":0.0018362008,"about_ca_system_score_gemma":0.0023642876,"threshold_uncertainty_score":0.19125545},"labels":[],"label_agreement":null},{"id":"W2012383679","doi":"10.1517/14712598.3.7.1093","title":"Peptide action in stroke therapy","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Excitotoxicity; Glutamate receptor; Glutamatergic; Neuroscience; Neurotransmission; Receptor; Biology; Excitatory postsynaptic potential; Postsynaptic potential; Pharmacology; Cell biology; Inhibitory postsynaptic potential; Biochemistry","score_opus":0.5746120417242411,"score_gpt":0.5249621414531427,"score_spread":0.04964990027109839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012383679","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001772084,0.99322295,0.0002444872,0.00066118175,0.0006943269,0.000011518153,0.000016215863,0.000015283495,0.004956916],"genre_scores_gemma":[0.0013675771,0.99294174,0.000457686,0.00075101346,0.00054766505,0.000021197757,0.000038157887,0.0000031646236,0.0038718744],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997849,0.00003677136,0.000023270873,0.000035129495,0.00009806584,0.000021915363],"domain_scores_gemma":[0.9998574,0.000044684963,0.000022684599,0.000007759915,0.000045128767,0.00002229826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053247815,0.0009561641,0.0015667329,0.0015649258,0.0003561623,0.0010471252,0.000977872,0.0018669359,0.008165597],"category_scores_gemma":[0.00042857046,0.0002021811,0.00037524663,0.0014213171,0.0006457074,0.0011345105,0.00065085967,0.0020553763,0.008019952],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000737521,0.00008781067,0.00008183684,0.0059586596,0.000043882,0.00061150885,0.00006240936,0.00034489017,0.0034742202,0.005492768,0.049531937,0.93423647],"study_design_scores_gemma":[0.000039938404,0.000093320334,0.00041565014,0.0014768399,0.000031882908,0.0021407336,0.000036576424,0.00006563069,0.00040950548,0.0027265775,0.9925528,0.000010446652],"about_ca_topic_score_codex":0.000881363,"about_ca_topic_score_gemma":0.0019543252,"teacher_disagreement_score":0.008165597,"about_ca_system_score_codex":0.00078958564,"about_ca_system_score_gemma":0.0008151574,"threshold_uncertainty_score":0.02731663},"labels":[],"label_agreement":null},{"id":"W2013336468","doi":"10.1517/14712598.8.9.1381","title":"Development of targeted oncolytic virotherapeutics through translational research","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jennerex Biotherapeutics (Canada)","funders":"","keywords":"Oncolytic virus; Translational research; Clinical trial; New product development; Medicine; Computer science; Virology; Virus; Business","score_opus":0.41272849454925636,"score_gpt":0.5039105132071549,"score_spread":0.09118201865789849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013336468","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011670099,0.98057497,0.0076899277,0.0028727122,0.0009697105,0.00007933813,0.00003534829,0.00006954311,0.0065414496],"genre_scores_gemma":[0.0050981794,0.9868929,0.0040375576,0.0010199903,0.00034733687,0.000068906724,0.000052471594,0.0000075663456,0.0024750961],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995302,0.00011382248,0.000035564506,0.000075049844,0.00020141846,0.00004402882],"domain_scores_gemma":[0.99968255,0.0001315078,0.00004669661,0.000021200574,0.00009055016,0.000027503354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019804677,0.0010570217,0.0011205667,0.0011726599,0.00023741514,0.0012946861,0.0011170891,0.0019630138,0.0027559574],"category_scores_gemma":[0.0007310765,0.00029665206,0.00047194862,0.00089549745,0.0010622921,0.0022561818,0.00062440033,0.0023253805,0.0025471044],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000092173446,0.00018263402,0.0001570918,0.0122877015,0.000060064667,0.0004929964,0.00012518791,0.0013687934,0.03642212,0.0502858,0.024789479,0.87373596],"study_design_scores_gemma":[0.00008104359,0.00033612075,0.0003479379,0.0017360178,0.000054689448,0.0016653122,0.00008885647,0.00064015784,0.0151905,0.012442871,0.96738565,0.000030844218],"about_ca_topic_score_codex":0.00047271157,"about_ca_topic_score_gemma":0.000526945,"teacher_disagreement_score":0.0027559574,"about_ca_system_score_codex":0.001454894,"about_ca_system_score_gemma":0.0017562647,"threshold_uncertainty_score":0.010556042},"labels":[],"label_agreement":null},{"id":"W2014099400","doi":"10.1517/14712598.2014.880420","title":"The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":142,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Micropharma (Canada)","funders":"","keywords":"Dysbiosis; Microbiome; Biology; Metagenomics; Gut flora; Bile acid; Disease; Metaproteomics; Bioinformatics; Physiology; Immunology; Medicine; Genetics; Internal medicine; Endocrinology; Gene","score_opus":0.06233905028199166,"score_gpt":0.38908393972810057,"score_spread":0.3267448894461089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014099400","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013704211,0.992755,0.0002798118,0.0039316057,0.0013342896,0.0000071523755,0.000055847195,0.000018407076,0.001480945],"genre_scores_gemma":[0.0011945305,0.99546176,0.00021213415,0.001282937,0.0008522372,0.000011192355,0.00005477799,0.0000031030943,0.0009273538],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996948,0.000089279194,0.000024371593,0.000051005867,0.000108962355,0.000031594485],"domain_scores_gemma":[0.9994804,0.00023256747,0.00006954676,0.0000123331965,0.00015291412,0.000052234867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064357306,0.00066980993,0.0010527566,0.0008209125,0.00022934483,0.0010986719,0.000646657,0.0017662529,0.0070265653],"category_scores_gemma":[0.001239858,0.00015397073,0.00051820395,0.0008516107,0.0004963006,0.0010642117,0.0007075907,0.0018366831,0.0026102953],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009751488,0.000038623963,0.00017776428,0.019710362,0.00014869982,0.00018551617,0.00007986381,0.00036227566,0.0016803545,0.0061251232,0.112175986,0.8592179],"study_design_scores_gemma":[0.000016017646,0.00007072603,0.0005575153,0.004937202,0.00009326884,0.00059229304,0.00007398719,0.00009698767,0.0002261714,0.0042757113,0.98904467,0.00001538872],"about_ca_topic_score_codex":0.0009854392,"about_ca_topic_score_gemma":0.0015825205,"teacher_disagreement_score":0.0070265653,"about_ca_system_score_codex":0.00068983436,"about_ca_system_score_gemma":0.0014348133,"threshold_uncertainty_score":0.023506165},"labels":[],"label_agreement":null},{"id":"W2016420042","doi":"10.1517/14712598.8.5.583","title":"Immunological reconstitution after hematopoietic cell transplantation – its relation to the contents of the graft","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Immunology; Immunity; Immune system; Transplantation; Hematopoietic cell; Haematopoiesis; Acquired immune system; Medicine; Innate immune system; CD34; Hematopoietic stem cell transplantation; Biology; Stem cell; Internal medicine; Cell biology","score_opus":0.1296901490297976,"score_gpt":0.3541800439455187,"score_spread":0.2244898949157211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016420042","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014903928,0.99910176,0.00004966069,0.00014103275,0.000109127584,0.0000023285056,0.0000064486762,0.0000017048811,0.00043893172],"genre_scores_gemma":[0.0009657868,0.9984339,0.000094752286,0.00015777258,0.00011325545,0.0000052429004,0.00001195041,5.496265e-7,0.00021676277],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996364,0.00009313592,0.000063960855,0.00004417916,0.0001393825,0.000022884857],"domain_scores_gemma":[0.99965656,0.00016941145,0.00008306076,0.000006354708,0.000071191454,0.000013483384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073497515,0.0006136254,0.001981767,0.0012626811,0.0001763524,0.00080406095,0.00092334254,0.0012726675,0.0019992343],"category_scores_gemma":[0.0009603322,0.00015469785,0.00048600908,0.0017278855,0.00039143118,0.00090102945,0.00032498877,0.00067915936,0.0013165339],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015172422,0.000051000694,0.000281041,0.043433655,0.00022038467,0.00067506044,0.000087373846,0.00030876056,0.0045594163,0.001563547,0.017596448,0.9310715],"study_design_scores_gemma":[0.0000812599,0.00043695664,0.0045789983,0.023047509,0.0007898293,0.009246008,0.0003227318,0.00020303596,0.003895962,0.0033671914,0.9539795,0.000051018975],"about_ca_topic_score_codex":0.0011719519,"about_ca_topic_score_gemma":0.0015226441,"teacher_disagreement_score":0.0019992343,"about_ca_system_score_codex":0.0006422055,"about_ca_system_score_gemma":0.0009782307,"threshold_uncertainty_score":0.0066880584},"labels":[],"label_agreement":null},{"id":"W2024010256","doi":"10.1517/14712598.2013.770835","title":"Vedolizumab for Crohn's disease","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"","keywords":"Vedolizumab; Medicine; Crohn's disease; Expert opinion; Adverse effect; Disease; Ustekinumab; Inflammatory bowel disease; Prednisone; Monoclonal antibody; Placebo; Intensive care medicine; Immunology; Internal medicine; Infliximab; Antibody; Alternative medicine; Pathology","score_opus":0.12473718159489504,"score_gpt":0.3899971346007448,"score_spread":0.26525995300584976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024010256","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015668255,0.9968664,0.0001357583,0.0005669598,0.00035883402,0.000007915574,0.000024027455,0.00000884004,0.0018744974],"genre_scores_gemma":[0.0015438526,0.99598616,0.00021192049,0.0005588469,0.00031936937,0.000010173415,0.000055512948,0.0000021078688,0.0013120037],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998373,0.000033134886,0.000019713247,0.00002870751,0.0000656435,0.000015461319],"domain_scores_gemma":[0.99985945,0.000054188007,0.000032540273,0.000003438234,0.000035016183,0.00001532116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034970272,0.00047203997,0.00087975163,0.0011912975,0.00017230799,0.0005855321,0.00059931533,0.0008811812,0.004575649],"category_scores_gemma":[0.0004163125,0.00012700936,0.0004149424,0.0008675506,0.00027730456,0.00058747974,0.0003926653,0.0012988137,0.0027506093],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009467009,0.000033921595,0.000082346,0.012756882,0.000085788706,0.000283891,0.00003043146,0.00017712358,0.0020279016,0.0020077156,0.04388779,0.9385315],"study_design_scores_gemma":[0.00005580984,0.00008955812,0.000505317,0.0044413707,0.000110954614,0.0021971737,0.00002653647,0.00008182489,0.00045363803,0.0013352969,0.99068975,0.000012764301],"about_ca_topic_score_codex":0.00065044075,"about_ca_topic_score_gemma":0.0015349573,"teacher_disagreement_score":0.004575649,"about_ca_system_score_codex":0.00042801173,"about_ca_system_score_gemma":0.0004946617,"threshold_uncertainty_score":0.015307069},"labels":[],"label_agreement":null},{"id":"W2027609803","doi":"10.1517/14712590903002039","title":"Reovirus-based therapy for cancer","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Oncolytic virus; Immune system; Medicine; Toxicity; Cancer therapy; Antibody; Radiation therapy; Virus; Cancer; Cancer research; Immunology; Virology; Internal medicine","score_opus":0.211350578863113,"score_gpt":0.4692002501159638,"score_spread":0.25784967125285074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027609803","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000288702,0.99342656,0.0006975228,0.00067389297,0.00078326074,0.000021612626,0.00002282243,0.000021661841,0.0040640403],"genre_scores_gemma":[0.001912013,0.9923449,0.000683258,0.0006222874,0.00031337066,0.000030743926,0.000060354636,0.000004826052,0.0040282076],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980944,0.000035709556,0.000011955045,0.000031207557,0.00009031369,0.000021373418],"domain_scores_gemma":[0.9998944,0.000043243566,0.000015844722,0.0000052876544,0.000027457707,0.000013865902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006442294,0.0009821319,0.0010785897,0.0014469499,0.0003158058,0.0006851834,0.0011634611,0.0017295494,0.004781676],"category_scores_gemma":[0.00035387638,0.00027246927,0.0005482135,0.0010282776,0.0005959586,0.0011752807,0.00055573415,0.0022777922,0.004444675],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011015016,0.0001727307,0.00010237361,0.0070302575,0.00007661868,0.00037420526,0.00006903238,0.000715701,0.010143948,0.008793641,0.0720661,0.9003452],"study_design_scores_gemma":[0.000041402032,0.00009346353,0.0001878681,0.00061401306,0.000022860013,0.0008641129,0.00001757331,0.00010831263,0.0014587532,0.0016323244,0.99494666,0.000012709349],"about_ca_topic_score_codex":0.0008643751,"about_ca_topic_score_gemma":0.0019424665,"teacher_disagreement_score":0.004781676,"about_ca_system_score_codex":0.00096037163,"about_ca_system_score_gemma":0.000595629,"threshold_uncertainty_score":0.015996277},"labels":[],"label_agreement":null},{"id":"W2031747016","doi":"10.1517/14712598.2014.922535","title":"Obinutuzumab for B-cell malignancies","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Obinutuzumab; Rituximab; Medicine; CD20; Chronic lymphocytic leukemia; Lymphoma; Oncology; Monoclonal antibody; Immunology; Internal medicine; Antibody; Leukemia","score_opus":0.25522970632836395,"score_gpt":0.4601535520919414,"score_spread":0.20492384576357747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031747016","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008091188,0.9979163,0.000078618825,0.0003795451,0.0002569717,0.0000047096582,0.00001971416,0.000006690028,0.0012564235],"genre_scores_gemma":[0.00086942007,0.9971137,0.00012388514,0.00050619035,0.0003229662,0.0000080441605,0.000054178625,0.000002269159,0.0009992244],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975365,0.000049370985,0.00002640356,0.000055776047,0.0000905623,0.000024158458],"domain_scores_gemma":[0.99968016,0.00012849654,0.00006382351,0.0000106969865,0.00008590767,0.000030828523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006005261,0.0006327779,0.0009312521,0.0019472324,0.00021080585,0.0008688792,0.00075531675,0.0011200908,0.006617311],"category_scores_gemma":[0.00080837973,0.00016890267,0.00052457186,0.0018231873,0.00039071558,0.0010185519,0.0005882016,0.0015887923,0.0040205223],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006699442,0.00003202424,0.00009333483,0.011250163,0.00006869476,0.0001268001,0.000038300444,0.00019424545,0.0009784079,0.0022575716,0.04156105,0.9433325],"study_design_scores_gemma":[0.000022131997,0.000053717373,0.00035649183,0.004503976,0.00007065488,0.0010044891,0.000019182089,0.000045573433,0.00029920513,0.0011348027,0.99248177,0.000007989349],"about_ca_topic_score_codex":0.0008161134,"about_ca_topic_score_gemma":0.001123016,"teacher_disagreement_score":0.006617311,"about_ca_system_score_codex":0.0006691537,"about_ca_system_score_gemma":0.00092042016,"threshold_uncertainty_score":0.022137105},"labels":[],"label_agreement":null},{"id":"W2043054600","doi":"10.1517/14712598.8.7.941","title":"Regulation of collagen-derived antiangiogenic factors by p53","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Endostatin; Angiogenesis; Cancer research; Endogeny; Limiting; Biology; Suppressor; Cancer; Antiangiogenic therapy; Genetics; Endocrinology","score_opus":0.11182517663032905,"score_gpt":0.3674271000397027,"score_spread":0.25560192340937365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043054600","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00084888324,0.994651,0.00071164966,0.00064026273,0.000299521,0.000009021584,0.000024312283,0.000017719964,0.002797649],"genre_scores_gemma":[0.0046576746,0.99226576,0.0006398193,0.00027309862,0.00026077873,0.00001499542,0.000044135613,0.00000250553,0.001841224],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987376,0.000024371235,0.000010631734,0.000025197864,0.00005203686,0.000013923814],"domain_scores_gemma":[0.99987304,0.000039761497,0.000031624175,0.00000454469,0.00003697537,0.000014075846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033427318,0.00053513056,0.00077128777,0.00065118197,0.00013493524,0.00046419777,0.00056868966,0.00088724215,0.0018812509],"category_scores_gemma":[0.00023314875,0.00014525258,0.0002289293,0.00057297706,0.00031861497,0.00055350276,0.00024823102,0.0007016149,0.0021227368],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012851371,0.000058028178,0.0003552888,0.0074268035,0.000057223362,0.00067561027,0.000053102533,0.0006355842,0.03901823,0.006239272,0.024236802,0.9211156],"study_design_scores_gemma":[0.000040304276,0.00019019365,0.0016061723,0.0010946204,0.000053887015,0.0032637515,0.000047322585,0.00033310574,0.014796216,0.0034120176,0.97513914,0.000023313694],"about_ca_topic_score_codex":0.0004897787,"about_ca_topic_score_gemma":0.0006480254,"teacher_disagreement_score":0.0018812509,"about_ca_system_score_codex":0.0005307677,"about_ca_system_score_gemma":0.00041539833,"threshold_uncertainty_score":0.0062933564},"labels":[],"label_agreement":null},{"id":"W2044528239","doi":"10.1517/14712598.2013.764411","title":"Systemic lupus erythematosus: an update on current pharmacotherapy and future directions","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Pharmacotherapy; Current (fluid); Immunology; Intensive care medicine; Internal medicine","score_opus":0.16642661034340644,"score_gpt":0.44488979218688984,"score_spread":0.2784631818434834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2044528239","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000054485194,0.99812084,0.00009093853,0.0009831674,0.00023496259,0.0000057499037,0.000022085842,0.000006211966,0.00048160003],"genre_scores_gemma":[0.00024645255,0.9987877,0.00018204622,0.00037172274,0.00021699347,0.0000064376604,0.000022176138,0.0000010408423,0.00016547114],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99945396,0.00013275773,0.0001167012,0.00007395758,0.00018750574,0.00003508851],"domain_scores_gemma":[0.99873215,0.00070838566,0.00017156606,0.000026390724,0.0002992996,0.00006217671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00158962,0.0010267245,0.00245694,0.0031881023,0.0003503474,0.0016064935,0.0012871407,0.0016143149,0.006755297],"category_scores_gemma":[0.0019330666,0.0003779417,0.001145294,0.003404971,0.00059631374,0.0019966138,0.0008737751,0.0025541065,0.002296347],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086672524,0.00007706072,0.00014911652,0.029720638,0.00016348112,0.00019226591,0.00006573707,0.00026976728,0.0004868767,0.0022179354,0.043080755,0.92348975],"study_design_scores_gemma":[0.000052511525,0.00013831342,0.0008305987,0.02660178,0.00040160076,0.0013384598,0.00012763606,0.00014932772,0.00016057174,0.0027569807,0.9674095,0.00003270181],"about_ca_topic_score_codex":0.0016786156,"about_ca_topic_score_gemma":0.004269092,"teacher_disagreement_score":0.006755297,"about_ca_system_score_codex":0.0011057947,"about_ca_system_score_gemma":0.0020388851,"threshold_uncertainty_score":0.022598684},"labels":[],"label_agreement":null},{"id":"W2050062331","doi":"10.1517/14712598.2.6.665","title":"3rd World Congress on Vaccines and Immunisation","year":2002,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Virology; Medicine; Vaccination; Immunology","score_opus":0.14760584393702697,"score_gpt":0.3670298203704592,"score_spread":0.21942397643343226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050062331","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020174047,0.5571812,0.00325054,0.08168433,0.118070096,0.0007063868,0.014806355,0.00082040596,0.22146334],"genre_scores_gemma":[0.013926097,0.38185927,0.0075568506,0.07358069,0.028671408,0.002921564,0.022969976,0.00047657345,0.46803755],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985051,0.0002060837,0.00015855039,0.00014202231,0.0007676845,0.0002205726],"domain_scores_gemma":[0.99793196,0.00021572497,0.00044480085,0.000081092905,0.00096192956,0.00036448002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029325988,0.0021498809,0.0018442807,0.0025591077,0.0009870582,0.0035784044,0.0021812972,0.009190372,0.03143246],"category_scores_gemma":[0.002811324,0.0006757633,0.001477582,0.0019316714,0.00084428873,0.0021719693,0.0014898827,0.008173815,0.03987783],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017681127,0.00006458529,0.00024350117,0.0005575977,0.00003629127,0.00009342676,0.000031510717,0.00012263452,0.0005610772,0.0015066133,0.9077221,0.088883914],"study_design_scores_gemma":[0.00002935776,0.000031979856,0.0012285887,0.00035195157,0.00003682098,0.000084427586,0.000018424851,0.00002930478,0.00022367938,0.00048721858,0.99746597,0.000012327958],"about_ca_topic_score_codex":0.012060323,"about_ca_topic_score_gemma":0.01622531,"teacher_disagreement_score":0.03143246,"about_ca_system_score_codex":0.0026782511,"about_ca_system_score_gemma":0.005760495,"threshold_uncertainty_score":0.10515201},"labels":[],"label_agreement":null},{"id":"W2052659698","doi":"10.1517/14712598.2015.1001735","title":"Communicating in context: a priority for gene therapy researchers","year":2015,"lang":"en","type":"editorial","venue":"Expert Opinion on Biological Therapy","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; NeuroDevNet","funders":"University of British Columbia; Canada Research Chairs","keywords":"Context (archaeology); Public opinion; Ethical issues; Engineering ethics; Public involvement; Bioethics; Political science; Public relations; Medicine; Biology; Politics; Engineering","score_opus":0.13378243306530818,"score_gpt":0.45526483396988165,"score_spread":0.3214824009045735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052659698","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005294856,0.016960228,0.0002600333,0.26953235,0.7120118,0.000012002576,0.000012004592,0.00003238669,0.0011261853],"genre_scores_gemma":[0.0014751134,0.016295798,0.0006279096,0.16805139,0.8059726,0.00004227819,0.000017440487,0.000046907608,0.0074705365],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98193514,0.0077182218,0.0021475276,0.0015973063,0.005785725,0.0008161721],"domain_scores_gemma":[0.92661077,0.050681286,0.0026238584,0.0015656924,0.013815909,0.0047024935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01839521,0.0023941305,0.0031982195,0.0015982387,0.004736351,0.0119443275,0.0040459055,0.03927011,0.0063904123],"category_scores_gemma":[0.05045407,0.00091418636,0.00256788,0.001037301,0.009423141,0.011495734,0.0032306167,0.04157062,0.0046556205],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025248719,0.000015107484,0.000029726863,0.00048014766,0.000021157142,0.00019777684,0.0002929477,0.000039769227,0.00016447424,0.0019299858,0.98079544,0.016008181],"study_design_scores_gemma":[0.000017844282,0.000020826976,0.00011579411,0.0008854546,0.000031782976,0.00023133228,0.00038288263,0.00007940165,0.000102659345,0.0037557085,0.9943504,0.000025873778],"about_ca_topic_score_codex":0.0022607183,"about_ca_topic_score_gemma":0.0052744118,"teacher_disagreement_score":0.03927011,"about_ca_system_score_codex":0.006024056,"about_ca_system_score_gemma":0.0071779722,"threshold_uncertainty_score":0.09728438},"labels":[],"label_agreement":null},{"id":"W2053775344","doi":"10.1517/14712598.7.11.1731","title":"Review of hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine safety and efficacy","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Adjuvant; CpG Oligodeoxynucleotide; Hepatitis B virus; Vaccination; Immunology; Virology; Antigen; Immune system; Hepatitis B; Titer; Antibody titer; Antibody; Virus; Biology","score_opus":0.18240606643472634,"score_gpt":0.4394716266530102,"score_spread":0.25706556021828386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053775344","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012532565,0.99877936,0.00007979024,0.00017345978,0.00018592807,0.000009236981,0.00002146522,0.0000048889565,0.00062054506],"genre_scores_gemma":[0.00045810058,0.9987582,0.00015485642,0.0001676038,0.000112306974,0.0000109102175,0.000033578443,0.0000010250232,0.0003033926],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99972934,0.00005576517,0.000057783785,0.000034913865,0.00010650203,0.000015624144],"domain_scores_gemma":[0.99950385,0.00023926295,0.00008346547,0.00000965319,0.00012849741,0.000035219706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008428266,0.00090599194,0.0021153733,0.0021315182,0.00021206909,0.00076578144,0.0011281752,0.0010172442,0.0050174636],"category_scores_gemma":[0.0011757968,0.00036286344,0.00064558187,0.0021808126,0.0002620576,0.0010308502,0.00039280453,0.0009010784,0.0025873368],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001610504,0.000071788985,0.00009233611,0.049826175,0.00017133477,0.00018990695,0.000033173197,0.00023466576,0.0016708769,0.0008856759,0.030279368,0.9163836],"study_design_scores_gemma":[0.00008886324,0.00030176886,0.0011447208,0.011129893,0.00048108285,0.0013439778,0.000043655607,0.00009751586,0.0009886762,0.0007091065,0.9836482,0.000022547523],"about_ca_topic_score_codex":0.00085960305,"about_ca_topic_score_gemma":0.0014919256,"teacher_disagreement_score":0.0050174636,"about_ca_system_score_codex":0.0005740572,"about_ca_system_score_gemma":0.0011999083,"threshold_uncertainty_score":0.016785085},"labels":[],"label_agreement":null},{"id":"W2056009313","doi":"10.1517/14712598.2011.548800","title":"Intramuscular cell transplantation as a potential treatment of myopathies: clinical and preclinical relevant data","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Wilfrid Laurier University; Centre hospitalier de l'Université Laval","funders":"","keywords":"Skeletal muscle; Transplantation; Medicine; Pathology; Bioinformatics; Biology; Internal medicine","score_opus":0.2393148947207628,"score_gpt":0.4463102190954453,"score_spread":0.20699532437468252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056009313","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029926558,0.9968118,0.00027890125,0.00045945848,0.00025172657,0.0000130110875,0.00003108246,0.000008461713,0.0018462775],"genre_scores_gemma":[0.001253161,0.99711454,0.00032499954,0.00034217953,0.00016604213,0.000014256024,0.00004586986,0.0000028979116,0.00073609565],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997825,0.000038600738,0.000024034762,0.000040174185,0.000097710305,0.000016881047],"domain_scores_gemma":[0.99963856,0.00018024747,0.00004915887,0.000009966204,0.00009550048,0.000026508096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084285636,0.0007593717,0.0015233126,0.001141967,0.00017645198,0.0008470252,0.0006910609,0.001242373,0.0043643233],"category_scores_gemma":[0.00067593623,0.00015164704,0.0005251337,0.0009960158,0.0004451448,0.0007915285,0.00041930744,0.001581378,0.0028814797],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000181061,0.00010949705,0.00011636885,0.016602943,0.000075790645,0.0002822893,0.000046386875,0.00032646552,0.007685016,0.0025252143,0.019240025,0.95280886],"study_design_scores_gemma":[0.00009399535,0.00056388235,0.0012817127,0.009216252,0.0002389888,0.002921874,0.000080234575,0.00017876967,0.003459433,0.0021872614,0.9797434,0.00003421827],"about_ca_topic_score_codex":0.00047658288,"about_ca_topic_score_gemma":0.0010707965,"teacher_disagreement_score":0.0043643233,"about_ca_system_score_codex":0.00039574603,"about_ca_system_score_gemma":0.0006094255,"threshold_uncertainty_score":0.014600098},"labels":[],"label_agreement":null},{"id":"W2056126151","doi":"10.1517/14712598.4.4.507","title":"Hepatocyte growth factor gene therapy for islet transplantation","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Institutes of Health; National Institute for Health and Care Research","keywords":"Islet; Transplantation; Hepatocyte growth factor; Biology; Beta cell; Immunology; Cancer research; Genetic enhancement; Context (archaeology); Pancreatic islets; Medicine; Endocrinology; Internal medicine; Diabetes mellitus; Gene","score_opus":0.20152012358907712,"score_gpt":0.4022186675813466,"score_spread":0.2006985439922695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056126151","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025675414,0.99471325,0.00058780686,0.0005095795,0.00059529836,0.000012057713,0.000012419295,0.000018389183,0.0032944316],"genre_scores_gemma":[0.0014392312,0.99435717,0.00057423505,0.00056915643,0.00037924713,0.000017015758,0.00003711192,0.0000032754888,0.002623526],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998066,0.000035964345,0.00001632712,0.000032348296,0.00009137009,0.000017385815],"domain_scores_gemma":[0.9998945,0.000036716974,0.000018815572,0.000006658645,0.000029066963,0.0000142486615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005234273,0.00097155577,0.0010460244,0.0016183571,0.00020836432,0.0005880786,0.00077151926,0.0012417873,0.005459557],"category_scores_gemma":[0.00031533107,0.00020213118,0.00048163775,0.001263152,0.0004888654,0.0009388788,0.00041409108,0.0014737479,0.005196519],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008773422,0.00013330036,0.00010759729,0.005581576,0.00005746923,0.00044041994,0.000031175143,0.00032051624,0.006172912,0.0024495162,0.034199663,0.9504181],"study_design_scores_gemma":[0.00007070834,0.00015088385,0.0007544632,0.0014333099,0.000054988202,0.002593411,0.000027961993,0.00013694102,0.0019756411,0.0018106314,0.9909741,0.000016778597],"about_ca_topic_score_codex":0.0008185964,"about_ca_topic_score_gemma":0.0015304849,"teacher_disagreement_score":0.005459557,"about_ca_system_score_codex":0.0005766609,"about_ca_system_score_gemma":0.0006467452,"threshold_uncertainty_score":0.018263996},"labels":[],"label_agreement":null},{"id":"W2056867349","doi":"10.1517/14712598.2.7.751","title":"HIV-1 drug resistance: can we overcome?","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Reverse transcriptase; Drug resistance; Drug; Nucleoside Reverse Transcriptase Inhibitor; Virology; Protease; Protease inhibitor (pharmacology); Biology; HIV drug resistance; Medicine; Human immunodeficiency virus (HIV); Immunology; Antiretroviral therapy; Viral load; Pharmacology; Genetics; Enzyme; RNA; Gene","score_opus":0.15405837618061594,"score_gpt":0.3821740819905895,"score_spread":0.22811570580997356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056867349","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023288834,0.9900975,0.00024441426,0.005664905,0.00071167387,0.000007478249,0.0000144587575,0.000014107546,0.0030126192],"genre_scores_gemma":[0.0018580848,0.99165654,0.00076022086,0.0024157423,0.00066061394,0.000016186817,0.000022686503,0.0000034240525,0.0026064697],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999686,0.00009576988,0.000024461397,0.00004073687,0.00011560142,0.00003746756],"domain_scores_gemma":[0.99977714,0.00007968021,0.000029629007,0.000011978933,0.00006845916,0.00003313621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010195125,0.0008110714,0.0016753745,0.0008838873,0.00038150136,0.0014943698,0.0011607391,0.0022367502,0.0070532947],"category_scores_gemma":[0.0009456569,0.00020131296,0.00034842914,0.00082372315,0.0008273796,0.00259033,0.000646288,0.002270687,0.0049337745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008619761,0.00010103562,0.00018586608,0.0068782787,0.00005484161,0.0003288221,0.00015712767,0.00016551276,0.00182778,0.008538892,0.065522276,0.9161534],"study_design_scores_gemma":[0.00004208955,0.00010986874,0.0004003832,0.0025289822,0.000045767792,0.0011005074,0.00021468649,0.00008838529,0.00033764876,0.0062622884,0.9888571,0.0000122468755],"about_ca_topic_score_codex":0.0008808567,"about_ca_topic_score_gemma":0.0022000303,"teacher_disagreement_score":0.0070532947,"about_ca_system_score_codex":0.0006606259,"about_ca_system_score_gemma":0.0011634035,"threshold_uncertainty_score":0.023595572},"labels":[],"label_agreement":null},{"id":"W2057415537","doi":"10.1517/14712598.2012.693474","title":"<b>Probiotics as oral health biotherapeutics</b>","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Oral microbiology and periodontitis research","field":"Dentistry","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Gingivitis; Periodontitis; Medicine; Oral health; Immunology; Oral Microbiome; Intensive care medicine; Oral cavity; Dentistry","score_opus":0.45089260106818485,"score_gpt":0.5190177562518071,"score_spread":0.06812515518362228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057415537","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028395737,0.9888698,0.0004793664,0.0028139611,0.0019504084,0.000014171408,0.00005138169,0.000019726982,0.0055172816],"genre_scores_gemma":[0.0026678117,0.98974216,0.000853049,0.0017852297,0.0011570908,0.000021191645,0.00009009727,0.000007029176,0.0036763276],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999647,0.00008708886,0.00004040695,0.000048359216,0.00014453886,0.00003252554],"domain_scores_gemma":[0.99967766,0.00011611888,0.000045962996,0.000014139174,0.00011899801,0.000027062675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005822717,0.000703565,0.00087486656,0.0011022881,0.00029100166,0.0012009043,0.00047658858,0.0018283798,0.010363715],"category_scores_gemma":[0.00063709833,0.00015928221,0.0003943885,0.0016096453,0.00052485446,0.0014139095,0.00067868805,0.0019706376,0.0063585676],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012315046,0.000064854896,0.00014268425,0.016161745,0.000051087325,0.00020167677,0.00008274233,0.00016559572,0.0074619213,0.008987088,0.07347648,0.89308107],"study_design_scores_gemma":[0.000011157862,0.000088576315,0.00054099265,0.003507634,0.000034467303,0.0008013594,0.00006432613,0.00006867866,0.0011146067,0.0021545703,0.99160117,0.000012414514],"about_ca_topic_score_codex":0.0008789519,"about_ca_topic_score_gemma":0.0011284836,"teacher_disagreement_score":0.010363715,"about_ca_system_score_codex":0.00044605744,"about_ca_system_score_gemma":0.0008957356,"threshold_uncertainty_score":0.034670115},"labels":[],"label_agreement":null},{"id":"W2059925584","doi":"10.1517/14712598.2013.743526","title":"Influence of lipoplex surface charge on siRNA delivery: application to the<i>in vitro</i>downregulation of CXCR4 HIV-1 co-receptor","year":2013,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Public Health Agency of Canada","funders":"Institut National de la Santé et de la Recherche Médicale; Public Health Agency of Canada","keywords":"Downregulation and upregulation; In vitro; Chemistry; Human immunodeficiency virus (HIV); Receptor; CXCR4; Cell biology; Surface charge; Pharmacology; Biophysics; Immunology; Biology; Biochemistry; Gene","score_opus":0.023968691748898152,"score_gpt":0.2919159093127898,"score_spread":0.26794721756389167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059925584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98757416,0.0040041436,0.0061681364,0.00021538428,0.000043067408,0.0000771926,0.00009156625,0.00005591059,0.0017703626],"genre_scores_gemma":[0.9920282,0.0028096002,0.0037288712,0.00011298844,0.000017477032,0.000041449508,0.00008239667,0.000016058886,0.0011630097],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99984634,0.000045912173,0.000014412147,0.000030967996,0.000037762,0.000024505322],"domain_scores_gemma":[0.9998759,0.000046713394,0.00003756402,0.0000074669115,0.0000226943,0.0000096745935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038611164,0.0003605541,0.00018647718,0.000121982746,0.00011746344,0.00035244165,0.00014486238,0.0003130426,0.00076605915],"category_scores_gemma":[0.00026070295,0.000108645494,0.0002324766,0.000080097474,0.00024151239,0.00022447201,0.00021464653,0.00025725036,0.00017833165],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063856394,0.000013584199,0.000071743525,0.000077391174,0.0000048670527,0.00003609766,0.000012355066,0.00010773605,0.9976252,0.000050499973,0.000030548246,0.0019062018],"study_design_scores_gemma":[0.000010664439,0.0002082272,0.0004927917,0.000004782746,0.00001673067,0.00005663914,0.0000066655894,0.0005412891,0.9978816,0.000015372458,0.0007614129,0.000003772417],"about_ca_topic_score_codex":0.00031379142,"about_ca_topic_score_gemma":0.00025456722,"teacher_disagreement_score":0.00076605915,"about_ca_system_score_codex":0.0003017339,"about_ca_system_score_gemma":0.00016164996,"threshold_uncertainty_score":0.0025627613},"labels":[],"label_agreement":null},{"id":"W2064487427","doi":"10.1517/14712598.2014.896335","title":"New developments in exon skipping and splice modulation therapies for neuromuscular diseases","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Exon skipping; Duchenne muscular dystrophy; Spinal muscular atrophy; Medicine; Dystrophin; Exon; Myopathy; Muscular dystrophy; SMA*; Bioinformatics; Alternative splicing; Biology; Genetics; Internal medicine; Disease; Gene","score_opus":0.19200563548559724,"score_gpt":0.43988141626171695,"score_spread":0.24787578077611971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064487427","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018174849,0.9963481,0.00026893392,0.00058219506,0.0003239575,0.000010262665,0.00002437054,0.000013137545,0.0022474383],"genre_scores_gemma":[0.0008081195,0.99705315,0.00039414357,0.00041832487,0.00023296646,0.0000110761575,0.000034521894,0.0000026413363,0.0010451009],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998091,0.00003341628,0.000024820842,0.000033481323,0.00008209698,0.000017142142],"domain_scores_gemma":[0.9997955,0.0000932454,0.000030110245,0.0000059314457,0.000056587483,0.000018587856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000559731,0.00070171483,0.000964856,0.0019082705,0.00024536502,0.00082142773,0.00059516256,0.0011020578,0.0061071874],"category_scores_gemma":[0.0004212981,0.00021001062,0.00050716475,0.0015093718,0.0003906508,0.0012960476,0.00061700627,0.0021102983,0.003401728],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005876892,0.000095258016,0.00009165741,0.017882343,0.00006595166,0.00028295116,0.00008532182,0.00026047748,0.004575205,0.005412354,0.029489925,0.9416998],"study_design_scores_gemma":[0.000017487373,0.00009356403,0.00034465827,0.0021364472,0.00005728975,0.0010532496,0.00004206035,0.000070399015,0.0005333803,0.0015920158,0.9940474,0.000011977463],"about_ca_topic_score_codex":0.0006077211,"about_ca_topic_score_gemma":0.0014470394,"teacher_disagreement_score":0.0061071874,"about_ca_system_score_codex":0.00048151542,"about_ca_system_score_gemma":0.0006910599,"threshold_uncertainty_score":0.020430565},"labels":[],"label_agreement":null},{"id":"W2067891932","doi":"10.1517/14712598.2013.849690","title":"Stem cells as a potential therapy for necrotizing enterocolitis","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Infant Nutrition and Health","field":"Nursing","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Necrotizing enterocolitis; Stem cell; Medicine; Disease; Stem-cell therapy; Enterocolitis; Mesenchymal stem cell; Intensive care medicine; Clinical trial; Cell therapy; Bioinformatics; Immunology; Internal medicine; Pathology; Biology","score_opus":0.21931025229118914,"score_gpt":0.432077471521882,"score_spread":0.21276721923069283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067891932","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009159657,0.9985201,0.00008747361,0.00037275613,0.00031111116,0.000004506228,0.000010554002,0.0000035543933,0.00059842836],"genre_scores_gemma":[0.000618397,0.9984017,0.00013954223,0.0002509507,0.00017149458,0.000007761078,0.00002041662,9.368511e-7,0.0003888614],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997856,0.000040092553,0.000028230623,0.00003243071,0.00009825735,0.000015462068],"domain_scores_gemma":[0.9997154,0.0001363686,0.000043760538,0.000005446905,0.00007976469,0.000019268571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005515242,0.0006667341,0.0010849398,0.0014934842,0.00017263854,0.0006349334,0.0007033505,0.0012339337,0.004136303],"category_scores_gemma":[0.0006769655,0.00015018972,0.0004636945,0.0012402672,0.0003474352,0.00071188237,0.0005034332,0.0016678126,0.0018698846],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060569466,0.000045630324,0.000083269595,0.019309234,0.000081046106,0.00017389815,0.000049188555,0.00024338736,0.0017659168,0.0023980625,0.027718509,0.9480711],"study_design_scores_gemma":[0.00004082473,0.00015220192,0.0005952516,0.010044302,0.00015534331,0.0012883622,0.00008086558,0.00010781374,0.0007760739,0.0017526471,0.98498833,0.000017958404],"about_ca_topic_score_codex":0.00076455896,"about_ca_topic_score_gemma":0.001470663,"teacher_disagreement_score":0.004136303,"about_ca_system_score_codex":0.0004044907,"about_ca_system_score_gemma":0.00059267913,"threshold_uncertainty_score":0.013837278},"labels":[],"label_agreement":null},{"id":"W2073735031","doi":"10.1517/14712598.7.11.1621","title":"Stem cell therapy for joint problems using the horse as a clinically relevant animal model","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Osteoarthritis; Stem cell; Articular cartilage; Joint disease; Cartilage; Medicine; Clinical trial; Stem-cell therapy; Animal model; Disease; Pathology; Bioinformatics; Biology; Internal medicine; Mesenchymal stem cell; Anatomy; Alternative medicine","score_opus":0.41343770787066864,"score_gpt":0.45639515892740135,"score_spread":0.04295745105673271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073735031","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003768635,0.9943204,0.0010337401,0.00059954316,0.0003920495,0.000027705835,0.00002484125,0.000018748728,0.0032061362],"genre_scores_gemma":[0.001809052,0.99433374,0.0010431918,0.0003418659,0.00018246015,0.00003354815,0.000045840323,0.0000034007937,0.002206863],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998098,0.000035795663,0.000019915004,0.000025323254,0.00009662461,0.000012521092],"domain_scores_gemma":[0.99983144,0.000076687946,0.000027429282,0.000007650091,0.000042066713,0.000014715141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007711091,0.0009102967,0.001421405,0.0016555547,0.00025122246,0.0006626188,0.00092850067,0.0015206692,0.006027483],"category_scores_gemma":[0.00039795198,0.00014463272,0.00040443387,0.0010982193,0.0005826159,0.0009326111,0.00037371903,0.001214132,0.003677293],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007983756,0.00016164925,0.00011925353,0.01496011,0.00007825686,0.0006884716,0.00008534092,0.0005226063,0.014304896,0.00503865,0.028519087,0.9354419],"study_design_scores_gemma":[0.00004644141,0.00023813188,0.00063309877,0.0025513736,0.000081418104,0.0025737847,0.00010052893,0.00015798507,0.0031622564,0.0025960116,0.98783594,0.000023017543],"about_ca_topic_score_codex":0.00079656637,"about_ca_topic_score_gemma":0.0016275157,"teacher_disagreement_score":0.006027483,"about_ca_system_score_codex":0.00041271135,"about_ca_system_score_gemma":0.000673737,"threshold_uncertainty_score":0.020163953},"labels":[],"label_agreement":null},{"id":"W2079056967","doi":"10.1517/14712598.2013.825243","title":"Monoclonal versus polyclonal anti-D in the treatment of ITP","year":2013,"lang":"en","type":"editorial","venue":"Expert Opinion on Biological Therapy","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services","funders":"","keywords":"Polyclonal antibodies; Monoclonal antibody; Medicine; Platelet; Immunology; Monoclonal; Antibody; Immune thrombocytopenia; Antigen","score_opus":0.09213275429221066,"score_gpt":0.3777085335788159,"score_spread":0.28557577928660527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079056967","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036333816,0.24596974,0.00039079392,0.05439878,0.6938685,0.000060199298,0.000084580024,0.00009236807,0.0047717653],"genre_scores_gemma":[0.0029216853,0.18572606,0.00054965675,0.07009755,0.726015,0.000066575485,0.000109501874,0.00003970766,0.014474248],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990453,0.00020103813,0.00017031094,0.000106352665,0.0004079602,0.000069067595],"domain_scores_gemma":[0.9979336,0.00090281,0.00019277762,0.000042032214,0.000695271,0.00023359597],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023743096,0.0012085509,0.0018597399,0.0009969306,0.00064580556,0.0018673721,0.0019877998,0.007320172,0.004613856],"category_scores_gemma":[0.004511784,0.0003997047,0.001105909,0.00066509895,0.0010512227,0.0017237115,0.00058596535,0.0105654225,0.0040109144],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021574565,0.000056814068,0.00004537494,0.0019169574,0.000063547406,0.00030451806,0.000022530556,0.00006511206,0.00048357007,0.0010882667,0.92545384,0.0702837],"study_design_scores_gemma":[0.00017029275,0.000101812686,0.00023690902,0.0008439594,0.00008434421,0.0005210525,0.000022183107,0.000121627665,0.0002662718,0.0007532099,0.99686486,0.000013397372],"about_ca_topic_score_codex":0.0005706528,"about_ca_topic_score_gemma":0.0016508775,"teacher_disagreement_score":0.007320172,"about_ca_system_score_codex":0.0014491251,"about_ca_system_score_gemma":0.0008040671,"threshold_uncertainty_score":0.015434861},"labels":[],"label_agreement":null},{"id":"W2080115034","doi":"10.1517/14712598.1.5.881","title":"Theratope® vaccine (STn-KLH)","year":2001,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Glycosylation and Glycoproteins Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Keyhole limpet hemocyanin; Immunotherapy; Immunostimulant; Vaccination; Immunology; Oncology; Clinical trial; Cancer vaccine; Breast cancer; Cancer; Cyclophosphamide; Immune system; Antigen; Internal medicine; Cancer immunotherapy; Chemotherapy","score_opus":0.17855899932676764,"score_gpt":0.43677442727424215,"score_spread":0.25821542794747454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080115034","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79418546,0.09229781,0.041541778,0.0033873268,0.00243268,0.0019675978,0.0031496861,0.0023948436,0.058642898],"genre_scores_gemma":[0.8654586,0.039041724,0.02146746,0.0013641221,0.0005031777,0.0010334998,0.0055621588,0.000131982,0.065437324],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99986744,0.000019922345,0.000004985923,0.000029102373,0.000060491428,0.000018006116],"domain_scores_gemma":[0.9999478,0.000007801139,0.000016646143,0.0000051341767,0.000006351736,0.000016289949],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020762143,0.00043458352,0.00037696387,0.00034375573,0.00012208876,0.00027435579,0.0002753626,0.0004986445,0.0061263163],"category_scores_gemma":[0.00014749095,0.00008888729,0.00026893246,0.00018701832,0.0002056322,0.0002922924,0.00035461277,0.0007118149,0.002201003],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021341632,0.0018009784,0.0010149317,0.0013364649,0.00006953933,0.00043216348,0.00007048013,0.0015866379,0.5212868,0.0029821016,0.013452709,0.4538331],"study_design_scores_gemma":[0.004319638,0.034598142,0.0072804373,0.0003883633,0.0002437312,0.0068616746,0.00007175231,0.0041412916,0.4188547,0.0018621208,0.5213302,0.000047816764],"about_ca_topic_score_codex":0.00028679473,"about_ca_topic_score_gemma":0.0004347422,"teacher_disagreement_score":0.0061263163,"about_ca_system_score_codex":0.00030155818,"about_ca_system_score_gemma":0.00035125285,"threshold_uncertainty_score":0.02049458},"labels":[],"label_agreement":null},{"id":"W2084040310","doi":"10.1517/14712598.1.2.205","title":"In utero stem cell transplantation: two steps forward but one step back?","year":2001,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"In utero; Transplantation; Stem cell; Haematopoiesis; Genetic enhancement; Medicine; Immunology; Hematopoietic stem cell transplantation; Pathological; Immune system; Fetus; Bioinformatics; Biology; Internal medicine; Pregnancy; Gene; Genetics","score_opus":0.29569321843290425,"score_gpt":0.4462934717339949,"score_spread":0.15060025330109067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084040310","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044256623,0.9806425,0.0010732767,0.013103624,0.0018698368,0.000009709247,0.00001391129,0.000020058811,0.0028244734],"genre_scores_gemma":[0.002422795,0.98727185,0.0017958946,0.003985497,0.0013151971,0.00001543706,0.000017106084,0.0000064189435,0.0031698546],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99965894,0.000099979596,0.000037861577,0.00004568015,0.00012074964,0.000036805563],"domain_scores_gemma":[0.99947315,0.00025529836,0.000056946516,0.000029762683,0.00012007248,0.00006477424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017578454,0.0008329751,0.0020284797,0.00073136255,0.00033820086,0.0016392854,0.0012752247,0.0031344825,0.005061074],"category_scores_gemma":[0.0010686971,0.00022681682,0.00046846003,0.00078157906,0.0015625353,0.003980761,0.0006404085,0.0038175213,0.0041296063],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019002988,0.00014571416,0.00041217363,0.007857044,0.00009161156,0.0016277184,0.00018923254,0.00030045837,0.0062776585,0.022179825,0.04784402,0.9128846],"study_design_scores_gemma":[0.00007504116,0.00036122955,0.00079359475,0.0036162992,0.00010195042,0.007076647,0.0007157299,0.00018508077,0.0024465113,0.023124082,0.9614457,0.00005812129],"about_ca_topic_score_codex":0.00086694525,"about_ca_topic_score_gemma":0.0022906088,"teacher_disagreement_score":0.005061074,"about_ca_system_score_codex":0.0006605003,"about_ca_system_score_gemma":0.0011966405,"threshold_uncertainty_score":0.016930938},"labels":[],"label_agreement":null},{"id":"W2086624612","doi":"10.1517/14712598.8.2.191","title":"Antigen-specific therapy of rheumatoid arthritis","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Western University","funders":"Newcastle University","keywords":"Immunotherapy; Immunology; Medicine; Immune system; Antigen; Autoimmunity; Rheumatoid arthritis","score_opus":0.18537649515428006,"score_gpt":0.39376500467670594,"score_spread":0.20838850952242588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086624612","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018789801,0.99758494,0.00021216879,0.00026919018,0.00032623467,0.00000937638,0.00001121658,0.00000952608,0.0013893418],"genre_scores_gemma":[0.0014718716,0.9965587,0.00031897478,0.0003162155,0.00030675504,0.000013764742,0.000036342786,0.0000015598441,0.0009757989],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976355,0.000049593742,0.00002157962,0.000033890246,0.00011066773,0.000020629139],"domain_scores_gemma":[0.99982697,0.000055557,0.000040577703,0.0000080679965,0.000049905855,0.000018947745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000629957,0.00084690214,0.0014182343,0.0016240072,0.0002174596,0.000528359,0.0008677304,0.0010491058,0.0034286247],"category_scores_gemma":[0.00037760695,0.0001762934,0.00038976507,0.0012486278,0.00041110383,0.00063265435,0.00038813584,0.0012405632,0.0039271167],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009984363,0.00009205327,0.000093566145,0.010036966,0.0000719292,0.00026932955,0.00003273832,0.0002236454,0.00519522,0.0021394242,0.022299761,0.95944554],"study_design_scores_gemma":[0.00008032412,0.00022553555,0.00074725936,0.0023264266,0.00010415234,0.0023903889,0.000039967177,0.000107375105,0.0017985367,0.0020416246,0.9901204,0.000017889995],"about_ca_topic_score_codex":0.00058875605,"about_ca_topic_score_gemma":0.0009923078,"teacher_disagreement_score":0.0034286247,"about_ca_system_score_codex":0.0004356659,"about_ca_system_score_gemma":0.00053156895,"threshold_uncertainty_score":0.01146996},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W2087733415","doi":"10.1517/14712598.2011.592490","title":"Emepepimut-S for non-small cell lung cancer","year":2011,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"vaccines and immunoinformatics approaches","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Immunotherapy; Medicine; MUC1; Clinical trial; Lung cancer; Oncology; Cancer; Cancer vaccine; Immune system; Drug; Cancer immunotherapy; Internal medicine; Immunology; Pharmacology","score_opus":0.08542551647419659,"score_gpt":0.31445524941100444,"score_spread":0.22902973293680784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087733415","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018208697,0.91647595,0.0040873196,0.016935816,0.002227633,0.00027348628,0.0010834566,0.00018250509,0.040525187],"genre_scores_gemma":[0.1490999,0.77990514,0.008680194,0.015303431,0.0030590026,0.0003601412,0.0031888594,0.00004457028,0.04035877],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999107,0.000023120032,0.0000106747275,0.000014382263,0.000030446348,0.000010614874],"domain_scores_gemma":[0.99989665,0.000037923674,0.000029281538,0.000003741287,0.000018092227,0.000014225461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031737352,0.00022396875,0.0003142773,0.0005128972,0.00011308191,0.00025902584,0.00022724153,0.0005420948,0.011834375],"category_scores_gemma":[0.00029726443,0.000045223303,0.0003242927,0.00038801745,0.00014820967,0.0003666418,0.00021278446,0.00046929627,0.0026865797],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007465941,0.00011006457,0.0005615887,0.0064199613,0.000100764824,0.0008126732,0.000023478884,0.00032142168,0.016429849,0.004703394,0.044196576,0.9255737],"study_design_scores_gemma":[0.00059966726,0.0016265009,0.0040329173,0.0017182163,0.00023906566,0.006364226,0.000037125104,0.00048550495,0.012335644,0.005103877,0.9674366,0.000020606418],"about_ca_topic_score_codex":0.00019870301,"about_ca_topic_score_gemma":0.0005976178,"teacher_disagreement_score":0.011834375,"about_ca_system_score_codex":0.00033281936,"about_ca_system_score_gemma":0.00039156686,"threshold_uncertainty_score":0.03958994},"labels":[],"label_agreement":null},{"id":"W2088888314","doi":"10.1517/14712598.4.12.1871","title":"Myoblast transplantation for inherited myopathies: a clinical approach","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"","keywords":"Transplantation; Myocyte; Immunosuppression; Medicine; Cell; Immunology; Cancer research; Bioinformatics; Biology; Internal medicine; Genetics","score_opus":0.19767963522054371,"score_gpt":0.44143888833381967,"score_spread":0.24375925311327595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088888314","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004081938,0.9925343,0.00087621866,0.0013461953,0.00059223926,0.000027187136,0.000021044021,0.000027139882,0.004167482],"genre_scores_gemma":[0.0018868196,0.99154246,0.0011781286,0.0011364019,0.000493998,0.000042539687,0.000051644427,0.0000050058907,0.0036630116],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983144,0.00002937828,0.000014731963,0.000029176997,0.00007919007,0.00001607062],"domain_scores_gemma":[0.99988174,0.000038719896,0.000015479536,0.000006379666,0.00003411754,0.000023533683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007376493,0.0011398678,0.0013904771,0.001282389,0.00028903683,0.0009780704,0.0011290675,0.0022935278,0.0064979],"category_scores_gemma":[0.0003014872,0.00022686204,0.00038556394,0.0009207333,0.0006144169,0.0012429304,0.0005716558,0.0019583288,0.006290173],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012996997,0.00017729416,0.00011793318,0.005008644,0.00005348311,0.00085653644,0.000045389224,0.0002629846,0.0077029713,0.0037243732,0.02871359,0.95320696],"study_design_scores_gemma":[0.0001464615,0.00036742023,0.0008918572,0.0020169232,0.00005420353,0.0046237605,0.000056721015,0.00012991906,0.0017862329,0.002568267,0.9873378,0.00002042833],"about_ca_topic_score_codex":0.00051849766,"about_ca_topic_score_gemma":0.001065959,"teacher_disagreement_score":0.0064979,"about_ca_system_score_codex":0.00060630275,"about_ca_system_score_gemma":0.0006558373,"threshold_uncertainty_score":0.021737635},"labels":[],"label_agreement":null},{"id":"W2090149045","doi":"10.1517/14728220802517935","title":"Trastuzumab cardiotoxicity: biological hypotheses and clinical open issues","year":2008,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Chemotherapy-induced cardiotoxicity and mitigation","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Trastuzumab; Cardiotoxicity; Medicine; Anthracycline; Oncology; Internal medicine; Breast cancer; Toxicity; Clinical trial; Adjuvant; Metastatic breast cancer; Cancer; Disease; Pharmacology","score_opus":0.35025699814929895,"score_gpt":0.44328700576051006,"score_spread":0.09303000761121111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090149045","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032101883,0.970998,0.00039803426,0.025589902,0.0018031085,0.0000098970095,0.000050149985,0.000007134282,0.00082273624],"genre_scores_gemma":[0.0069186883,0.9647402,0.00043300132,0.017013684,0.010131658,0.000044913722,0.000097981945,0.000006301877,0.0006135305],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9984993,0.000647032,0.00020830086,0.00024854098,0.0003004336,0.00009646998],"domain_scores_gemma":[0.9905806,0.006732235,0.0010184298,0.00014786966,0.0013068749,0.00021411254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045572147,0.0006840452,0.0026149324,0.0007637994,0.0003337274,0.002114692,0.0019252993,0.0046418305,0.005099615],"category_scores_gemma":[0.0074418113,0.0002532894,0.001215668,0.0008486604,0.0022366224,0.0030514172,0.0008824298,0.0037717854,0.001473701],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072941155,0.00015161607,0.0010990576,0.051296614,0.0007528269,0.0012978327,0.000275712,0.00074709085,0.002206364,0.026477719,0.113165535,0.80180025],"study_design_scores_gemma":[0.0003728493,0.00052543683,0.0023122078,0.033775482,0.0013045386,0.0032266292,0.00069840206,0.00079549896,0.0010030993,0.08171869,0.87417537,0.00009180904],"about_ca_topic_score_codex":0.00046598355,"about_ca_topic_score_gemma":0.0007256389,"teacher_disagreement_score":0.005099615,"about_ca_system_score_codex":0.0011224411,"about_ca_system_score_gemma":0.0021468971,"threshold_uncertainty_score":0.024101079},"labels":[],"label_agreement":null},{"id":"W2096272151","doi":"10.1517/14712598.2012.679652","title":"Stem cells combined with bone graft substitutes in skeletal tissue engineering","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kensington Health","funders":"National Institute for Health and Care Research","keywords":"Mesenchymal stem cell; Stem cell; Induced pluripotent stem cell; Embryonic stem cell; Tissue engineering; Periosteum; Stem cell transplantation for articular cartilage repair; Clinical uses of mesenchymal stem cells; Bone marrow; Adipose tissue; Cell biology; Regenerative medicine; Umbilical cord; Adult stem cell; Biomedical engineering; Medicine; Chemistry; Immunology; Anatomy; Biology; Internal medicine; Biochemistry","score_opus":0.19062535733660024,"score_gpt":0.3929160616133326,"score_spread":0.20229070427673235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096272151","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001436398,0.9979013,0.00024396814,0.00017004326,0.00025706613,0.000008100922,0.0000087414355,0.000004958695,0.0012622005],"genre_scores_gemma":[0.0010213224,0.9971559,0.0003596979,0.00018174775,0.00017473544,0.000011577787,0.000023645254,0.0000023538148,0.0010690083],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99967885,0.000049963128,0.000030746185,0.00004933237,0.00016863296,0.000022509024],"domain_scores_gemma":[0.99979216,0.00008789707,0.000034792673,0.0000055653354,0.00006206399,0.00001753608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008142153,0.0011186353,0.0017298013,0.0024050062,0.00027590498,0.00095777423,0.00087443483,0.0016718531,0.0048052697],"category_scores_gemma":[0.0004419677,0.00035063445,0.00053531677,0.0024163004,0.00074932113,0.0013228989,0.00079634204,0.0016705889,0.0036079786],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006010287,0.00009330014,0.00008913568,0.017507782,0.00007144592,0.00032969026,0.00007263382,0.00046807382,0.008422136,0.0060020764,0.015351261,0.9515323],"study_design_scores_gemma":[0.000024475925,0.0001380308,0.0005441411,0.003648245,0.00008897399,0.0016039364,0.00006743322,0.0001514066,0.0030641498,0.00261898,0.9880238,0.00002624992],"about_ca_topic_score_codex":0.0009072829,"about_ca_topic_score_gemma":0.001550071,"teacher_disagreement_score":0.0048052697,"about_ca_system_score_codex":0.0006475837,"about_ca_system_score_gemma":0.00068318716,"threshold_uncertainty_score":0.016075194},"labels":[],"label_agreement":null},{"id":"W2099780631","doi":"10.1517/14712598.6.7.685","title":"Pertussis immunisation in adolescents and adults –<i>Bordetella pertussis</i>epidemiology should guide vaccination recommendations","year":2006,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bordetella pertussis; Whooping cough; Pediatrics; Vaccination; Booster dose; Pertussis vaccine; Diphtheria; Immunology; Immunization; Immune system","score_opus":0.17963763364229834,"score_gpt":0.4204783383208303,"score_spread":0.24084070467853197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099780631","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010872991,0.07154188,0.012228685,0.7653944,0.03466088,0.0011695387,0.004980646,0.0017039664,0.097447045],"genre_scores_gemma":[0.1346752,0.23971748,0.10724797,0.34599224,0.04291209,0.00430064,0.014370337,0.0010075372,0.10977656],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996527,0.0016916319,0.00051619986,0.0001511809,0.00084354385,0.00027049193],"domain_scores_gemma":[0.98743874,0.002611842,0.0010134056,0.0004338461,0.006271668,0.0022304782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050847363,0.0006860204,0.0009811429,0.0014685644,0.0006316388,0.0016704068,0.0012743991,0.0035118924,0.0071653323],"category_scores_gemma":[0.026226632,0.00043769958,0.00089909165,0.000636911,0.0005580792,0.0016037296,0.0011460918,0.005826342,0.0074082473],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008591931,0.000195872,0.008153962,0.0011138637,0.000045320056,0.00031654147,0.00043476207,0.0002509945,0.00043436422,0.0019002989,0.78777415,0.19929391],"study_design_scores_gemma":[0.00010168834,0.00022763654,0.034280825,0.008903059,0.000108807326,0.0007266503,0.0008489928,0.00039743702,0.0004171745,0.0046547195,0.9492754,0.00005753605],"about_ca_topic_score_codex":0.015857963,"about_ca_topic_score_gemma":0.020314913,"teacher_disagreement_score":0.015857963,"about_ca_system_score_codex":0.0011148985,"about_ca_system_score_gemma":0.0051758788,"threshold_uncertainty_score":0.031531334},"labels":[],"label_agreement":null},{"id":"W2103654989","doi":"10.1517/14712598.2012.721765","title":"Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Spasticity; Multiple sclerosis; Medicine; Urinary system; Internal medicine; Physical therapy; Psychiatry","score_opus":0.262619153442457,"score_gpt":0.41079029027563396,"score_spread":0.14817113683317695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103654989","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033423202,0.99004716,0.00026441464,0.002463872,0.0007308783,0.000022575477,0.000095211966,0.000019816203,0.0030138597],"genre_scores_gemma":[0.03210033,0.9581477,0.0006066835,0.0042587626,0.0014900997,0.000040345192,0.00015133552,0.000007577095,0.0031972004],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981445,0.00005338372,0.000027401782,0.000026220301,0.000059611517,0.000018943008],"domain_scores_gemma":[0.99976856,0.000098111384,0.00006454318,0.000002939393,0.00005374743,0.00001207559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037906895,0.0002492665,0.0005385941,0.00051534816,0.00012448421,0.0003339422,0.0003870929,0.00067044154,0.0037705132],"category_scores_gemma":[0.00062459824,0.00005676596,0.00040660857,0.00033387568,0.00019292856,0.00028819262,0.0002129446,0.0006880541,0.0007372202],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012395136,0.00010719676,0.00042463056,0.035281107,0.0003124123,0.0006992427,0.00015124102,0.00030628484,0.009163108,0.0017233569,0.033740886,0.9168511],"study_design_scores_gemma":[0.00079281395,0.0022037223,0.007081328,0.023459168,0.0011397462,0.0059540975,0.00032833286,0.0004967505,0.007939486,0.0025562174,0.9479865,0.00006191143],"about_ca_topic_score_codex":0.0006970682,"about_ca_topic_score_gemma":0.002225801,"teacher_disagreement_score":0.0037705132,"about_ca_system_score_codex":0.0002618643,"about_ca_system_score_gemma":0.0003408351,"threshold_uncertainty_score":0.0126135945},"labels":[],"label_agreement":null},{"id":"W2103930742","doi":"10.1517/14712598.3.8.1295","title":"World Conference on Lung Cancer","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Ferroptosis and cancer prognosis","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; International agency; Medicine; Cancer; Family medicine; Agency (philosophy); Gerontology; Library science; Oncology; Internal medicine; Sociology; Social science","score_opus":0.2072470305878788,"score_gpt":0.40351943176139266,"score_spread":0.19627240117351386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103930742","genre_codex":"other","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012860638,0.15827231,0.0014622238,0.14099427,0.3012768,0.00038957453,0.0034289085,0.00041994132,0.39247003],"genre_scores_gemma":[0.009752297,0.09314224,0.0013850587,0.037111353,0.110284455,0.0005298979,0.0051174117,0.00025295894,0.7424243],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99875665,0.0002076874,0.000080534475,0.00018942298,0.0005664093,0.00019944302],"domain_scores_gemma":[0.9980526,0.00013650634,0.00013034348,0.00007888824,0.00084522896,0.00075643527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015525785,0.0013280615,0.00075983023,0.0014761293,0.0009256287,0.0035010357,0.0011956305,0.0029848858,0.12680145],"category_scores_gemma":[0.003186039,0.00020910986,0.0009751084,0.0009092686,0.00052130874,0.001317407,0.0018290309,0.003818359,0.09300483],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036000132,0.000015017136,0.00015114041,0.0001511009,0.000008784231,0.00007112056,0.000012868085,0.000023185912,0.00017094843,0.0008069205,0.95930445,0.03924846],"study_design_scores_gemma":[0.000005662921,0.000010891358,0.0003990449,0.000110768975,0.0000041168346,0.00009915224,0.000011879329,0.000011804454,0.0000356379,0.00026856133,0.99904007,0.000002399552],"about_ca_topic_score_codex":0.0033253313,"about_ca_topic_score_gemma":0.007937907,"teacher_disagreement_score":0.12680145,"about_ca_system_score_codex":0.0021768368,"about_ca_system_score_gemma":0.0031589633,"threshold_uncertainty_score":0.42419308},"labels":[],"label_agreement":null},{"id":"W2104334055","doi":"10.1517/14712598.6.1.23","title":"Pancreatic islet transplantation for treating diabetes","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transplantation; Islet; Immunosuppression; Medicine; Diabetes mellitus; Pancreas transplantation; Islet cell transplantation; Type 1 diabetes; Kidney transplantation; Internal medicine; Intensive care medicine; Endocrinology","score_opus":0.1532808932183194,"score_gpt":0.4049886632638141,"score_spread":0.2517077700454947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104334055","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001121432,0.9946849,0.00030043034,0.0005754304,0.00068132847,0.000011473381,0.000011128424,0.000010981909,0.003612314],"genre_scores_gemma":[0.0009160405,0.9956489,0.00037495152,0.0006459099,0.0005203448,0.0000115218,0.000030101894,0.0000026055004,0.001849581],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997422,0.000053581014,0.000021990087,0.000038365844,0.00012122598,0.000022642022],"domain_scores_gemma":[0.99983203,0.00005957085,0.000027967759,0.000010610951,0.000044491582,0.00002533853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007497475,0.0010663591,0.0015186794,0.0020108053,0.000337298,0.0009486407,0.00082030956,0.0013886641,0.008137076],"category_scores_gemma":[0.0004913597,0.00017875488,0.0005496612,0.0018103833,0.0005453263,0.0012358952,0.0007072779,0.0021700396,0.0068287724],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008838746,0.000106092164,0.000104348896,0.007866242,0.00007135004,0.00050351,0.000051368523,0.00022331392,0.0033436595,0.0032272246,0.05420092,0.93021363],"study_design_scores_gemma":[0.000052347426,0.000090727546,0.00040308724,0.0021143546,0.00006210295,0.0023944604,0.000037520527,0.00005215289,0.0007308175,0.0021150846,0.99193513,0.000012208124],"about_ca_topic_score_codex":0.00064171816,"about_ca_topic_score_gemma":0.0010385381,"teacher_disagreement_score":0.008137076,"about_ca_system_score_codex":0.00048775805,"about_ca_system_score_gemma":0.0007506805,"threshold_uncertainty_score":0.027221262},"labels":[],"label_agreement":null},{"id":"W2105558584","doi":"10.1517/14712598.5.10.1281","title":"Live bacterial cells as orally delivered therapeutics","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Infant Nutrition and Health","field":"Nursing","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Immune system; Medicine; Immunology; Biology; Probiotic; Intensive care medicine; Bacteria","score_opus":0.23554789703954135,"score_gpt":0.44540556594411856,"score_spread":0.20985766890457722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105558584","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00065953814,0.99534804,0.0009037367,0.00015297504,0.00025447656,0.0000102526965,0.0000073597953,0.000011678769,0.0026520153],"genre_scores_gemma":[0.0034279814,0.9914324,0.0012480987,0.00016067966,0.00013376417,0.00002362535,0.000021610298,0.0000042505094,0.0035476207],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997261,0.000057476922,0.00001908902,0.000040205334,0.00013666615,0.000020459483],"domain_scores_gemma":[0.9998996,0.000044824712,0.000018015817,0.0000048067723,0.000022774451,0.000009949811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005842884,0.0008868623,0.0013602419,0.0014031823,0.00022374593,0.000839878,0.00074353564,0.0014179932,0.0029105367],"category_scores_gemma":[0.00028628687,0.00026573832,0.0003547967,0.00087525,0.0005653724,0.0009627619,0.00062184304,0.001350511,0.0029453477],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108871674,0.00017332131,0.000118998454,0.011088334,0.00004119401,0.0005418531,0.00020360498,0.0006511573,0.055019267,0.008375303,0.008451068,0.91522706],"study_design_scores_gemma":[0.00003719926,0.00039486313,0.00049390056,0.0022044773,0.000061155,0.0017426681,0.000102956314,0.00023272788,0.016770357,0.0022901369,0.97564334,0.000026133017],"about_ca_topic_score_codex":0.0006683188,"about_ca_topic_score_gemma":0.0011043887,"teacher_disagreement_score":0.0029105367,"about_ca_system_score_codex":0.0006371214,"about_ca_system_score_gemma":0.0004696547,"threshold_uncertainty_score":0.009736657},"labels":[],"label_agreement":null},{"id":"W2106522681","doi":"10.1517/14712598.2013.812629","title":"Quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine (MenACWY-TT): a review","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reactogenicity; Toxoid; Tetanus; Conjugate vaccine; Medicine; Immunogenicity; Neisseria meningitidis; Vaccination; Meningococcal disease; Meningococcal vaccine; Immunology; Pediatrics; Immunization; Virology; Antigen; Biology","score_opus":0.13174182670930829,"score_gpt":0.3786822260094649,"score_spread":0.2469403993001566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106522681","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000949863,0.9980698,0.00010741793,0.00071119104,0.00029995662,0.00000913142,0.000038689454,0.000005567077,0.0006632352],"genre_scores_gemma":[0.00056642306,0.99836713,0.00014200268,0.00040877526,0.00014893537,0.000011958184,0.000037573824,0.000001074944,0.00031621705],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972683,0.000059042006,0.000041210536,0.000049091625,0.00010170944,0.000022067416],"domain_scores_gemma":[0.9992143,0.00041952197,0.0001385164,0.000009964748,0.00018591949,0.00003174277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007366152,0.0006743823,0.0010866502,0.0014544417,0.00016585254,0.00091766584,0.0007795744,0.0012076274,0.003591063],"category_scores_gemma":[0.0014813966,0.00020283934,0.00072273373,0.0013329249,0.00029622472,0.0009579495,0.00040250804,0.0011221082,0.0014148557],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010527743,0.00005430807,0.0001921221,0.06578898,0.00021211249,0.00012769013,0.00007557876,0.00034380253,0.0010499754,0.002114214,0.05073336,0.87920254],"study_design_scores_gemma":[0.000029192293,0.00013213283,0.00069584366,0.030589815,0.0004575438,0.00064188265,0.00007391396,0.00010960611,0.00037173877,0.0014107124,0.96547,0.00001763615],"about_ca_topic_score_codex":0.0011760376,"about_ca_topic_score_gemma":0.0015415392,"teacher_disagreement_score":0.003591063,"about_ca_system_score_codex":0.00053160894,"about_ca_system_score_gemma":0.0014103148,"threshold_uncertainty_score":0.012013316},"labels":[],"label_agreement":null},{"id":"W2110077613","doi":"10.1517/14712598.2011.536530","title":"Immune monitoring of pancreatic islet graft: towards a better understanding, detection and treatment of harmful events","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Islet; Transplantation; Immune system; Autoimmunity; Immunology; Medicine; Transplant rejection; Intensive care medicine; Diabetes mellitus; Internal medicine; Endocrinology","score_opus":0.2188828599284303,"score_gpt":0.39258257992319356,"score_spread":0.17369971999476327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110077613","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020098199,0.99703145,0.00045430294,0.0012663995,0.00040505617,0.0000059040685,0.0000059963636,0.000008129616,0.0006217505],"genre_scores_gemma":[0.0012762554,0.9961732,0.0007986785,0.00065089663,0.0006089231,0.000009428298,0.000013844394,0.0000020951602,0.00046669744],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99943346,0.0001577353,0.00006827168,0.00005955494,0.00024713454,0.000033828368],"domain_scores_gemma":[0.99920255,0.00033101204,0.000116261544,0.000024125095,0.00026831953,0.00005768541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015322807,0.00083575345,0.0018418763,0.0013702563,0.00017473417,0.0009770157,0.0009381688,0.0018069097,0.0019010776],"category_scores_gemma":[0.0012810328,0.00022399545,0.0005054804,0.0010348827,0.00067280856,0.0018337955,0.00051731756,0.0023041647,0.0022132432],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011821496,0.00012394115,0.00044898767,0.012862879,0.00010254144,0.00033575247,0.00006325817,0.0004183236,0.0048532933,0.002406158,0.02377598,0.9544908],"study_design_scores_gemma":[0.00009858477,0.00042009653,0.00461145,0.0076623927,0.00029411155,0.005444005,0.00024805253,0.00058287516,0.0041381475,0.0058177775,0.97062206,0.00006048712],"about_ca_topic_score_codex":0.0007914305,"about_ca_topic_score_gemma":0.000859678,"teacher_disagreement_score":0.0019010776,"about_ca_system_score_codex":0.0007171599,"about_ca_system_score_gemma":0.0011554175,"threshold_uncertainty_score":0.008103609},"labels":[],"label_agreement":null},{"id":"W2110517597","doi":"10.1517/14712598.2010.528387","title":"Nanoscaffold based stem cell regeneration therapy: recent advancement and future potential","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Electrospun Nanofibers in Biomedical Applications","field":"Materials Science","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Stem cell; Regeneration (biology); Stem-cell therapy; Medicine; Biology; Cell biology","score_opus":0.06386919091040937,"score_gpt":0.34084808727388083,"score_spread":0.27697889636347145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110517597","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005422892,0.99712366,0.00048723276,0.00056050526,0.00017039706,0.0000040940577,0.000007827574,0.000007385043,0.0010966539],"genre_scores_gemma":[0.0025669283,0.9950197,0.00068425894,0.00028069736,0.00020712391,0.000007622893,0.000014521191,0.0000022173056,0.0012169727],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99988854,0.000014597717,0.00001086731,0.000019345674,0.00005333877,0.000013389678],"domain_scores_gemma":[0.99980015,0.00008994111,0.000024733665,0.0000041432613,0.00005891427,0.000022119835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006660599,0.00043878073,0.0005938881,0.00072239566,0.00016851613,0.0005069625,0.00043948082,0.0010662397,0.0021867652],"category_scores_gemma":[0.00034729764,0.00012372258,0.0002635256,0.0007324583,0.00039481116,0.0010269657,0.00035565233,0.0008455617,0.0012051006],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009711177,0.00010513823,0.00017346881,0.010548443,0.00004121598,0.0003064736,0.00010526203,0.00058257533,0.02103018,0.0051729656,0.01223597,0.9496013],"study_design_scores_gemma":[0.000028899487,0.00030292425,0.0010696116,0.0018895122,0.00007234487,0.002100276,0.0001595381,0.00045772226,0.011225565,0.0037803655,0.9788841,0.0000291179],"about_ca_topic_score_codex":0.00053279445,"about_ca_topic_score_gemma":0.0013082611,"teacher_disagreement_score":0.0021867652,"about_ca_system_score_codex":0.0004459656,"about_ca_system_score_gemma":0.0006280997,"threshold_uncertainty_score":0.0073155165},"labels":[],"label_agreement":null},{"id":"W2111021925","doi":"10.1517/14712598.5.1.97","title":"Progress in prion vaccines and immunotherapies","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Prion Diseases and Protein Misfolding","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; University of Toronto","funders":"","keywords":"Epitope; Gene isoform; Virology; Antibody; Prion protein; Immunotherapy; Biology; Immunology; Computational biology; Immune system; Medicine; Disease; Genetics","score_opus":0.08530481527831522,"score_gpt":0.39987048508160705,"score_spread":0.3145656698032918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111021925","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020749166,0.9967445,0.00061766297,0.00059023337,0.00042628212,0.000008248037,0.00000889008,0.000015765205,0.0013809986],"genre_scores_gemma":[0.0012259318,0.9959573,0.00082117197,0.00050901825,0.00036890307,0.000018092982,0.000027049397,0.0000037680304,0.0010687822],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994972,0.00010818668,0.000038962397,0.00007763213,0.0002308121,0.00004720916],"domain_scores_gemma":[0.99968374,0.00013565997,0.0000389091,0.000017210885,0.00008711199,0.000037458114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015789985,0.0011779026,0.0019780048,0.0018104214,0.00031688492,0.0012820953,0.0013467002,0.0024799446,0.003248541],"category_scores_gemma":[0.00076002174,0.00036810155,0.0004941014,0.0016050182,0.0008524176,0.0019153339,0.0007953388,0.0027313433,0.0040472145],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010677691,0.00015173858,0.00011365822,0.009252588,0.000064118,0.00036751814,0.00009064743,0.00072264066,0.012752277,0.010820869,0.02744682,0.93811035],"study_design_scores_gemma":[0.00004065112,0.00014900464,0.00033448637,0.0015913214,0.00004227693,0.0010400094,0.000042805146,0.00016936612,0.0024136615,0.0052971733,0.9888598,0.00001956513],"about_ca_topic_score_codex":0.0007773182,"about_ca_topic_score_gemma":0.0009448018,"teacher_disagreement_score":0.003248541,"about_ca_system_score_codex":0.0010280845,"about_ca_system_score_gemma":0.0009360375,"threshold_uncertainty_score":0.010867476},"labels":[],"label_agreement":null},{"id":"W2111772750","doi":"10.1517/14712598.7.9.1415","title":"Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Oncolytic virus; Myxoma virus; Virotherapy; Vaccinia; Tropism; Virus; Virology; Tissue tropism; Cancer; Biology; Cancer research; Immunology; Gene","score_opus":0.20941624472468517,"score_gpt":0.4613797584558881,"score_spread":0.2519635137312029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111772750","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021216972,0.99528307,0.00044117778,0.0010310314,0.00060599006,0.000008534081,0.000010091737,0.000013716583,0.0023941058],"genre_scores_gemma":[0.0009088204,0.995349,0.0005028153,0.00060294656,0.00038367088,0.000013748662,0.000018701301,0.0000021545059,0.0022180732],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998448,0.00003088625,0.000011925554,0.000026023023,0.00007274051,0.000013701012],"domain_scores_gemma":[0.9998872,0.0000453479,0.00001440526,0.0000050133335,0.00002971975,0.000018283179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004755904,0.00073434925,0.0011017082,0.0014669962,0.00032217745,0.00091038045,0.00077572284,0.0019236798,0.0033917427],"category_scores_gemma":[0.00032191712,0.0002577657,0.00033023424,0.0013649586,0.0007484618,0.001871303,0.0005290643,0.0019453502,0.0029745123],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009531398,0.00010844167,0.0001222259,0.0077733123,0.00004814365,0.0005304099,0.000106752086,0.00056068174,0.009506973,0.013706836,0.055629652,0.91181135],"study_design_scores_gemma":[0.000020637177,0.00007430556,0.00026691862,0.00081976206,0.000016321052,0.0012746204,0.000047837668,0.00008504393,0.000671837,0.0035864962,0.9931244,0.000011761075],"about_ca_topic_score_codex":0.0005788683,"about_ca_topic_score_gemma":0.0012318991,"teacher_disagreement_score":0.0033917427,"about_ca_system_score_codex":0.00079825777,"about_ca_system_score_gemma":0.0008204839,"threshold_uncertainty_score":0.011346519},"labels":[],"label_agreement":null},{"id":"W2116144836","doi":"10.1517/14712598.2011.538677","title":"Immunotherapy for metastatic prostate cancer: where are we at with sipuleucel-T?","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Prostate cancer; Immunotherapy; Cancer; Clinical trial; Oncology; Clinical endpoint; Internal medicine; Cancer vaccine; Immune system; Cancer immunotherapy; Malignancy; Population; Immunology","score_opus":0.11307659179833304,"score_gpt":0.37802113644184104,"score_spread":0.26494454464350803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116144836","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008715878,0.9978998,0.00011055605,0.0011590082,0.0003092344,0.00000424224,0.000008009372,0.0000056352756,0.0004164044],"genre_scores_gemma":[0.00046835354,0.99778557,0.00021973324,0.00073725404,0.0003172123,0.000009151719,0.000013992204,0.0000016697429,0.00044702968],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998276,0.000041956333,0.000021768985,0.000026668966,0.00006262085,0.000019311576],"domain_scores_gemma":[0.99977,0.00008507648,0.00004205554,0.000008702423,0.00006158898,0.000032495245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007670033,0.0006954203,0.0016072118,0.0010594446,0.00023583746,0.0009903904,0.0008286222,0.0016384567,0.0029830092],"category_scores_gemma":[0.0007248134,0.0001932515,0.0005768121,0.0014097119,0.0004706705,0.0024471367,0.00044912123,0.002318704,0.003218982],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012652272,0.00007288991,0.00018291766,0.013022205,0.00008261297,0.00023279859,0.00007724405,0.00019810734,0.0028183344,0.0024791965,0.04064019,0.9400669],"study_design_scores_gemma":[0.00006955869,0.00021929914,0.0009951175,0.0059090983,0.00012412552,0.0026548726,0.00014370045,0.00009666417,0.0007780641,0.0029553832,0.98602504,0.000029058412],"about_ca_topic_score_codex":0.00080127956,"about_ca_topic_score_gemma":0.0013268819,"teacher_disagreement_score":0.0029830092,"about_ca_system_score_codex":0.00060546084,"about_ca_system_score_gemma":0.0009233601,"threshold_uncertainty_score":0.009979129},"labels":[],"label_agreement":null},{"id":"W2116315024","doi":"10.1517/14712598.2013.833601","title":"Improvement of gastrointestinal health status in subjects consuming<i>Lactobacillus reuteri</i>NCIMB 30242 capsules: a<i>post-hoc</i>analysis of a randomized controlled trial","year":2013,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Probiotics and Fermented Foods","field":"Agricultural and Biological Sciences","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre; McGill University; Micropharma (Canada); Université du Québec à Montréal","funders":"","keywords":"Lactobacillus reuteri; Medicine; Diarrhea; Placebo; Internal medicine; Clinical trial; Post-hoc analysis; Randomized controlled trial; Clinical endpoint; Gastroenterology; Double blind; Probiotic; Pathology; Alternative medicine","score_opus":0.03721049144491918,"score_gpt":0.2873916802764125,"score_spread":0.2501811888314933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116315024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921462,0.0034460311,0.00031474483,0.00020703336,0.00028430898,0.002534128,0.00036979734,0.00006880415,0.0006288174],"genre_scores_gemma":[0.99140406,0.0021365837,0.0012298572,0.00034689961,0.00045451394,0.0027410034,0.00051535654,0.000019669045,0.0011518954],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99844736,0.0008827304,0.00015271644,0.00021696732,0.00011621091,0.00018411985],"domain_scores_gemma":[0.9982046,0.00060440664,0.00052762823,0.00013720534,0.00018562571,0.00034052596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002824357,0.0015738575,0.004268283,0.0005348789,0.00047482373,0.0010655163,0.0008657561,0.0016018335,0.0037911406],"category_scores_gemma":[0.0022883683,0.00066173775,0.0027109615,0.00047194192,0.0010801753,0.00066177506,0.0004139985,0.0015947706,0.00047666035],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9864313,0.004522754,0.0004021477,0.0004789981,0.0009057955,0.000015656145,0.000019469899,0.00005319225,0.0024116316,0.000011381153,0.00010880295,0.004638692],"study_design_scores_gemma":[0.7612655,0.22994529,0.0050550494,0.00005112824,0.001906717,0.000018940287,0.000030029412,0.00019403346,0.0012203796,0.000025112415,0.0002712428,0.000016480202],"about_ca_topic_score_codex":0.0009660357,"about_ca_topic_score_gemma":0.0014727006,"teacher_disagreement_score":0.004268283,"about_ca_system_score_codex":0.0006770168,"about_ca_system_score_gemma":0.0011643897,"threshold_uncertainty_score":0.014936805},"labels":[],"label_agreement":null},{"id":"W2117989459","doi":"10.1517/14712598.2012.745507","title":"Oncolytic reovirus type 3 (Dearing) as a novel therapy in head and neck cancer","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Oncolytics Biotech; Cancer Research UK","keywords":"Oncolytic virus; Head and neck cancer; Medicine; Radiation therapy; Combination therapy; Chemotherapy; Cancer; Cancer research; Oncology; Internal medicine","score_opus":0.26031126105683533,"score_gpt":0.4696592634367377,"score_spread":0.20934800237990236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117989459","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0048112543,0.97543675,0.0027471713,0.0072684023,0.0027181387,0.000055866243,0.00014311635,0.00005629791,0.0067630955],"genre_scores_gemma":[0.048298575,0.9340592,0.0029378356,0.005471427,0.0022472641,0.00010719727,0.0003754474,0.00002354587,0.0064795655],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976176,0.00006896569,0.00001351083,0.0000389265,0.00008684522,0.000030048759],"domain_scores_gemma":[0.9997583,0.000099309575,0.00004045826,0.0000075538674,0.00007223272,0.000022171433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007704994,0.00029175976,0.00047306024,0.0003432061,0.00015625433,0.0008478909,0.0004692441,0.0012417507,0.00337685],"category_scores_gemma":[0.00055363204,0.000089815665,0.00050189235,0.00021715628,0.0004010738,0.0008478784,0.0003466369,0.0015431099,0.001099916],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066538993,0.00013186203,0.0007733424,0.01264251,0.00015723155,0.0007812306,0.00017956647,0.0011954705,0.036544394,0.012926573,0.07219142,0.8618111],"study_design_scores_gemma":[0.00012393427,0.0006215796,0.00093941274,0.0021263342,0.00014768174,0.002248696,0.00012388878,0.00059087743,0.010029838,0.0038836594,0.97912836,0.000035748864],"about_ca_topic_score_codex":0.00057650433,"about_ca_topic_score_gemma":0.0015199061,"teacher_disagreement_score":0.00337685,"about_ca_system_score_codex":0.00063817395,"about_ca_system_score_gemma":0.0006479612,"threshold_uncertainty_score":0.0112966895},"labels":[],"label_agreement":null},{"id":"W2118336485","doi":"10.1517/14712598.5.11.1415","title":"Current status of animal-to-human transplantation","year":2005,"lang":"en","type":"editorial","venue":"Expert Opinion on Biological Therapy","topic":"Xenotransplantation and immune response","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Heart, Lung, and Blood Institute; Canadian Institutes of Health Research; National Institutes of Health","keywords":"Xenotransplantation; Transplantation; Organ transplantation; Medicine; Graft rejection; Immunology; Intensive care medicine; Biology; Internal medicine","score_opus":0.08197580101850363,"score_gpt":0.41958958718160244,"score_spread":0.3376137861630988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118336485","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021538362,0.29318753,0.0009616402,0.077729754,0.6216709,0.00002427927,0.000036977533,0.00014179871,0.006031764],"genre_scores_gemma":[0.0024722791,0.30968586,0.00080794026,0.057555094,0.6200013,0.00003816782,0.00006174085,0.00004726532,0.009330333],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973322,0.00066845125,0.000419842,0.00023604563,0.0012020883,0.00014137982],"domain_scores_gemma":[0.98939216,0.005156379,0.0004952811,0.00031915065,0.0034457822,0.0011913019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008640942,0.0013703691,0.0021376854,0.0010467197,0.0010391977,0.003944041,0.0020580334,0.00789449,0.008182568],"category_scores_gemma":[0.01143605,0.0004301977,0.000999208,0.00070795673,0.0020554927,0.0039424454,0.0010741415,0.012411996,0.0047560777],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009166835,0.00004422299,0.000069799615,0.0018090699,0.0000459557,0.00036722198,0.0000497424,0.00008767918,0.00055627915,0.0040576174,0.84761035,0.14521044],"study_design_scores_gemma":[0.000022077067,0.000035581495,0.000111461384,0.00047997295,0.000022469645,0.00041151672,0.000027934286,0.000056019744,0.00009271908,0.0016597485,0.9970728,0.000007613633],"about_ca_topic_score_codex":0.00037358544,"about_ca_topic_score_gemma":0.00079501903,"teacher_disagreement_score":0.008640942,"about_ca_system_score_codex":0.0013522229,"about_ca_system_score_gemma":0.00161832,"threshold_uncertainty_score":0.045698225},"labels":[],"label_agreement":null},{"id":"W2120169125","doi":"10.1517/14712598.3.2.215","title":"Adult stem cell therapy for heart failure","year":2003,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital","funders":"","keywords":"Stem cell; Medicine; Vasculogenesis; Progenitor cell; Stem-cell therapy; Cell therapy; Induced pluripotent stem cell; Bone marrow; Heart failure; Adult stem cell; Endothelial stem cell; Cancer research; Pathology; Immunology; Cardiology; Cell biology; Biology; Mesenchymal stem cell; Embryonic stem cell; In vitro","score_opus":0.25877000713205034,"score_gpt":0.44854271323490535,"score_spread":0.18977270610285502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120169125","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021763048,0.994111,0.0005190067,0.00058391015,0.0007908871,0.000014061621,0.000014125721,0.000015099506,0.0037342194],"genre_scores_gemma":[0.0014189376,0.9930682,0.0006434022,0.0006462809,0.00048394044,0.00002394931,0.000040716386,0.000003150133,0.0036714082],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998305,0.00003425314,0.00001648282,0.00002282356,0.00008304955,0.000012933738],"domain_scores_gemma":[0.9998889,0.0000439791,0.000016437973,0.000005403043,0.000030140296,0.000015152415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005736934,0.0009503351,0.0010393373,0.0016060484,0.00026307272,0.0005332487,0.00079093734,0.0012044613,0.0074594393],"category_scores_gemma":[0.00035045264,0.00013198181,0.00042526974,0.001337466,0.00047430507,0.00082002894,0.0004574081,0.001453988,0.0049124286],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007323153,0.00010818831,0.00009108094,0.0047934344,0.00005637316,0.0004145902,0.000048393114,0.0003107827,0.0028389695,0.0034313437,0.041536104,0.9462976],"study_design_scores_gemma":[0.00005161143,0.00012923454,0.00051544904,0.0012038755,0.000045815195,0.0018995433,0.000030157784,0.00009610172,0.00060547655,0.002531743,0.9928803,0.000010667068],"about_ca_topic_score_codex":0.0006663612,"about_ca_topic_score_gemma":0.0014192591,"teacher_disagreement_score":0.0074594393,"about_ca_system_score_codex":0.0004204051,"about_ca_system_score_gemma":0.00054797105,"threshold_uncertainty_score":0.02495426},"labels":[],"label_agreement":null},{"id":"W2121661128","doi":"10.1517/14712598.8.9.1337","title":"Gene therapy of arthritis and orthopaedic disorders: current experimental approaches in China and in Canada","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Genetic enhancement; Medicine; China; Intensive care medicine; Bioinformatics; Gene; Political science; Biology; Genetics","score_opus":0.12175382309577786,"score_gpt":0.365207489598627,"score_spread":0.2434536665028491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121661128","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000564496,0.99554044,0.00011116852,0.00092242047,0.00012923931,0.000009496372,0.00002048755,0.0000054590005,0.0026968583],"genre_scores_gemma":[0.0021282814,0.99620974,0.00020579847,0.00027551854,0.00005920358,0.0000086121845,0.000021963897,0.0000013378426,0.0010894997],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995771,0.000050706163,0.000044783214,0.00005006784,0.00021026284,0.00006696968],"domain_scores_gemma":[0.9995284,0.000100642654,0.00006795621,0.000011261186,0.00021489157,0.00007695008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015016054,0.0006308053,0.00078756653,0.0022154609,0.0006957113,0.0012182274,0.000736544,0.0012485749,0.0033472995],"category_scores_gemma":[0.0006401227,0.000199808,0.0003754964,0.0050458405,0.001157381,0.0009917798,0.00067920634,0.0007990474,0.0007202039],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001562422,0.000086614666,0.00095987873,0.010764366,0.00004958375,0.00055555266,0.00045288738,0.00053174194,0.004047765,0.0073544784,0.02784199,0.9471989],"study_design_scores_gemma":[0.0000517923,0.00020016165,0.0053441636,0.004253062,0.00011510716,0.0011939644,0.0005487527,0.00016378197,0.0020478596,0.0016536906,0.9843837,0.000044008062],"about_ca_topic_score_codex":0.2125187,"about_ca_topic_score_gemma":0.3344348,"teacher_disagreement_score":0.7874813,"about_ca_system_score_codex":0.006398844,"about_ca_system_score_gemma":0.01780568,"threshold_uncertainty_score":0.42256337},"labels":[],"label_agreement":null},{"id":"W2122440892","doi":"10.1517/14712598.2013.814637","title":"Genomic instability in multiple myeloma: mechanisms and therapeutic implications","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heritage Medical Research Clinic; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Genome instability; Biology; Chromosome instability; Epigenetics; Comparative genomic hybridization; Multiple myeloma; Somatic evolution in cancer; Genetics; Homologous recombination; Computational biology; Genome; Gene; Cancer research; DNA damage; DNA; Chromosome; Immunology","score_opus":0.26650271805668735,"score_gpt":0.4271962167632671,"score_spread":0.16069349870657973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122440892","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009036125,0.9979709,0.00009841566,0.0008230025,0.00026113502,0.0000032480837,0.000015881844,0.0000068827603,0.0007301825],"genre_scores_gemma":[0.0006718896,0.99802566,0.00013126094,0.00038037868,0.00024248238,0.000005732711,0.000027228922,0.0000011290995,0.00051419216],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998048,0.0000368566,0.000017901266,0.000032287986,0.00008669934,0.000021548594],"domain_scores_gemma":[0.9997887,0.00007094905,0.00003980413,0.0000051275274,0.000073872776,0.000021575845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053607504,0.0007353121,0.0012908764,0.0012613541,0.00024581907,0.00074387545,0.0008781909,0.0014285621,0.0038862259],"category_scores_gemma":[0.0005392383,0.00018507904,0.00047675695,0.0013114635,0.00045985178,0.0008964647,0.00056443125,0.0018678558,0.0024160543],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000084402025,0.000044921053,0.00011133963,0.01278468,0.00008695883,0.00029349866,0.000048063594,0.0004668526,0.0024790713,0.003270401,0.059577603,0.9207522],"study_design_scores_gemma":[0.000028063607,0.00009297419,0.0006477316,0.0042071436,0.00009430224,0.0017611403,0.000064421365,0.00012620684,0.0005394246,0.002777447,0.9896421,0.000019124873],"about_ca_topic_score_codex":0.00091031974,"about_ca_topic_score_gemma":0.0018098087,"teacher_disagreement_score":0.0038862259,"about_ca_system_score_codex":0.0007443637,"about_ca_system_score_gemma":0.0008412231,"threshold_uncertainty_score":0.013000727},"labels":[],"label_agreement":null},{"id":"W2128183109","doi":"10.1517/14712598.1.6.923","title":"Developments in liposomal drug delivery systems","year":2001,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":339,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Liposome; Drug delivery; Medicine; Drug; Pharmacology; Clinical trial; Drug carrier; Targeted drug delivery; Biology; Chemistry; Internal medicine","score_opus":0.1247826064773836,"score_gpt":0.3687485482794017,"score_spread":0.24396594180201808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128183109","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020252038,0.9684628,0.01661566,0.0013465503,0.0008857544,0.00015119146,0.00007985319,0.00016697905,0.010265887],"genre_scores_gemma":[0.0099300975,0.9543774,0.022116229,0.001460257,0.0004523212,0.0002773123,0.00017860133,0.00004543517,0.011162414],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993111,0.000109717665,0.00006247126,0.00015148519,0.00031299563,0.00005237785],"domain_scores_gemma":[0.9996922,0.000111825095,0.00005720336,0.000019703773,0.000092858994,0.000026261687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013759754,0.0010324862,0.0013840286,0.0019862102,0.00043450086,0.0014908542,0.0010489918,0.0021481323,0.002895839],"category_scores_gemma":[0.000685543,0.00058354344,0.00047048257,0.001355321,0.00091358024,0.0026762572,0.0013312225,0.0026966187,0.0051925965],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012191745,0.00017138226,0.0001273487,0.009534108,0.00006482983,0.00077496376,0.00028087062,0.0015827542,0.1298941,0.038054682,0.014047123,0.80534595],"study_design_scores_gemma":[0.000025613095,0.00018331398,0.00013081059,0.0005289101,0.000027186092,0.0012972703,0.00003115804,0.00048335988,0.029932637,0.002793579,0.964526,0.000040105624],"about_ca_topic_score_codex":0.00070059457,"about_ca_topic_score_gemma":0.00049834605,"teacher_disagreement_score":0.002895839,"about_ca_system_score_codex":0.0012937948,"about_ca_system_score_gemma":0.00074529246,"threshold_uncertainty_score":0.009687543},"labels":[],"label_agreement":null},{"id":"W2133192063","doi":"10.1517/14712598.8.4.463","title":"Oncolytic virotherapy for multiple myeloma","year":2008,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Mount Sinai Hospital; Toronto General Hospital; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Oncolytic virus; Virotherapy; Multiple myeloma; Medicine; Cancer research; Virology; Immunology; Tumor cells","score_opus":0.19491580122188426,"score_gpt":0.43800906222506286,"score_spread":0.2430932610031786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133192063","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029815198,0.99692196,0.00039804148,0.00027256442,0.00024019845,0.000011343277,0.000015284499,0.000014188174,0.001828322],"genre_scores_gemma":[0.0015912729,0.9960497,0.00045784947,0.00025084207,0.00015944477,0.000014907174,0.00004219498,0.0000026831826,0.0014311024],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998491,0.000025257294,0.000013342765,0.000022904182,0.0000768122,0.000012580557],"domain_scores_gemma":[0.9999018,0.000032381227,0.0000196498,0.000004362083,0.000030237421,0.000011583999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043626162,0.00065908994,0.0009905598,0.0015331615,0.00020956375,0.00054021546,0.00068604917,0.0010358182,0.003010983],"category_scores_gemma":[0.00032565277,0.00019551972,0.00040223476,0.0013749937,0.00029031056,0.00069627847,0.00041684997,0.0013438315,0.0027905805],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009766165,0.00009952747,0.00012823752,0.009401924,0.00007942729,0.00033744719,0.00004469622,0.00038720184,0.010957355,0.0032307496,0.024113057,0.95112276],"study_design_scores_gemma":[0.00004595689,0.00014710973,0.0005611983,0.0013728839,0.00007217448,0.0021756126,0.000022278135,0.00014495768,0.003334688,0.0015102364,0.990599,0.000014001192],"about_ca_topic_score_codex":0.0006005221,"about_ca_topic_score_gemma":0.0008962273,"teacher_disagreement_score":0.003010983,"about_ca_system_score_codex":0.0006888089,"about_ca_system_score_gemma":0.00062377704,"threshold_uncertainty_score":0.010072768},"labels":[],"label_agreement":null},{"id":"W2135293060","doi":"10.1517/14712590903110709","title":"Nimotuzumab: a novel anti-EGFR monoclonal antibody that retains anti-EGFR activity while minimizing skin toxicity","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McGill University","funders":"","keywords":"Nimotuzumab; Medicine; Monoclonal antibody; Clinical trial; Pharmacology; Epidermal growth factor receptor; Drug; Toxicity; EGFR inhibitors; Oncology; Cancer research; Cancer; Antibody; Immunology; Internal medicine","score_opus":0.2533466771946822,"score_gpt":0.4340411261167223,"score_spread":0.18069444892204012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135293060","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00055415946,0.9953453,0.000601471,0.00041098436,0.0001909544,0.000018315588,0.000028850705,0.000018684901,0.0028313764],"genre_scores_gemma":[0.002924008,0.99267876,0.0009208638,0.00037496895,0.0001768195,0.000024031186,0.00010794153,0.0000029536275,0.002789641],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998109,0.000030265655,0.000016962507,0.000029422677,0.0000927094,0.000019786672],"domain_scores_gemma":[0.99992883,0.000017505658,0.00001834752,0.000002489431,0.000019691584,0.0000131135575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046661563,0.00063923834,0.0012889385,0.0014976163,0.00018427274,0.00065693544,0.0008947925,0.0008412544,0.0025021548],"category_scores_gemma":[0.00026718818,0.00015973621,0.00032683313,0.0012678644,0.00027837366,0.0006816627,0.0003541246,0.00078399706,0.002668864],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099573816,0.00010614084,0.00014888332,0.0074070697,0.00007496518,0.00043827714,0.000027392281,0.00029529716,0.010254709,0.0021865102,0.018269053,0.9606922],"study_design_scores_gemma":[0.000058510363,0.00014105861,0.0005580567,0.00073258486,0.00006227048,0.0022572489,0.000021028927,0.00010982774,0.0033510667,0.0007721214,0.9919226,0.000013667925],"about_ca_topic_score_codex":0.000730082,"about_ca_topic_score_gemma":0.0018073124,"teacher_disagreement_score":0.0025021548,"about_ca_system_score_codex":0.0006638049,"about_ca_system_score_gemma":0.00067473174,"threshold_uncertainty_score":0.008370519},"labels":[],"label_agreement":null},{"id":"W2136385642","doi":"10.1517/14712598.2012.657622","title":"Obinutuzumab for the treatment of lymphoproliferative disorders","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Calgary","funders":"","keywords":"Obinutuzumab; Rituximab; Medicine; Antibody-dependent cell-mediated cytotoxicity; CD20; Clinical trial; Lymphoma; Oncology; Monoclonal antibody; Immunology; Monoclonal antibody therapy; Internal medicine; Antibody","score_opus":0.28090023864748026,"score_gpt":0.44167147150498937,"score_spread":0.1607712328575091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136385642","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006685931,0.99877995,0.00006431361,0.00017763553,0.00016961452,0.000004883749,0.00001103818,0.0000049799496,0.00072067406],"genre_scores_gemma":[0.0006390788,0.9981363,0.00012608554,0.00022545551,0.00019683868,0.000007353364,0.000032003816,0.0000014383374,0.00063536066],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999767,0.000043779874,0.000028425226,0.000040780174,0.00009754224,0.000022418373],"domain_scores_gemma":[0.99977154,0.00008192161,0.000053471253,0.000006681061,0.00006118261,0.00002521024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054259726,0.000921827,0.0014156745,0.0024502398,0.00026367613,0.0007999082,0.00086947967,0.0010109835,0.005049552],"category_scores_gemma":[0.0005817722,0.00021256383,0.0005513356,0.0022510234,0.0004033506,0.00083976594,0.0006310182,0.001606671,0.0034580017],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000736539,0.000048842696,0.00008763133,0.013495532,0.00009773222,0.00019893062,0.000034870936,0.00023269728,0.0012221748,0.0011903917,0.034345344,0.9489722],"study_design_scores_gemma":[0.000046948557,0.00007483971,0.0005451735,0.004276083,0.00013596861,0.0017402945,0.000026932892,0.00006449648,0.00039645575,0.0011085763,0.99157214,0.00001217938],"about_ca_topic_score_codex":0.0009401933,"about_ca_topic_score_gemma":0.0015715297,"teacher_disagreement_score":0.005049552,"about_ca_system_score_codex":0.0006460807,"about_ca_system_score_gemma":0.00088466913,"threshold_uncertainty_score":0.016892433},"labels":[],"label_agreement":null},{"id":"W2136686197","doi":"10.1517/14712598.2.8.793","title":"Islet transplantation for diabetes: current status and future prospects","year":2002,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Islet; Transplantation; Immunosuppression; Xenotransplantation; Context (archaeology); Medicine; Immunology; Islet cell transplantation; Diabetes mellitus; Biology; Internal medicine; Endocrinology","score_opus":0.13386832083026895,"score_gpt":0.3889620883406808,"score_spread":0.25509376751041185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136686197","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008989002,0.9968184,0.00015385404,0.0011114809,0.0006073632,0.0000039138904,0.000006353658,0.000009636367,0.0011990578],"genre_scores_gemma":[0.00042924,0.9974688,0.00023857846,0.00065431785,0.0006071399,0.0000060400166,0.000011941398,0.0000018184638,0.0005821299],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996669,0.000083449646,0.000042347976,0.000046105055,0.00012676732,0.000034431778],"domain_scores_gemma":[0.9992055,0.00044023478,0.00007310384,0.000026984913,0.00015278316,0.00010127554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018984365,0.0010480294,0.001730994,0.0014798329,0.0004691665,0.0015943941,0.0011819504,0.002374504,0.0072702803],"category_scores_gemma":[0.0012289493,0.00025207252,0.0005852478,0.002166465,0.0008344083,0.0028505342,0.0008225893,0.0023959419,0.004109996],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013188733,0.00011947353,0.00016922866,0.0068111084,0.000045360575,0.0003892688,0.00004933682,0.00030059172,0.0012342684,0.002940745,0.04145489,0.9463538],"study_design_scores_gemma":[0.00005117594,0.00016099731,0.0006506595,0.0031341426,0.00008681799,0.0016495252,0.00011533798,0.000101862315,0.00027995033,0.0038818233,0.98986685,0.000020868474],"about_ca_topic_score_codex":0.0006857547,"about_ca_topic_score_gemma":0.0014745994,"teacher_disagreement_score":0.0072702803,"about_ca_system_score_codex":0.00064055197,"about_ca_system_score_gemma":0.0013612178,"threshold_uncertainty_score":0.024321496},"labels":[],"label_agreement":null},{"id":"W2138376454","doi":"10.1517/14712598.4.6.927","title":"Antisense approaches in prostate cancer","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Clusterin in disease pathology","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Prostate cancer; Clusterin; Cancer research; Cancer; Gene; Biology; Oligonucleotide; Antisense therapy; Prostate; Apoptosis; Genetics","score_opus":0.4175150990230393,"score_gpt":0.4700249454075821,"score_spread":0.05250984638454281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138376454","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015528107,0.9970799,0.00025840264,0.00021335212,0.00030505107,0.000009255705,0.000008617718,0.000010183052,0.0019598673],"genre_scores_gemma":[0.0011383315,0.9957081,0.0004357316,0.00030006847,0.00021722142,0.000016289088,0.000029435821,0.0000025687789,0.0021521798],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999811,0.000031809286,0.000017254195,0.000032931734,0.000088980654,0.000017980441],"domain_scores_gemma":[0.9998857,0.000041608706,0.000020680434,0.0000048831917,0.000032567386,0.000014701997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000562844,0.0009629265,0.0011603854,0.0017923794,0.0003514329,0.0007237735,0.0008369396,0.0013519009,0.0036431833],"category_scores_gemma":[0.00028821817,0.0002906127,0.00039471837,0.001418426,0.00054115703,0.00081541686,0.00058091804,0.0018100044,0.0033808884],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000741464,0.0001022247,0.00013036776,0.008211136,0.000054163032,0.0006182283,0.000085686304,0.0004315351,0.009811728,0.005198813,0.027949,0.947333],"study_design_scores_gemma":[0.000024870802,0.00009939283,0.00042265383,0.0008655512,0.00003148119,0.0024210482,0.00003865058,0.000065830805,0.0015125434,0.0015995163,0.99290437,0.000014066135],"about_ca_topic_score_codex":0.0011607623,"about_ca_topic_score_gemma":0.0027124924,"teacher_disagreement_score":0.0036431833,"about_ca_system_score_codex":0.0007535244,"about_ca_system_score_gemma":0.0006606382,"threshold_uncertainty_score":0.01218766},"labels":[],"label_agreement":null},{"id":"W2140207145","doi":"10.1517/14712598.2011.557657","title":"The role of bevacizumab in colorectal cancer: understanding its benefits and limitations","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; University of Alberta","funders":"","keywords":"Bevacizumab; Colorectal cancer; Medicine; Oncology; Clinical trial; Angiogenesis; Cancer; Expert opinion; Adjuvant; Internal medicine; Bioinformatics; Intensive care medicine; Chemotherapy; Biology","score_opus":0.35379127628350016,"score_gpt":0.40764959911489307,"score_spread":0.05385832283139291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140207145","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006652649,0.99855345,0.00005573667,0.0008715556,0.0001233951,0.0000019133397,0.000005610542,0.0000015910382,0.00032026498],"genre_scores_gemma":[0.000536333,0.9984408,0.00015015938,0.00043781885,0.00019417377,0.00000461864,0.000009537672,7.1892407e-7,0.00022586396],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999627,0.00011302491,0.000051178984,0.00004746685,0.00014012514,0.00002119404],"domain_scores_gemma":[0.9992198,0.0003997984,0.00012928901,0.000016610611,0.00019698509,0.000037487895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013936848,0.0005946868,0.0014838482,0.0015410064,0.00020644256,0.000913417,0.00077682355,0.0014965779,0.0017735114],"category_scores_gemma":[0.0017587317,0.00023158637,0.00052615,0.0017583033,0.00052204565,0.0017587127,0.00043611194,0.0019631174,0.0009806476],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011042223,0.0000331449,0.00013767875,0.018905077,0.00011382197,0.00017878434,0.0000615391,0.0003074788,0.0014596657,0.0034417624,0.028683206,0.9465674],"study_design_scores_gemma":[0.000057059708,0.00016851311,0.0014110453,0.011965722,0.00025302483,0.0017566814,0.00008784157,0.0002498284,0.000637286,0.0036337513,0.97975117,0.000028155728],"about_ca_topic_score_codex":0.0023423075,"about_ca_topic_score_gemma":0.0049127196,"teacher_disagreement_score":0.0023423075,"about_ca_system_score_codex":0.0009161068,"about_ca_system_score_gemma":0.0014569189,"threshold_uncertainty_score":0.007370651},"labels":[],"label_agreement":null},{"id":"W2144847294","doi":"10.1517/14712590903439702","title":"Trastuzumab for gastric cancer","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Alberta Cancer Foundation","funders":"","keywords":"Medicine; Trastuzumab; Cancer; Oncology; Chemotherapy; Internal medicine; Targeted therapy; Breast cancer","score_opus":0.4923854008211455,"score_gpt":0.5606512124964915,"score_spread":0.06826581167534601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144847294","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014978112,0.9982572,0.000064439344,0.00026825262,0.00017470402,0.000004890494,0.000009175626,0.0000050977396,0.0010664096],"genre_scores_gemma":[0.0020146505,0.99573886,0.0001728605,0.00040631482,0.00029336245,0.000011030965,0.000037669153,0.0000016667612,0.0013235802],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981076,0.00004770846,0.000025035413,0.000028111373,0.000071021765,0.000017409264],"domain_scores_gemma":[0.999838,0.00006417467,0.000043694094,0.000004904806,0.000035258035,0.0000138191535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052534515,0.00071139133,0.0011629188,0.001644592,0.00016900287,0.00061530294,0.00067921635,0.0009588954,0.0035750854],"category_scores_gemma":[0.00065465976,0.00016006647,0.0004679117,0.0015576791,0.00024493053,0.0006086955,0.00042780512,0.0009897287,0.0020241211],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012371887,0.000058621852,0.00020688468,0.014239223,0.00014920314,0.00047563895,0.0000480629,0.00029650412,0.0016781144,0.0016148252,0.04752474,0.9335845],"study_design_scores_gemma":[0.000119480625,0.00012314948,0.0010859073,0.0045747478,0.00022087544,0.0035645026,0.00003233284,0.00012865831,0.001029729,0.0013447468,0.9877626,0.000013315514],"about_ca_topic_score_codex":0.0008081094,"about_ca_topic_score_gemma":0.0012831099,"teacher_disagreement_score":0.0035750854,"about_ca_system_score_codex":0.0006235987,"about_ca_system_score_gemma":0.00064866623,"threshold_uncertainty_score":0.011959851},"labels":[],"label_agreement":null},{"id":"W2145525874","doi":"10.1517/14712598.2014.866648","title":"Adult adherent stromal cells in the management of graft-versus-host disease","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Clinical trial; Graft-versus-host disease; Mesenchymal stem cell; Clinical endpoint; Transplantation; Disease; Stem cell; Intensive care medicine; Refractory (planetary science); Immunology; Oncology; Internal medicine; Pathology; Biology","score_opus":0.248931904013494,"score_gpt":0.45673517761548627,"score_spread":0.20780327360199227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145525874","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006931251,0.9990108,0.00006818432,0.00026191844,0.00013987272,0.0000039598435,0.000010010663,0.0000024542198,0.00043352807],"genre_scores_gemma":[0.0005649701,0.9988483,0.00010080348,0.00016293227,0.00009873825,0.000004532686,0.000014873733,6.2817355e-7,0.0002041768],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997427,0.000059498423,0.00003770591,0.000038233713,0.00010343423,0.000018513174],"domain_scores_gemma":[0.9996557,0.00017883949,0.000060347713,0.0000066773637,0.00008019262,0.000018286253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006827654,0.0005099907,0.0011033487,0.0015831467,0.00016224402,0.00074144226,0.0006742808,0.00093623775,0.0031538696],"category_scores_gemma":[0.00083929556,0.00014322244,0.000493986,0.0013619206,0.00037452774,0.00073423836,0.00046605352,0.0013134741,0.0013359191],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087889406,0.00004253951,0.00009521689,0.02429932,0.00012819079,0.00011902656,0.00004389831,0.00030053887,0.001344229,0.0023906713,0.01767186,0.9534767],"study_design_scores_gemma":[0.000046616035,0.00013961218,0.00085226865,0.0126746595,0.0002374625,0.0011655304,0.000078249635,0.0001319586,0.0006206258,0.0022013308,0.9818319,0.000019613088],"about_ca_topic_score_codex":0.00094415527,"about_ca_topic_score_gemma":0.0014918838,"teacher_disagreement_score":0.0031538696,"about_ca_system_score_codex":0.00042251655,"about_ca_system_score_gemma":0.00082950265,"threshold_uncertainty_score":0.010550737},"labels":[],"label_agreement":null},{"id":"W2145931873","doi":"10.1517/14712598.1.4.583","title":"Block copolymeric biotransport carriers as versatile vehicles for drug delivery","year":2001,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Advanced Polymer Synthesis and Characterization","field":"Chemistry","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Supratek Pharma (Canada)","funders":"","keywords":"Copolymer; Amphiphile; Flexibility (engineering); Drug delivery; Block (permutation group theory); Drug; Drug carrier; Combinatorial chemistry; Nanotechnology; Computer science; Chemistry; Materials science; Biochemical engineering; Mathematics; Pharmacology; Polymer; Organic chemistry; Engineering; Biology","score_opus":0.08563207482724042,"score_gpt":0.35223633752692635,"score_spread":0.26660426269968596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145931873","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062110517,0.97829103,0.008700398,0.00028796925,0.00040491295,0.000076047014,0.00006244816,0.00008729632,0.00587886],"genre_scores_gemma":[0.025107237,0.9535329,0.009989112,0.00033316002,0.0002209737,0.00013106212,0.00019383013,0.000027538268,0.010464312],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999806,0.000033383814,0.000015234252,0.000033588098,0.000091235335,0.000020600502],"domain_scores_gemma":[0.9999317,0.000019867368,0.000020847507,0.000005069685,0.000014386981,0.000008057984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005126433,0.0007988829,0.00082973705,0.0011165023,0.00020108219,0.00070452044,0.0005614991,0.00090708333,0.0020775206],"category_scores_gemma":[0.00019469911,0.00028702724,0.00029479744,0.00083513686,0.00038571152,0.0013461604,0.00044345364,0.0008616352,0.0036196576],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011850036,0.000119177304,0.00012636863,0.0058351597,0.000049409704,0.00056294835,0.00010846717,0.0013098101,0.32567358,0.012052442,0.0048740963,0.64917004],"study_design_scores_gemma":[0.0000443634,0.00042161773,0.00048439406,0.00046947598,0.000064363834,0.0016757717,0.000034295572,0.00074560643,0.12569691,0.0018665029,0.86845595,0.00004081184],"about_ca_topic_score_codex":0.00042784325,"about_ca_topic_score_gemma":0.0006200257,"teacher_disagreement_score":0.0020775206,"about_ca_system_score_codex":0.0005616423,"about_ca_system_score_gemma":0.0003403784,"threshold_uncertainty_score":0.006950021},"labels":[],"label_agreement":null},{"id":"W2147070032","doi":"10.1517/14712598.5.3.313","title":"Involvement of ICAM-1 in bone metabolism: a potential target in the treatment of bone diseases?","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Osteoclast; Medicine; Osteoporosis; Rheumatoid arthritis; Intercellular Adhesion Molecule-1; Bone remodeling; Bone disease; Inflammation; Cell adhesion molecule; Immunology; Receptor; Internal medicine","score_opus":0.15203345513730984,"score_gpt":0.4260539516775159,"score_spread":0.2740204965402061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147070032","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015160789,0.9963374,0.00022828951,0.0012978506,0.00072146044,0.000007671784,0.000011793556,0.000009897311,0.0012339179],"genre_scores_gemma":[0.00095688144,0.9954384,0.0004817983,0.000916562,0.00073180976,0.000017182341,0.000026651896,0.000002231253,0.0014284077],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998031,0.00004278019,0.000022065122,0.000032575448,0.00007670449,0.000022695094],"domain_scores_gemma":[0.9997856,0.00007458989,0.00002846892,0.000011300689,0.00006507353,0.000034972516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007788526,0.0009119175,0.0019661142,0.0012926062,0.00033696406,0.0010343894,0.0011477224,0.002071565,0.0049891416],"category_scores_gemma":[0.0004771456,0.000253146,0.00042482893,0.001379561,0.000724115,0.0019994522,0.0005011683,0.0022739777,0.0053686025],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017573102,0.00014741762,0.00017769822,0.008520003,0.00007159678,0.00050306524,0.000066910914,0.00031787532,0.00519116,0.005241016,0.052893557,0.926694],"study_design_scores_gemma":[0.00008885281,0.00023903385,0.0007113999,0.0017840053,0.00007407995,0.0018764371,0.00007665685,0.00013038103,0.0007857024,0.0032123537,0.990998,0.000022992626],"about_ca_topic_score_codex":0.0006518084,"about_ca_topic_score_gemma":0.0016087512,"teacher_disagreement_score":0.0049891416,"about_ca_system_score_codex":0.0006329697,"about_ca_system_score_gemma":0.0007997288,"threshold_uncertainty_score":0.016690373},"labels":[],"label_agreement":null},{"id":"W2147109841","doi":"10.1517/14712598.2015.971749","title":"Erythropoiesis-stimulating agents in allogeneic and autologous hematopoietic stem cell transplantation","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; Stem cell; Expert opinion; Intensive care medicine; Haematopoiesis; Hematopoietic stem cell transplantation; Erythropoiesis; Transplantation; Aplastic anemia; Clinical trial; Anemia; Oncology; Immunology; Internal medicine; Bone marrow","score_opus":0.15419707096536678,"score_gpt":0.4010795418792463,"score_spread":0.24688247091387955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147109841","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000039640272,0.99955577,0.000016129256,0.00011938906,0.000052754716,0.000004708429,0.000011868469,0.0000010929195,0.00019857238],"genre_scores_gemma":[0.00062822585,0.9989342,0.00007210583,0.000170375,0.00005138042,0.000009734343,0.000017913368,4.6244557e-7,0.00011550545],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993742,0.00017052941,0.00013902246,0.00006896827,0.00021456886,0.000032784355],"domain_scores_gemma":[0.9987337,0.0007931883,0.00027965548,0.000014596424,0.00015001948,0.000028893179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011783134,0.0006875051,0.002236065,0.0028179488,0.00021244532,0.00098166,0.00092055433,0.0012151864,0.00489162],"category_scores_gemma":[0.0027297607,0.0002481811,0.0015730964,0.002812272,0.0003665831,0.0007856648,0.00053871865,0.0012064598,0.00067870965],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015689155,0.00004794149,0.00018373488,0.24914855,0.0009104931,0.00013160727,0.000072699084,0.00024776606,0.000521731,0.0018247186,0.022347169,0.7244068],"study_design_scores_gemma":[0.00019502272,0.00020584857,0.002314656,0.22721055,0.00436891,0.001679885,0.00015208677,0.00014925684,0.00055136945,0.0025901159,0.76054823,0.000034107557],"about_ca_topic_score_codex":0.0018937269,"about_ca_topic_score_gemma":0.003597043,"teacher_disagreement_score":0.00489162,"about_ca_system_score_codex":0.0007885311,"about_ca_system_score_gemma":0.0017606542,"threshold_uncertainty_score":0.016364157},"labels":[],"label_agreement":null},{"id":"W2147154643","doi":"10.1517/14712598.7.11.1723","title":"L-BLP25: a MUC1-targeted peptide vaccine therapy in prostate cancer","year":2007,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Alberta","funders":"","keywords":"Prostate cancer; Medicine; MUC1; Cancer vaccine; Antigen; Cancer; Peptide vaccine; Oncology; Prostate-specific antigen; Immunotherapy; Cancer research; Immunology; Internal medicine; Epitope","score_opus":0.12476821738793602,"score_gpt":0.39932030448054656,"score_spread":0.27455208709261053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147154643","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047533223,0.9956216,0.00046132132,0.0008671009,0.000720416,0.00001549705,0.000019562402,0.000020821013,0.0017983506],"genre_scores_gemma":[0.0016482298,0.9938611,0.0006162745,0.000838695,0.0004693003,0.000024572957,0.00006305615,0.0000032245528,0.0024756135],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985886,0.000026805863,0.000011012672,0.000022674074,0.000063149906,0.000017493334],"domain_scores_gemma":[0.9998944,0.00003080418,0.000017262517,0.0000034977736,0.00003355118,0.000020495405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005930637,0.0008682313,0.0011431577,0.0011376521,0.00020378613,0.00061632216,0.0009316538,0.0014499569,0.0027329805],"category_scores_gemma":[0.00032220175,0.00022280033,0.00040270283,0.001168714,0.00039450734,0.0011457343,0.0003878821,0.0016052229,0.0031936576],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017989539,0.00015997801,0.000096115735,0.005387816,0.000058401918,0.00038477566,0.000032999727,0.00058635476,0.007004416,0.002011752,0.048113406,0.93598413],"study_design_scores_gemma":[0.00010255899,0.00026803464,0.0007021473,0.0010282462,0.000053430686,0.002052484,0.000032053962,0.00023345265,0.001457808,0.0015160306,0.9925355,0.000018362121],"about_ca_topic_score_codex":0.0006349355,"about_ca_topic_score_gemma":0.0012705578,"teacher_disagreement_score":0.0027329805,"about_ca_system_score_codex":0.0006926645,"about_ca_system_score_gemma":0.0006519908,"threshold_uncertainty_score":0.009142756},"labels":[],"label_agreement":null},{"id":"W2149106614","doi":"10.1517/14712598.6.1.73","title":"The emerging role of recombinant activated Factor VII (rFVIIa) in the treatment of blunt traumatic haemorrhage","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Novo Nordisk","keywords":"Coagulopathy; Medicine; Recombinant factor VIIa; Haemophilia; Coagulation; Factor VII; Transfusion therapy; Factor IX; Intensive care medicine; Surgery; Blood transfusion; Internal medicine","score_opus":0.2772478901078796,"score_gpt":0.4655169931661655,"score_spread":0.18826910305828592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149106614","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017051611,0.9980135,0.00013984786,0.00044092865,0.00020411417,0.000004228916,0.000008872278,0.000003874647,0.0010140149],"genre_scores_gemma":[0.0006756403,0.99814093,0.0002509072,0.00022391914,0.00022999388,0.0000042641896,0.000016798196,8.602665e-7,0.00045663296],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972767,0.0000597288,0.000040251824,0.00003348795,0.00011932217,0.000019506972],"domain_scores_gemma":[0.9996283,0.00015788451,0.00006221518,0.000008736185,0.00011113817,0.000031711857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007483278,0.0006078934,0.0014993722,0.0017005218,0.0002049004,0.0008369715,0.00084368075,0.0011361463,0.00421882],"category_scores_gemma":[0.00071381003,0.00019291606,0.00044085897,0.0018996873,0.0003891447,0.0011409862,0.00037695255,0.0012623287,0.0028506792],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010674381,0.00008558166,0.00014552711,0.016129784,0.000096424694,0.000589583,0.00006911895,0.00028805828,0.0031209516,0.0021196196,0.023758866,0.9534897],"study_design_scores_gemma":[0.00007575137,0.000256965,0.0010960484,0.004424879,0.00018143101,0.0034094995,0.00011222821,0.00013986648,0.00085155957,0.0019744267,0.987455,0.000022407636],"about_ca_topic_score_codex":0.0010716051,"about_ca_topic_score_gemma":0.0018251131,"teacher_disagreement_score":0.00421882,"about_ca_system_score_codex":0.00049312273,"about_ca_system_score_gemma":0.0008431889,"threshold_uncertainty_score":0.014113367},"labels":[],"label_agreement":null},{"id":"W2150081030","doi":"10.1517/14712598.2015.983897","title":"The capsular group B meningococcal vaccine, 4CMenB: clinical experience and potential efficacy","year":2014,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Medical Research Council; Sparks; Action Medical Research","keywords":"Reactogenicity; Medicine; Meningococcal disease; Immunogenicity; Context (archaeology); Group B; Meningococcal vaccine; Clinical trial; European union; Meningitis; Group A; Pediatrics; Neisseria meningitidis; Intensive care medicine; Immunology; Immunization; Internal medicine; Antigen","score_opus":0.052579186302081936,"score_gpt":0.34492859288552663,"score_spread":0.2923494065834447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150081030","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034101244,0.94845486,0.0009040509,0.009596613,0.00066414074,0.00006568632,0.00012780513,0.000013760016,0.006071858],"genre_scores_gemma":[0.20584446,0.77645695,0.0031769625,0.00968868,0.0015479322,0.00013060971,0.0006590008,0.000024519923,0.002470875],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991497,0.0004310063,0.0000667789,0.000083876286,0.00018622403,0.00008247312],"domain_scores_gemma":[0.9979978,0.0012157961,0.00026302412,0.000060785453,0.0003053526,0.00015708194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004159115,0.0004228441,0.00084112654,0.000218697,0.0001793071,0.000991545,0.00049765204,0.0012332204,0.002839523],"category_scores_gemma":[0.0051558237,0.00009757359,0.00046189944,0.00030110253,0.00049253507,0.0009680635,0.0003804432,0.001589934,0.0008106677],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031371482,0.0004971174,0.0030977647,0.005132602,0.0002681105,0.0005544717,0.0003638824,0.00055082404,0.0068557435,0.0014863209,0.019700406,0.95835567],"study_design_scores_gemma":[0.0031713855,0.035991292,0.026758997,0.01984058,0.0013683424,0.01083965,0.00090358156,0.0009609942,0.016966866,0.0056085796,0.8774551,0.00013464622],"about_ca_topic_score_codex":0.00042876435,"about_ca_topic_score_gemma":0.000546043,"teacher_disagreement_score":0.004159115,"about_ca_system_score_codex":0.0004725791,"about_ca_system_score_gemma":0.00074776175,"threshold_uncertainty_score":0.021995723},"labels":[],"label_agreement":null},{"id":"W2152228047","doi":"10.1517/14712598.4.5.631","title":"Stem cell bioengineering for regenerative medicine","year":2004,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Stem cell; Regenerative medicine; Embryonic stem cell; Biology; Stem cell biology; Computational biology; Transplantation; Cellular differentiation; Biotechnology; Cell biology; Medicine; Genetics; Embryo; Gene; Embryogenesis","score_opus":0.16387817595006207,"score_gpt":0.40478039732466314,"score_spread":0.24090222137460107,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152228047","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012552859,0.9889059,0.0014195078,0.0012638897,0.001302898,0.000022161952,0.000025192156,0.000025795793,0.006909162],"genre_scores_gemma":[0.0015521822,0.9894192,0.0017283955,0.00097529107,0.0007224234,0.000036652942,0.00006620548,0.000007022387,0.005492586],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994937,0.00008186215,0.000044076027,0.00006841697,0.0002771469,0.00003476451],"domain_scores_gemma":[0.99969006,0.000105755076,0.000040564177,0.000025176616,0.000101091646,0.000037464353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012490775,0.0014935703,0.001766639,0.0022129337,0.000559712,0.00144799,0.001503663,0.0029502865,0.012403827],"category_scores_gemma":[0.00056969986,0.00037059851,0.0007045258,0.0025593925,0.0014324193,0.002405052,0.0011473906,0.0029575091,0.013355607],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046432524,0.00006755725,0.00009290266,0.009195622,0.00005726744,0.0003948726,0.000089355795,0.0005981974,0.009498745,0.02752231,0.054404695,0.89803207],"study_design_scores_gemma":[0.000010211186,0.000025663772,0.0001178194,0.000770193,0.000015449177,0.0005444998,0.000023297129,0.00006115953,0.0010011201,0.0057235095,0.99169636,0.000010659124],"about_ca_topic_score_codex":0.0009605373,"about_ca_topic_score_gemma":0.0014387688,"teacher_disagreement_score":0.012403827,"about_ca_system_score_codex":0.0015444909,"about_ca_system_score_gemma":0.0014333916,"threshold_uncertainty_score":0.041494906},"labels":[],"label_agreement":null},{"id":"W2155747763","doi":"10.1517/14712598.2013.784266","title":"From the Zeno's paradoxes to novel immunotherapeutic agents for kidney cancer: moving from an era of wrong premises and conclusions to a better comprehension of immunology","year":2013,"lang":"en","type":"letter","venue":"Expert Opinion on Biological Therapy","topic":"Empathy and Medical Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Zeno's paradoxes; Tortoise; Comprehension; Perception; Medicine; Aesthetics; Philosophy; Epistemology; Biology; Zoology","score_opus":0.11253763910774385,"score_gpt":0.3887531931756504,"score_spread":0.27621555406790654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155747763","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034331254,0.005051541,0.00017400124,0.98521245,0.008523904,0.000003461639,0.0000053580666,0.000008581361,0.000677453],"genre_scores_gemma":[0.011075076,0.0073164236,0.00041730024,0.9367064,0.042985838,0.000020318988,0.000007837441,0.000012227425,0.001458485],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99591005,0.00193041,0.00036188285,0.0004004169,0.0010301858,0.00036718082],"domain_scores_gemma":[0.9859664,0.010989324,0.0006412676,0.00026516645,0.0013780296,0.0007598765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057880804,0.0006009959,0.00155074,0.00065078394,0.0034110036,0.0036307217,0.001540512,0.03539357,0.003118032],"category_scores_gemma":[0.030874912,0.00039860923,0.0012147635,0.00057226175,0.0069190045,0.0082781175,0.0021510618,0.04565005,0.002206028],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001766632,0.00010234452,0.0005994157,0.00037972187,0.00005094241,0.009425052,0.0010740584,0.00019379394,0.0006974366,0.032332662,0.9097401,0.045227755],"study_design_scores_gemma":[0.0003208898,0.0001847815,0.00062690984,0.0008212961,0.00006121382,0.01467419,0.0016703156,0.00096099393,0.00054779195,0.09697612,0.88304067,0.00011493692],"about_ca_topic_score_codex":0.0020256485,"about_ca_topic_score_gemma":0.0031968134,"teacher_disagreement_score":0.03539357,"about_ca_system_score_codex":0.0052064974,"about_ca_system_score_gemma":0.0036966933,"threshold_uncertainty_score":0.037775934},"labels":[],"label_agreement":null},{"id":"W2159512922","doi":"10.1517/14712590902942284","title":"Costimulatory blockade with belatacept in clinical and experimental transplantation – a review","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Belatacept; Abatacept; Immunosuppression; Transplantation; Medicine; Organ transplantation; Clinical trial; Immunology; CD80; Pharmacology; Oncology; Kidney transplantation; Internal medicine; Biology; Rituximab; Antibody; In vitro; Cytotoxic T cell","score_opus":0.1881148553626472,"score_gpt":0.47522044437996946,"score_spread":0.2871055890173223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159512922","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013015645,0.9989537,0.00011235951,0.00012932277,0.00012318206,0.000007519251,0.00001115144,0.0000053345875,0.0005271955],"genre_scores_gemma":[0.00064094097,0.9986903,0.00021061771,0.00011990511,0.00008235686,0.000010599511,0.000022185695,0.0000010212283,0.0002220374],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997869,0.000046923455,0.000042667,0.000030250587,0.000078120596,0.000015252278],"domain_scores_gemma":[0.9996704,0.00017103295,0.000059090326,0.000008130095,0.00006854042,0.000022834794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007623244,0.00076086127,0.0018263297,0.0019739396,0.00019423444,0.00072182826,0.0009881288,0.00090444076,0.0029709465],"category_scores_gemma":[0.00067718426,0.00026050094,0.00046655955,0.002221081,0.00034184195,0.0009638274,0.00040845273,0.0010311401,0.0016723967],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119553035,0.000098366494,0.000120179124,0.022580376,0.00012916797,0.00017183046,0.000036234876,0.00038043386,0.0013973962,0.0013314872,0.018176906,0.9554581],"study_design_scores_gemma":[0.00008675884,0.00023307986,0.0012573163,0.009463509,0.00032214503,0.0017762805,0.00007383829,0.0001938788,0.0007591669,0.0014011344,0.98440695,0.000025957672],"about_ca_topic_score_codex":0.0008039741,"about_ca_topic_score_gemma":0.0014234878,"teacher_disagreement_score":0.0029709465,"about_ca_system_score_codex":0.0005812196,"about_ca_system_score_gemma":0.000980195,"threshold_uncertainty_score":0.0099387765},"labels":[],"label_agreement":null},{"id":"W2160274449","doi":"10.1517/14712598.2015.977249","title":"The effect of parathyroid hormone and teriparatide on fracture healing","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Bone health and treatments","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Teriparatide; Parathyroid hormone; Bone healing; Medicine; Internal medicine; Osteoporosis; Endocrinology; Bioinformatics; Biology; Surgery; Calcium","score_opus":0.09238361252833933,"score_gpt":0.43412428351101423,"score_spread":0.3417406709826749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160274449","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009218767,0.99918026,0.000033386314,0.00012645162,0.00010180227,0.000004781577,0.00001379474,0.000001925138,0.00044543267],"genre_scores_gemma":[0.0008542446,0.9985409,0.00010050046,0.00014072526,0.00008823317,0.000009053603,0.000019111045,6.5594276e-7,0.0002465437],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999684,0.000059456303,0.00006409163,0.000048139307,0.00012576772,0.000018611236],"domain_scores_gemma":[0.99958915,0.00021939477,0.00008371399,0.000006572043,0.000087918364,0.000013224198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059661845,0.0006003032,0.0011989886,0.0017471686,0.00017936644,0.00067112496,0.00080597383,0.0010439552,0.0042090076],"category_scores_gemma":[0.00113302,0.00024687956,0.0007752506,0.0014676977,0.00028445447,0.00062133686,0.00041158573,0.0010037591,0.0013842738],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016200509,0.000053423355,0.00015507286,0.06312991,0.00025161332,0.00014317447,0.000054028405,0.00021231775,0.0017438437,0.0013653833,0.018439272,0.9142899],"study_design_scores_gemma":[0.00011898529,0.00034918397,0.0027502351,0.027920498,0.00080871343,0.0023060502,0.000116144336,0.00019837663,0.0017771898,0.0015806186,0.96203536,0.00003852556],"about_ca_topic_score_codex":0.0011065702,"about_ca_topic_score_gemma":0.001827167,"teacher_disagreement_score":0.0042090076,"about_ca_system_score_codex":0.00040786483,"about_ca_system_score_gemma":0.00081020006,"threshold_uncertainty_score":0.014080524},"labels":[],"label_agreement":null},{"id":"W2162039329","doi":"10.1517/14712598.2012.685713","title":"Oncolytic virotherapy for renal cell carcinoma: a novel treatment paradigm?","year":2012,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Alberta Cancer Foundation; University of Calgary","funders":"","keywords":"Oncolytic virus; Virotherapy; Medicine; Immunotherapy; Disease; Immune system; Renal cell carcinoma; Malignancy; Cancer research; Immunology; Oncology; Internal medicine","score_opus":0.2400492890182544,"score_gpt":0.4259792513334449,"score_spread":0.1859299623151905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162039329","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012756778,0.99712306,0.0003218626,0.0010806731,0.00039006557,0.000007516947,0.000012720519,0.0000091441425,0.0009274891],"genre_scores_gemma":[0.0009152408,0.99713385,0.00031224548,0.0005592103,0.00030171077,0.000011907655,0.000021683869,0.000002109143,0.00074206514],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998586,0.000034044042,0.000012230927,0.000025791114,0.000053724292,0.00001551796],"domain_scores_gemma":[0.9998722,0.000049262166,0.000020533844,0.0000054592483,0.000039143153,0.0000134474285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006938884,0.0007033639,0.0011752436,0.0009968608,0.00021726312,0.00096510927,0.00090221886,0.0014955628,0.0026921623],"category_scores_gemma":[0.00041853805,0.00022860256,0.00044116584,0.0009966575,0.0006929596,0.0016882392,0.00048456466,0.0027589814,0.0021523056],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001038621,0.00009047409,0.0000928927,0.009312044,0.00006852202,0.00027232806,0.00006167644,0.00060765597,0.0048326696,0.012245372,0.04382203,0.9284905],"study_design_scores_gemma":[0.00004526673,0.00013795603,0.00033078852,0.0022376254,0.000054748674,0.0014429128,0.000046563917,0.00021309724,0.0011951044,0.0036013837,0.9906731,0.000021342172],"about_ca_topic_score_codex":0.0008304933,"about_ca_topic_score_gemma":0.0019321046,"teacher_disagreement_score":0.0026921623,"about_ca_system_score_codex":0.000947124,"about_ca_system_score_gemma":0.00080623844,"threshold_uncertainty_score":0.009006202},"labels":[],"label_agreement":null},{"id":"W2163096595","doi":"10.1517/14712598.2013.779249","title":"New developments in lentiviral vector design, production and purification","year":2013,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":115,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; PROTEO","funders":"","keywords":"Genetic enhancement; Lentivirus; Viral vector; Vector (molecular biology); Retrovirus; Bioproduction; Vectors in gene therapy; Computational biology; Recombinant DNA; Gene delivery; Biology; Virology; Biotechnology; Gene; Human immunodeficiency virus (HIV); Virus; Genetics; Viral disease","score_opus":0.21384630436002708,"score_gpt":0.4105336812077076,"score_spread":0.19668737684768053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2163096595","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006337416,0.98264676,0.010061902,0.0010393808,0.00096466334,0.00006463816,0.00009262716,0.00009876994,0.004397539],"genre_scores_gemma":[0.002980192,0.98596907,0.007436329,0.0007892055,0.00044524184,0.00008510711,0.00022449954,0.000021313619,0.002049047],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990227,0.00015679463,0.00010173362,0.00011904941,0.0005454855,0.000054288466],"domain_scores_gemma":[0.99939966,0.00021553313,0.000093055794,0.00003576624,0.00022304348,0.000033017157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018709406,0.0009846297,0.0011962292,0.0019040222,0.00027257737,0.001483488,0.0012668353,0.0013032481,0.0026089114],"category_scores_gemma":[0.001141346,0.00051411893,0.0007857101,0.0018511773,0.00076841854,0.0016452513,0.0006456474,0.0033023562,0.0032481642],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062990424,0.000094682815,0.00026428487,0.013823952,0.00007772955,0.0003761411,0.00013926368,0.0006875327,0.032630906,0.014078984,0.028756276,0.90900725],"study_design_scores_gemma":[0.000017532304,0.00009576209,0.00030064918,0.0010722289,0.00005691562,0.0014675884,0.000026814592,0.0002850113,0.0105667915,0.0024150943,0.98366433,0.00003113931],"about_ca_topic_score_codex":0.00095630396,"about_ca_topic_score_gemma":0.00084919715,"teacher_disagreement_score":0.0026089114,"about_ca_system_score_codex":0.0009810256,"about_ca_system_score_gemma":0.0010806415,"threshold_uncertainty_score":0.009894609},"labels":[],"label_agreement":null},{"id":"W2166481231","doi":"10.1517/14712598.5.6.809","title":"Refining an Alzheimer’s vaccine to avoid an inflammatory response","year":2005,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; University of Toronto","funders":"","keywords":"Immune system; Meningoencephalitis; Immunotherapy; Immunology; Disease; Medicine; Epitope; Peptide vaccine; Alzheimer's disease; Clinical trial; Antibody; Internal medicine","score_opus":0.32650752973233327,"score_gpt":0.49549101078151686,"score_spread":0.1689834810491836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166481231","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00072619744,0.99098504,0.0014246949,0.0018857202,0.00090878626,0.00003806291,0.000025760963,0.00002961062,0.0039762026],"genre_scores_gemma":[0.0032459453,0.98747534,0.0026469778,0.001995467,0.00041400682,0.000049437433,0.0000661445,0.0000052223627,0.004101444],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972194,0.00006967358,0.000025715754,0.00003485319,0.000116391115,0.00003130889],"domain_scores_gemma":[0.9998361,0.000049602495,0.000027686492,0.000009094459,0.000059999562,0.00001763059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010863872,0.0010528152,0.0014225311,0.0012595406,0.00024387374,0.000956226,0.00097332033,0.0020864417,0.003564764],"category_scores_gemma":[0.0005714562,0.00024597638,0.0005032466,0.0008775573,0.00054458814,0.0017340659,0.00046108296,0.001979582,0.0035390328],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014651507,0.0001972616,0.00015153171,0.011453223,0.00010711823,0.00041825703,0.0000878412,0.00072752015,0.01837922,0.009747033,0.03662121,0.92196333],"study_design_scores_gemma":[0.000093153474,0.00020444934,0.0003624046,0.0017574241,0.00007338994,0.00095620815,0.00005228482,0.0001732419,0.0027417075,0.0037039586,0.98986584,0.000015938687],"about_ca_topic_score_codex":0.0010992849,"about_ca_topic_score_gemma":0.0018458473,"teacher_disagreement_score":0.003564764,"about_ca_system_score_codex":0.00075086905,"about_ca_system_score_gemma":0.0009008569,"threshold_uncertainty_score":0.01192534},"labels":[],"label_agreement":null},{"id":"W2166847481","doi":"10.1517/14712598.2012.631909","title":"International seminar on the red blood cells as vehicles for drugs","year":2011,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"International Society for Cellular Therapy","funders":"","keywords":"Medicine; Red blood cell; Pharmacology; Immunology","score_opus":0.12817692438234457,"score_gpt":0.3355154922616316,"score_spread":0.207338567879287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166847481","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007917109,0.5329275,0.009343321,0.05169595,0.19829929,0.0002414918,0.0005011283,0.00044283742,0.19863136],"genre_scores_gemma":[0.050473474,0.32039332,0.006146716,0.0152257215,0.07826679,0.00036438252,0.0007369031,0.000300933,0.5280917],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99907386,0.00013848783,0.000051331033,0.00019087715,0.00036004453,0.00018536863],"domain_scores_gemma":[0.99960667,0.00007151786,0.000043100914,0.000015790012,0.00012428634,0.00013856855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014684532,0.0015942309,0.00069388346,0.0010707281,0.0005716809,0.0022756443,0.0010247051,0.0022022706,0.028985908],"category_scores_gemma":[0.00073257386,0.00033266263,0.00091020745,0.00052794593,0.000592379,0.0018615288,0.0017247931,0.0032250124,0.011027035],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050112663,0.00032715214,0.00021922897,0.0018265642,0.00006181497,0.00040826682,0.0003916277,0.0005046026,0.027046332,0.04037667,0.70384514,0.22449145],"study_design_scores_gemma":[0.0000139107315,0.00012811043,0.00022414222,0.00020426548,0.000012848011,0.0002308899,0.000046131852,0.00010125819,0.0034894056,0.0017044079,0.99383545,0.000009205654],"about_ca_topic_score_codex":0.00023815903,"about_ca_topic_score_gemma":0.00032326786,"teacher_disagreement_score":0.028985908,"about_ca_system_score_codex":0.0013391777,"about_ca_system_score_gemma":0.0012137428,"threshold_uncertainty_score":0.09696758},"labels":[],"label_agreement":null},{"id":"W2167573919","doi":"10.1517/14712598.2014.959924","title":"Update on belimumab for the management of systemic lupus erythematosus","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Belimumab; Medicine; Clinical trial; Placebo; Intensive care medicine; Immunology; Internal medicine; B-cell activating factor; Alternative medicine; Antibody; B cell; Pathology","score_opus":0.16357567254011562,"score_gpt":0.4257702727252415,"score_spread":0.26219460018512586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167573919","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032788917,0.96367824,0.0004780934,0.018881254,0.009379828,0.000036706035,0.00023187847,0.000051824165,0.006934245],"genre_scores_gemma":[0.0021531386,0.96443075,0.0011100168,0.016988255,0.0098549435,0.00006650526,0.00041587045,0.000017206818,0.004963405],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992866,0.00019769387,0.000113551476,0.000065361164,0.0002804033,0.000056452198],"domain_scores_gemma":[0.99813074,0.00067744247,0.00023843917,0.000029003933,0.0007828707,0.00014153996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013221968,0.0006428822,0.0010531815,0.0012884333,0.00027664303,0.0012083206,0.0010253848,0.0021933613,0.006451919],"category_scores_gemma":[0.002964029,0.0002625518,0.0008761307,0.001021818,0.00040144316,0.001439156,0.0006585744,0.0038538128,0.004610721],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000213478,0.000053941778,0.00012907089,0.007849535,0.00010573089,0.00025544342,0.00006246159,0.00016409422,0.0009795052,0.0025509568,0.30574504,0.6818907],"study_design_scores_gemma":[0.00004462359,0.000079399775,0.0002597863,0.002468904,0.00007805676,0.00040179715,0.000014353227,0.00003819647,0.00010328885,0.0006550219,0.995849,0.000007605739],"about_ca_topic_score_codex":0.0012301526,"about_ca_topic_score_gemma":0.0031167413,"teacher_disagreement_score":0.006451919,"about_ca_system_score_codex":0.00088785915,"about_ca_system_score_gemma":0.0013351858,"threshold_uncertainty_score":0.021583796},"labels":[],"label_agreement":null},{"id":"W2167992220","doi":"10.1517/14712598.2014.924496","title":"Efficacy and safety of subcutaneous interferon-β-1a in patients with a first demyelinating event and early multiple sclerosis","year":2014,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"EMD Serono; Teva Pharmaceutical Industries","keywords":"Multiple sclerosis; Medicine; Demyelinating disease; Event (particle physics); Immunology; Interferon; Physics","score_opus":0.1471201261681221,"score_gpt":0.3693502222295723,"score_spread":0.22223009606145022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167992220","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013860216,0.99945635,0.00001955332,0.000080794285,0.000044505334,0.0000040065343,0.00001233644,0.0000011319803,0.00024260314],"genre_scores_gemma":[0.0018999066,0.9976483,0.000072432194,0.00014149923,0.000058531754,0.000009824109,0.00002213532,6.048289e-7,0.00014668015],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973744,0.00007443202,0.00005649426,0.00003726245,0.00007848157,0.000015767984],"domain_scores_gemma":[0.9995338,0.00027839883,0.000105031504,0.00000613058,0.000060397462,0.000016365153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082886463,0.00045485413,0.0018087047,0.00090366893,0.00012256257,0.0005206704,0.00057120924,0.0008897583,0.003152428],"category_scores_gemma":[0.0014294282,0.00014985025,0.00085454347,0.0009442825,0.0002143886,0.0004115412,0.0002549274,0.0008306761,0.00065297674],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004666544,0.000059692073,0.00021732884,0.08663443,0.00056009804,0.00012612311,0.00004686245,0.00015280688,0.0010699795,0.0007561193,0.0099829845,0.89992696],"study_design_scores_gemma":[0.0011279042,0.001660749,0.010967878,0.15889709,0.0064377165,0.0055159233,0.00027339035,0.00033367632,0.0023528782,0.0025505798,0.8098004,0.00008178407],"about_ca_topic_score_codex":0.0008250606,"about_ca_topic_score_gemma":0.0012672928,"teacher_disagreement_score":0.003152428,"about_ca_system_score_codex":0.00040566444,"about_ca_system_score_gemma":0.0007309421,"threshold_uncertainty_score":0.010545909},"labels":[],"label_agreement":null},{"id":"W2168921856","doi":"10.1517/14712598.1.1.121","title":"O-raffinose-polymerised haemoglobin. A biochemical and pharmacological profile of an oxygen carrier","year":2001,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Hemoglobin structure and function","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Raffinose; Nitric oxide; Oxygen; Chemistry; Hemodynamics; Medicine; Perioperative; Blood volume; Biochemistry; Pharmacology; Surgery; Internal medicine","score_opus":0.07237689146987646,"score_gpt":0.3724817281050197,"score_spread":0.30010483663514326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168921856","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54328173,0.38510606,0.03750063,0.0032851351,0.00068168686,0.0005692693,0.0014984224,0.00031159905,0.027765486],"genre_scores_gemma":[0.8916096,0.07912303,0.009785413,0.0011916094,0.0003133196,0.0002045464,0.0018380249,0.00003328471,0.015901161],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999441,0.00001049606,0.0000023554717,0.000011223478,0.000023388817,0.000008468646],"domain_scores_gemma":[0.99995923,0.000008427629,0.000011940838,0.0000018768857,0.0000100239895,0.000008510284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014863469,0.00024518569,0.0001460219,0.00017271923,0.000042406165,0.00018374654,0.00018514064,0.0004990491,0.0011531855],"category_scores_gemma":[0.00011226172,0.000053869528,0.000112401605,0.000114562776,0.00008296016,0.00014245466,0.00007616143,0.00031943314,0.00054753665],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041600107,0.00011680526,0.00023803605,0.00068299327,0.000017947088,0.00024053527,0.00002071999,0.00046903334,0.9119554,0.00077178096,0.001609415,0.083461344],"study_design_scores_gemma":[0.00024786382,0.006566739,0.009394043,0.00019832642,0.0001235336,0.0033494278,0.00003517388,0.0027694476,0.7852447,0.0005630626,0.19147082,0.00003686198],"about_ca_topic_score_codex":0.0003570535,"about_ca_topic_score_gemma":0.0004108789,"teacher_disagreement_score":0.0011531855,"about_ca_system_score_codex":0.00021021636,"about_ca_system_score_gemma":0.00008024319,"threshold_uncertainty_score":0.0038577318},"labels":[],"label_agreement":null},{"id":"W2198610527","doi":"10.1517/14712598.2015.1083552","title":"Biosimilar monoclonal antibodies: the scientific basis for extrapolation","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Infliximab; Medicine; Pharmacology; Disease; Internal medicine","score_opus":0.38047339994214074,"score_gpt":0.4642009020635223,"score_spread":0.08372750212138158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2198610527","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036265916,0.9691668,0.0029976603,0.020286819,0.002019565,0.000047852936,0.000046943223,0.00001796581,0.005053728],"genre_scores_gemma":[0.00887667,0.96782774,0.003650438,0.014869567,0.0031478978,0.0001014528,0.000074542964,0.000014347356,0.0014373946],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99091583,0.0031273908,0.0010940215,0.0007936951,0.003865434,0.00020366268],"domain_scores_gemma":[0.98099935,0.013568699,0.0017188698,0.00056082587,0.0029058051,0.00024637915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013663639,0.00077007775,0.0016653427,0.0019471677,0.0004663806,0.0032486704,0.002305204,0.005600867,0.003271362],"category_scores_gemma":[0.01982877,0.00041132176,0.0008824953,0.0017253697,0.0055190143,0.005295333,0.0014910458,0.008688651,0.0022417223],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015228294,0.00008904451,0.00047999754,0.022512734,0.00013559019,0.0005714672,0.0004179951,0.0008049678,0.002756481,0.14257337,0.05659571,0.7729103],"study_design_scores_gemma":[0.000045180743,0.0001138795,0.00046796954,0.013785402,0.00010123371,0.001790296,0.00024740683,0.0003232923,0.0014874155,0.052067544,0.92952234,0.00004802242],"about_ca_topic_score_codex":0.0008721652,"about_ca_topic_score_gemma":0.0008412945,"teacher_disagreement_score":0.013663639,"about_ca_system_score_codex":0.0021367753,"about_ca_system_score_gemma":0.003803972,"threshold_uncertainty_score":0.072261095},"labels":[],"label_agreement":null},{"id":"W2202409929","doi":"10.1517/14712598.2016.1118045","title":"Novel approaches to biological therapy for psoriatic arthritis","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Psoriatic arthritis; Medicine; Etanercept; Psoriasis; Computational biology; Dermatology; Biology; Immunology; Rheumatoid arthritis","score_opus":0.611622334140147,"score_gpt":0.4386725925280474,"score_spread":0.17294974161209958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2202409929","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029587127,0.9988601,0.00006240378,0.00028738633,0.00015829699,0.000003970112,0.00001021723,0.0000026460878,0.00058534095],"genre_scores_gemma":[0.0003746859,0.9987048,0.0001279744,0.00029411088,0.00017218127,0.0000055081136,0.000016394786,8.2967745e-7,0.00030354856],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995338,0.00010538579,0.00008024664,0.000064612024,0.00019012946,0.000025940903],"domain_scores_gemma":[0.9994011,0.00032808087,0.00009641724,0.000017302626,0.00012826174,0.000028799714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008625014,0.00076878176,0.0012818939,0.0028321957,0.00028786887,0.0010520718,0.0006195652,0.0012832707,0.0072346814],"category_scores_gemma":[0.0012459565,0.00023053198,0.000834217,0.0023556545,0.0005772923,0.0013050864,0.00074168824,0.0021683841,0.002667316],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061629726,0.00005668292,0.00008670489,0.042219277,0.00013853749,0.00013388759,0.00006600326,0.00019353941,0.00092890667,0.0048374194,0.030374603,0.9209027],"study_design_scores_gemma":[0.00002604925,0.000065761866,0.00047821086,0.014954726,0.00015035839,0.0010345193,0.000051356204,0.000056203953,0.00024693305,0.002388625,0.98053247,0.000014896812],"about_ca_topic_score_codex":0.0012308006,"about_ca_topic_score_gemma":0.0022337534,"teacher_disagreement_score":0.0072346814,"about_ca_system_score_codex":0.0006746289,"about_ca_system_score_gemma":0.0012668322,"threshold_uncertainty_score":0.024202466},"labels":[],"label_agreement":null},{"id":"W2221971298","doi":"10.1517/14712598.2016.1121231","title":"Vedolizumab for the treatment of ulcerative colitis","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Vedolizumab; Ulcerative colitis; Medicine; Colitis; Intensive care medicine; Internal medicine; Disease","score_opus":0.16582781536460267,"score_gpt":0.4142006915334602,"score_spread":0.2483728761688575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2221971298","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000064075364,0.9987993,0.00005620196,0.00035045051,0.00015912313,0.0000032374642,0.000011971189,0.000003204229,0.0005524561],"genre_scores_gemma":[0.00072580733,0.9983475,0.00008989252,0.00033047656,0.00017551695,0.000004002593,0.000021955619,8.941748e-7,0.0003039468],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997956,0.000048934948,0.0000307033,0.00003653033,0.000071518014,0.00001667785],"domain_scores_gemma":[0.99968326,0.00016334612,0.00006461263,0.000007176545,0.00006016887,0.000021451988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051957543,0.0004814567,0.0009276297,0.001629284,0.00017790994,0.00070863846,0.00059593166,0.0009410115,0.003854492],"category_scores_gemma":[0.00083800533,0.00013592535,0.00053381367,0.0012077827,0.0003673489,0.00073247124,0.0004433655,0.001375959,0.0016590087],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103093036,0.000032421816,0.00013850714,0.026121391,0.00014713274,0.00022868374,0.000040307834,0.00020422411,0.0012089917,0.0023970592,0.03443961,0.93493855],"study_design_scores_gemma":[0.00004699181,0.00009469838,0.00075571163,0.011330368,0.00025761654,0.0024674637,0.000045188695,0.0000811126,0.00036636667,0.0018227575,0.9827131,0.000018488645],"about_ca_topic_score_codex":0.0007195718,"about_ca_topic_score_gemma":0.0015173206,"teacher_disagreement_score":0.003854492,"about_ca_system_score_codex":0.00044993972,"about_ca_system_score_gemma":0.00070608855,"threshold_uncertainty_score":0.012894511},"labels":[],"label_agreement":null},{"id":"W2298021796","doi":"10.1517/14712598.2016.1167868","title":"Vascular endothelial growth factor inhibitor use and treatment approach for choroidal neovascularization secondary to pathologic myopia","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Aflibercept; Ranibizumab; Medicine; Macular degeneration; Choroidal neovascularization; Ophthalmology; Vascular endothelial growth factor; Bevacizumab; Surgery; VEGF receptors; Internal medicine; Chemotherapy","score_opus":0.1476687661530578,"score_gpt":0.36970562108051064,"score_spread":0.22203685492745284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2298021796","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011498509,0.9979662,0.00008400967,0.00032644867,0.00019015034,0.0000067340898,0.000016958715,0.0000053482895,0.0012891641],"genre_scores_gemma":[0.0010316073,0.99767464,0.00019054911,0.00032303634,0.0002057484,0.000007129537,0.00002997694,0.0000010042869,0.00053630746],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998436,0.000024704,0.000030051651,0.00002934859,0.00005981428,0.00001243525],"domain_scores_gemma":[0.99982244,0.000074682815,0.000045518096,0.0000036468987,0.00004213515,0.000011536117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002934173,0.0004944298,0.00067342795,0.0016892827,0.00021051422,0.0005261505,0.0005323785,0.0007805277,0.0040859445],"category_scores_gemma":[0.00056558795,0.0001244873,0.0004985461,0.00090863946,0.0002324323,0.00064200873,0.00031417335,0.0011232193,0.0013563146],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059202655,0.00006055888,0.00023168257,0.025384966,0.00011499456,0.00048744798,0.00005354286,0.00023250283,0.0014336775,0.0021703593,0.03862314,0.931148],"study_design_scores_gemma":[0.000033794266,0.00012554393,0.0018153704,0.015362364,0.0003046823,0.007304227,0.0000743816,0.00017061812,0.0006590181,0.0013214288,0.97280777,0.000020950903],"about_ca_topic_score_codex":0.0009996383,"about_ca_topic_score_gemma":0.0020601165,"teacher_disagreement_score":0.0040859445,"about_ca_system_score_codex":0.00043452837,"about_ca_system_score_gemma":0.0007196948,"threshold_uncertainty_score":0.013668895},"labels":[],"label_agreement":null},{"id":"W2302397867","doi":"10.1517/14712598.2016.1134483","title":"<i>Mycobacterium phlei</i>cell wall-nucleic acid complex in the treatment of nonmuscle invasive bladder cancer unresponsive to bacillus Calmette-Guerin","year":2015,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Telesta Therapeutics (Canada); Queen's University","funders":"","keywords":"Medicine; Bladder cancer; Cystectomy; Regimen; Clinical trial; BCG vaccine; Refractory (planetary science); Oncology; Internal medicine; Intensive care medicine; Surgery; Cancer; Immunology; Vaccination; Biology","score_opus":0.26248453615048944,"score_gpt":0.4282477445639823,"score_spread":0.16576320841349285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2302397867","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010625843,0.99711347,0.00006754582,0.00076523656,0.00047270756,0.000010309882,0.000033140208,0.0000062268605,0.0014250396],"genre_scores_gemma":[0.0010804882,0.99619734,0.00014289843,0.0009908141,0.00042926884,0.000012000003,0.000069379756,0.0000020799253,0.0010757457],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980086,0.000044037504,0.000027585891,0.00002902834,0.000083548264,0.000014960876],"domain_scores_gemma":[0.9997235,0.00011044126,0.0000692815,0.000006102575,0.00007310073,0.000017590111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043175867,0.00046352303,0.0007515412,0.0012361706,0.00015405648,0.00051613303,0.00052814855,0.0009286189,0.004957708],"category_scores_gemma":[0.0007140134,0.000108827575,0.00048453073,0.0011190563,0.0003057416,0.00069483503,0.00038098922,0.0012074059,0.002182514],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013383606,0.00003849802,0.000119248514,0.043803968,0.00012741105,0.00017050849,0.000056836296,0.00021614687,0.0024028304,0.0023234235,0.09509719,0.8555101],"study_design_scores_gemma":[0.000040800773,0.00013613404,0.0009231657,0.013385084,0.00016677263,0.0012885783,0.000046025158,0.00008264627,0.0007010778,0.0010789684,0.9821353,0.000015457219],"about_ca_topic_score_codex":0.0010809931,"about_ca_topic_score_gemma":0.0017532278,"teacher_disagreement_score":0.004957708,"about_ca_system_score_codex":0.000450092,"about_ca_system_score_gemma":0.00071393856,"threshold_uncertainty_score":0.016585171},"labels":[],"label_agreement":null},{"id":"W2320245919","doi":"10.1517/14712598.2010.532483","title":"siRNA therapy for cancer and non-lethal diseases such as arthritis and osteoporosis","year":2010,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Genetic enhancement; Rheumatoid arthritis; Gene silencing; Osteoporosis; Osteoarthritis; Arthritis; Bioinformatics; Cancer; Disease; Immunology; Pathology; Internal medicine; Gene; Alternative medicine; Biology","score_opus":0.0684498500099538,"score_gpt":0.38252299792797106,"score_spread":0.31407314791801727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320245919","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000450106,0.9907804,0.0014186689,0.0010043315,0.00091147167,0.000023968081,0.000030537904,0.00003107779,0.0053494405],"genre_scores_gemma":[0.0024378055,0.99071306,0.0010557832,0.0006415991,0.00036364718,0.000033189976,0.000058998157,0.0000071466548,0.0046887556],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981314,0.000033760283,0.000018179317,0.000028493523,0.00009130501,0.0000150760425],"domain_scores_gemma":[0.99987745,0.000042830154,0.000020978321,0.0000053483323,0.000040009796,0.000013338424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033070336,0.00071471016,0.0010308592,0.0011447624,0.00028434925,0.0005825587,0.000521604,0.001216619,0.0040957048],"category_scores_gemma":[0.0003101409,0.00015939707,0.00043657032,0.0008034536,0.00046192497,0.0009081146,0.00043625495,0.0013520458,0.0036699956],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076296186,0.00009781285,0.000117104624,0.013239009,0.00007163119,0.00048530792,0.000104944775,0.00033900212,0.032303274,0.0070337327,0.04500814,0.90112364],"study_design_scores_gemma":[0.000022854209,0.00013887322,0.0005589617,0.0010767608,0.000054507113,0.0022435274,0.00004225703,0.00014472418,0.0059606545,0.002038427,0.9877008,0.000017768669],"about_ca_topic_score_codex":0.0007777465,"about_ca_topic_score_gemma":0.0013777582,"teacher_disagreement_score":0.0040957048,"about_ca_system_score_codex":0.00050393614,"about_ca_system_score_gemma":0.00086658855,"threshold_uncertainty_score":0.0137014985},"labels":[],"label_agreement":null},{"id":"W2335443846","doi":"10.1517/14712598.2016.1169268","title":"Prospect of ultrasound-mediated gene delivery in cardiovascular applications","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Institute of Circulatory and Respiratory Health; Canadian Institutes of Health Research","keywords":"Gene delivery; Medicine; Genetic enhancement; Computational biology; Gene; Biology; Bioinformatics; Genetics","score_opus":0.059132822661843124,"score_gpt":0.30462247758819266,"score_spread":0.24548965492634955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335443846","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00046464542,0.99375445,0.0011301421,0.0007161523,0.000390842,0.000010323917,0.000021009859,0.000014585992,0.0034978967],"genre_scores_gemma":[0.0035664893,0.99312794,0.00078344735,0.00037635377,0.00027972637,0.000014907439,0.000031377785,0.000004009246,0.0018156953],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998246,0.00003749499,0.00001343506,0.00003396026,0.00007078952,0.00001969646],"domain_scores_gemma":[0.99981457,0.000099425764,0.000025802943,0.000004828499,0.00004436662,0.00001111601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004661168,0.00055542146,0.00062096363,0.0011267634,0.00019016874,0.0007792636,0.00041348752,0.0013820134,0.0039564595],"category_scores_gemma":[0.00039552126,0.00022005176,0.000484118,0.0007878326,0.0004582509,0.0010571157,0.00046569316,0.0015060576,0.0020455886],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006635163,0.00007139921,0.00016091105,0.019887185,0.000054002583,0.00041957805,0.00016121795,0.0008281411,0.031896483,0.014270313,0.02482549,0.90735894],"study_design_scores_gemma":[0.000011937537,0.00014377375,0.00044542068,0.0023370893,0.000054991175,0.0016629138,0.0000688792,0.00031804832,0.0067400215,0.0032730603,0.9849194,0.000024373672],"about_ca_topic_score_codex":0.0005273771,"about_ca_topic_score_gemma":0.0006697678,"teacher_disagreement_score":0.0039564595,"about_ca_system_score_codex":0.00042657735,"about_ca_system_score_gemma":0.0005740903,"threshold_uncertainty_score":0.013235688},"labels":[],"label_agreement":null},{"id":"W2412338323","doi":"10.1080/14712598.2016.1193594","title":"HIV-1 Immunogen: an overview of almost 30 years of clinical testing of a candidate therapeutic vaccine","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Clinical trial; HIV vaccine; Immunogen; AIDS Vaccines; Intensive care medicine; Immunology; Human immunodeficiency virus (HIV); Vaccine trial; Virology; Internal medicine","score_opus":0.4007525412356802,"score_gpt":0.4963771413272392,"score_spread":0.09562460009155899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412338323","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053143624,0.998259,0.00009681584,0.000499192,0.00021005385,0.000006893361,0.000016394659,0.000004477642,0.00085409463],"genre_scores_gemma":[0.00041040702,0.99850935,0.00016077625,0.0003461847,0.00019006415,0.000010492641,0.000024514831,0.0000014210704,0.00034684959],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99953246,0.000105754836,0.00006450764,0.00007049152,0.00019092615,0.000035930625],"domain_scores_gemma":[0.9993081,0.00040572372,0.00007371724,0.000015786261,0.00015867095,0.000038014765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011655361,0.0009901348,0.0016269828,0.0025504755,0.00028971385,0.0011523152,0.0009993017,0.0019095704,0.004320559],"category_scores_gemma":[0.0013356984,0.00037504226,0.0007370435,0.001968715,0.00058991375,0.0015817748,0.0005977477,0.0023713503,0.0026645001],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009662967,0.0000784666,0.00012999,0.027478015,0.000089688016,0.00020325162,0.00006891555,0.00027675956,0.001721679,0.005314171,0.04486666,0.9196758],"study_design_scores_gemma":[0.000020229596,0.00011280225,0.0003747858,0.008571397,0.00009021848,0.0008788203,0.000050409864,0.0000787175,0.00038680618,0.0017984804,0.9876195,0.000017887935],"about_ca_topic_score_codex":0.00087082904,"about_ca_topic_score_gemma":0.0014175066,"teacher_disagreement_score":0.004320559,"about_ca_system_score_codex":0.0007925663,"about_ca_system_score_gemma":0.0011899173,"threshold_uncertainty_score":0.014453709},"labels":[],"label_agreement":null},{"id":"W2463180023","doi":"10.1080/14712598.2016.1205582","title":"Ustekinumab: a novel therapeutic option in Crohn’s disease","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Ustekinumab; Medicine; Crohn's disease; Disease; Expert opinion; Vedolizumab; Monoclonal; Tumor necrosis factor alpha; Intensive care medicine; Monoclonal antibody; Immunology; Internal medicine; Infliximab; Antibody","score_opus":0.11186438393638137,"score_gpt":0.38005003603072296,"score_spread":0.2681856520943416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2463180023","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008188709,0.9983015,0.00008219512,0.000505412,0.00023087722,0.0000036732297,0.000013310709,0.0000048303223,0.00077620544],"genre_scores_gemma":[0.0008254769,0.9979546,0.00011761547,0.00037517917,0.00023293948,0.000005681021,0.000023665074,0.0000011644947,0.00046365836],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978226,0.0000451339,0.00002868081,0.0000366675,0.00008630817,0.00002094574],"domain_scores_gemma":[0.9997949,0.00009785251,0.000038831982,0.000005453987,0.000043909968,0.000019106654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004913948,0.0005810692,0.0011292036,0.001489355,0.00021254217,0.0009958441,0.0007070623,0.0013607176,0.0048251995],"category_scores_gemma":[0.0005370296,0.00018627051,0.0005509287,0.0011413667,0.00040305732,0.0011058442,0.0006007648,0.002210119,0.0026650615],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008068745,0.000039615454,0.00009651224,0.014872332,0.00008617384,0.00025022912,0.000043466014,0.00019657088,0.0013576093,0.003326416,0.027516004,0.95213443],"study_design_scores_gemma":[0.000040282186,0.00008546742,0.0004896378,0.006734048,0.00012089099,0.0021553792,0.000050506776,0.00008756517,0.0003816803,0.002427539,0.9874105,0.000016490427],"about_ca_topic_score_codex":0.00042362622,"about_ca_topic_score_gemma":0.0010104068,"teacher_disagreement_score":0.0048251995,"about_ca_system_score_codex":0.0004370581,"about_ca_system_score_gemma":0.00056877156,"threshold_uncertainty_score":0.016141891},"labels":[],"label_agreement":null},{"id":"W2508017949","doi":"10.1080/14712598.2016.1235149","title":"Biomaterial strategies to improve the efficacy of bone marrow cell therapy for myocardial infarction","year":2016,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Tissue Engineering and Regenerative Medicine","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Ontario Ministry of Research and Innovation; Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Research, Innovation and Science","keywords":"Medicine; Cell therapy; Biomaterial; Myocardial infarction; Clinical trial; Intensive care medicine; Stem-cell therapy; Transplantation; Stem cell; Pathology; Internal medicine; Biomedical engineering; Biology","score_opus":0.08882421842129841,"score_gpt":0.38483580552993746,"score_spread":0.29601158710863906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508017949","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012567072,0.99857676,0.00012742242,0.00028598693,0.0002401378,0.000006875461,0.000010032418,0.0000036930373,0.00062342477],"genre_scores_gemma":[0.000917046,0.9981406,0.00019055029,0.00022029913,0.00013018925,0.000009744435,0.000018750477,0.0000011189829,0.00037169948],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997315,0.000048344355,0.00004740219,0.00003939333,0.0001131844,0.000020173788],"domain_scores_gemma":[0.9996923,0.00015439931,0.000060307866,0.0000064991395,0.000073082425,0.0000134996535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006366695,0.0006915623,0.0010344613,0.0016902905,0.00016456617,0.0007676752,0.0006594069,0.0013694944,0.0032064768],"category_scores_gemma":[0.0008995973,0.0001944466,0.0006313237,0.0010345008,0.0003345719,0.000890524,0.0004936372,0.0012546041,0.0013330698],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008126162,0.000077490324,0.000105639,0.040689763,0.0001613016,0.00021296037,0.000065565546,0.00037663552,0.005021632,0.0049166097,0.021879416,0.9264117],"study_design_scores_gemma":[0.000036975565,0.00014826322,0.0007225466,0.010363242,0.00021254706,0.0012519031,0.0000730393,0.00016722688,0.0021802192,0.0022291378,0.98259085,0.000023991171],"about_ca_topic_score_codex":0.00059908803,"about_ca_topic_score_gemma":0.0011546072,"teacher_disagreement_score":0.0032064768,"about_ca_system_score_codex":0.0004618572,"about_ca_system_score_gemma":0.00071840966,"threshold_uncertainty_score":0.0107268095},"labels":[],"label_agreement":null},{"id":"W2727069163","doi":"10.1080/14712598.2017.1346080","title":"Cellular mechanisms underlying cardiac engraftment of stem cells","year":2017,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Tissue Engineering and Regenerative Medicine","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Institute of Circulatory and Respiratory Health; Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Stem cell; Ex vivo; Regeneration (biology); Cell therapy; Transplantation; Cell; Limiting; Cancer research; Cell biology; Biology; Neuroscience; Medicine; Immunology; In vivo; Internal medicine; Biotechnology","score_opus":0.42307159238040176,"score_gpt":0.44437146097184466,"score_spread":0.021299868591442894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2727069163","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032077217,0.99526334,0.0006347253,0.0007467806,0.000435582,0.000008334635,0.000036650992,0.000010235061,0.0025434843],"genre_scores_gemma":[0.0028878339,0.995291,0.00022827888,0.0003789589,0.00027734006,0.000010942724,0.000049817318,0.000002204267,0.0008736227],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997439,0.000040828185,0.00002497765,0.00005644949,0.00010790073,0.000025989992],"domain_scores_gemma":[0.999762,0.000095887015,0.00004262519,0.0000071903805,0.00007301193,0.00001925865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005841962,0.000537636,0.0007531249,0.0010634551,0.00020347838,0.0010668992,0.00071196107,0.0012876918,0.0037743],"category_scores_gemma":[0.0005472972,0.00017493055,0.0003535306,0.0007054641,0.00087534555,0.0011595223,0.0006494144,0.0014433456,0.0021314358],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009113587,0.000042036943,0.00022590681,0.023280086,0.00007003615,0.00040775456,0.00016111211,0.0007959788,0.024878995,0.032967545,0.023756765,0.89332265],"study_design_scores_gemma":[0.000012119233,0.000099813915,0.0008347391,0.0038239039,0.000049326394,0.0012091838,0.000098949065,0.00018892661,0.005432855,0.009132322,0.9790922,0.00002567301],"about_ca_topic_score_codex":0.0005984617,"about_ca_topic_score_gemma":0.00072278857,"teacher_disagreement_score":0.0037743,"about_ca_system_score_codex":0.0006622182,"about_ca_system_score_gemma":0.00089880393,"threshold_uncertainty_score":0.012626231},"labels":[],"label_agreement":null},{"id":"W2749145761","doi":"10.1080/14712598.2017.1363886","title":"Bezlotoxumab for the prevention of<i>Clostridium difficile</i>recurrence","year":2017,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Sanofi Pasteur; U.S. Food and Drug Administration; Pfizer","keywords":"Medicine; Intensive care medicine","score_opus":0.439279009154149,"score_gpt":0.5042040518800215,"score_spread":0.06492504272587246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2749145761","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016865788,0.9978537,0.000078797864,0.00062518055,0.000278673,0.000009032423,0.000032786273,0.0000051037623,0.0009479621],"genre_scores_gemma":[0.002003215,0.9965701,0.00014855916,0.0005222644,0.00020599508,0.000009692726,0.000047963647,0.0000014475922,0.0004907212],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99970764,0.00007731589,0.000039958428,0.000042843672,0.00010820389,0.000024003048],"domain_scores_gemma":[0.99964046,0.00016946593,0.000092295515,0.0000070397055,0.00007404754,0.000016674087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005205455,0.0004611698,0.00092734484,0.0010417704,0.0001556316,0.0007070939,0.0006286492,0.0010062883,0.005218244],"category_scores_gemma":[0.0012353085,0.000112299516,0.000960595,0.0008525923,0.0002443947,0.00060607254,0.0003406542,0.0011356572,0.0012092815],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022161602,0.000050677907,0.00023097622,0.06736309,0.0005096981,0.00018170502,0.000057830577,0.00028037987,0.0015038125,0.0030062285,0.052323338,0.8742708],"study_design_scores_gemma":[0.0002001283,0.00020826927,0.0016014548,0.033907324,0.0010735445,0.0016636145,0.00008420779,0.0002152798,0.00086837023,0.0022980156,0.95785195,0.000027887943],"about_ca_topic_score_codex":0.001131628,"about_ca_topic_score_gemma":0.0018279247,"teacher_disagreement_score":0.005218244,"about_ca_system_score_codex":0.0004659793,"about_ca_system_score_gemma":0.00096459675,"threshold_uncertainty_score":0.01745677},"labels":[],"label_agreement":null},{"id":"W2912092093","doi":"10.1080/14712598.2019.1575359","title":"Disease modeling of cardiac arrhythmias using human induced pluripotent stem cells","year":2019,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Cardiac electrophysiology and arrhythmias","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Institute of Circulatory and Respiratory Health","keywords":"Induced pluripotent stem cell; Disease; Neuroscience; Medicine; Bioinformatics; Stem cell; Genome editing; Biology; Phenotype; Ex vivo; Computational biology; Pathology; Embryonic stem cell; In vivo; CRISPR; Cell biology; Genetics; Gene","score_opus":0.2512743457737118,"score_gpt":0.40365702252840946,"score_spread":0.15238267675469763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912092093","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007376726,0.9893672,0.002662633,0.00093793805,0.00065848976,0.00003858046,0.00015116057,0.000040688195,0.0054056053],"genre_scores_gemma":[0.0064752796,0.98883283,0.0013540878,0.00071697263,0.00032111196,0.000035275334,0.00026082722,0.000007696898,0.0019958583],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998031,0.000041487714,0.000023416675,0.000030585375,0.00008551841,0.000015918426],"domain_scores_gemma":[0.9998313,0.00007175538,0.000027283466,0.000006163903,0.000052188167,0.000011180989],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005238753,0.0004872987,0.00061059784,0.0007267829,0.00009986307,0.0006815763,0.00052838825,0.0007392164,0.0030747806],"category_scores_gemma":[0.00043821387,0.000107144624,0.00049148075,0.00048100302,0.00021098182,0.000488398,0.00042857107,0.0010398241,0.0017394869],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006650694,0.000047084537,0.00022989369,0.019194301,0.00011850683,0.00040295167,0.00007295093,0.0009736489,0.020290336,0.008727824,0.026725313,0.9231507],"study_design_scores_gemma":[0.000026690494,0.00012987004,0.0006355671,0.003800056,0.00016724615,0.0014521643,0.00004629166,0.0003995044,0.006443716,0.0033398997,0.98353666,0.000022237751],"about_ca_topic_score_codex":0.00039592,"about_ca_topic_score_gemma":0.00062219874,"teacher_disagreement_score":0.0030747806,"about_ca_system_score_codex":0.00025805712,"about_ca_system_score_gemma":0.0004184441,"threshold_uncertainty_score":0.010286212},"labels":[],"label_agreement":null},{"id":"W2939487002","doi":"10.1080/14712598.2019.1608179","title":"Facing the future: challenges and opportunities in adoptive T cell therapy in cancer","year":2019,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Immunotherapy; Tumor microenvironment; Chimeric antigen receptor; T cell; Cancer immunotherapy; Context (archaeology); Medicine; Adoptive cell transfer; Cell therapy; Cancer; Cancer research; Immune system; Immunology; Cell; Biology; Internal medicine","score_opus":0.5050365452917507,"score_gpt":0.4602758091893972,"score_spread":0.04476073610235348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2939487002","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007765097,0.994409,0.00023195014,0.003588838,0.00080086815,0.000003814096,0.000012623598,0.000009354171,0.0008658545],"genre_scores_gemma":[0.0007705252,0.99551195,0.00026030783,0.001877766,0.0009224653,0.000008083235,0.000022431388,0.0000020966988,0.0006243508],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963164,0.000111097004,0.000028244502,0.000047776397,0.00013676967,0.00004444264],"domain_scores_gemma":[0.99931586,0.00036112673,0.000056127355,0.000015477755,0.00019518017,0.00005631694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013585996,0.00053429726,0.0009612504,0.0009939602,0.00025523992,0.0011857225,0.0008615169,0.0021326025,0.003995888],"category_scores_gemma":[0.0010584681,0.00017749803,0.0006399375,0.0009643096,0.00074982404,0.0022651798,0.00068862183,0.0037794132,0.0022996014],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008374517,0.000063506086,0.00009480092,0.012746504,0.0000636496,0.00020224253,0.0000934736,0.00052239804,0.0021721825,0.0112078935,0.08845168,0.8842978],"study_design_scores_gemma":[0.000021056721,0.000092052884,0.00021764608,0.002970124,0.000042911288,0.00047795664,0.00007973095,0.00013483701,0.00025813002,0.0055573396,0.9901335,0.000014706186],"about_ca_topic_score_codex":0.0008627915,"about_ca_topic_score_gemma":0.0018686125,"teacher_disagreement_score":0.003995888,"about_ca_system_score_codex":0.00085470185,"about_ca_system_score_gemma":0.0014431565,"threshold_uncertainty_score":0.013367593},"labels":[],"label_agreement":null},{"id":"W2982452225","doi":"10.1080/14712598.2020.1685976","title":"Blockade of the CD47-SIRPα axis: a promising approach for cancer immunotherapy","year":2019,"lang":"en","type":"editorial","venue":"Expert Opinion on Biological Therapy","topic":"Phagocytosis and Immune Regulation","field":"Immunology and Microbiology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"","keywords":"Cancer immunotherapy; Blockade; CD47; Immunotherapy; Medicine; Cancer; Immunology; Cancer research; Immune system; Internal medicine; Receptor","score_opus":0.05707326455684902,"score_gpt":0.3338030003295742,"score_spread":0.2767297357727252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982452225","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014935248,0.08299488,0.00058952294,0.05821347,0.8544884,0.000046501154,0.00014883919,0.00011948825,0.0032495193],"genre_scores_gemma":[0.001429206,0.0867037,0.00042512565,0.057041924,0.83053994,0.000051129875,0.00018242738,0.00006504834,0.023561483],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985598,0.00027004778,0.00016406758,0.00018043819,0.0006901563,0.00013552565],"domain_scores_gemma":[0.996218,0.0013413767,0.00024530373,0.00009101307,0.0014050431,0.00069918326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036230157,0.0019547206,0.0018559695,0.0012533009,0.0009411146,0.0031786286,0.002359975,0.0077697914,0.00779478],"category_scores_gemma":[0.005596391,0.00059397274,0.001558082,0.000606885,0.0013412073,0.0031589756,0.0012838887,0.016153745,0.00817943],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070132504,0.000015107466,0.000019514544,0.00041831724,0.000024460038,0.000101839294,0.000010671968,0.00003968469,0.00029737304,0.00081310177,0.9756409,0.022548864],"study_design_scores_gemma":[0.0000691349,0.00006476821,0.00011770823,0.00027680953,0.0000371644,0.00020916191,0.000016822578,0.000102675964,0.00023253904,0.001685301,0.9971733,0.000014556313],"about_ca_topic_score_codex":0.0006956009,"about_ca_topic_score_gemma":0.0023838389,"teacher_disagreement_score":0.00779478,"about_ca_system_score_codex":0.0016568177,"about_ca_system_score_gemma":0.0015922027,"threshold_uncertainty_score":0.026076078},"labels":[],"label_agreement":null},{"id":"W3001974054","doi":"10.1080/14712598.2020.1718097","title":"Epidemiological data and utilization patterns of anti-TNF alpha therapy in the Hungarian ulcerative colitis population between 2012-2016","year":2020,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Infliximab; Medicine; Adalimumab; Ulcerative colitis; Reimbursement; Epidemiology; Internal medicine; Population; Retrospective cohort study; Maintenance therapy; Pediatrics; Tumor necrosis factor alpha; Disease; Chemotherapy; Health care; Environmental health","score_opus":0.1693804087647284,"score_gpt":0.37346683809806874,"score_spread":0.20408642933334034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001974054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99732673,0.0006853806,0.000055484812,0.00004568027,0.00000519484,0.000007806571,0.0016665458,0.00000258235,0.00020464574],"genre_scores_gemma":[0.99779403,0.000380752,0.000060896153,0.000031572206,0.000006807131,0.0000099193185,0.0016414514,9.693432e-7,0.00007366531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928385,0.0001506238,0.0001792503,0.00016690574,0.00011562194,0.000103652514],"domain_scores_gemma":[0.9985361,0.00015579702,0.0010094101,0.00006223041,0.000121701974,0.000114760245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006768967,0.00015026376,0.0003139623,0.0012346221,0.00020756936,0.00058732403,0.00020129705,0.0002553643,0.0011270365],"category_scores_gemma":[0.0014412826,0.00018640075,0.00037352098,0.0022300687,0.0002305942,0.000332461,0.00039189734,0.0002850482,0.00016641713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004939339,0.000013414543,0.9984938,0.000024578827,0.00003807068,0.00004468658,0.00004675754,0.00004013587,0.000054391057,0.000013308676,0.00012754995,0.0010537935],"study_design_scores_gemma":[0.0000020976697,0.000019275303,0.99947256,0.000007924046,0.000015501737,0.00012560928,0.00009953384,0.00006754537,0.00001945238,0.000005257843,0.0001634326,0.0000017913203],"about_ca_topic_score_codex":0.008250534,"about_ca_topic_score_gemma":0.007084655,"teacher_disagreement_score":0.008250534,"about_ca_system_score_codex":0.0006616139,"about_ca_system_score_gemma":0.00051421154,"threshold_uncertainty_score":0.016405046},"labels":[],"label_agreement":null},{"id":"W4213140979","doi":"10.1517/eobt.3.6.1001.21267","title":"Drug discovery for inflammatory diseases","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Immunology; Drug discovery; Innate immune system; Immune system; Chemokine; Autoimmunity; Bioinformatics; Biology","score_opus":0.0927975923568113,"score_gpt":0.3822565203587953,"score_spread":0.28945892800198403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213140979","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029588807,0.80406535,0.011777979,0.046442878,0.017709438,0.0003475382,0.00096882833,0.0006946411,0.115034394],"genre_scores_gemma":[0.034674436,0.769,0.016338551,0.030491251,0.008730201,0.00051745895,0.0019235706,0.00015133605,0.13817312],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992686,0.0001921033,0.000049975402,0.000115397976,0.0002586956,0.000115179624],"domain_scores_gemma":[0.99938667,0.00013726437,0.000058797927,0.00006159895,0.00017001644,0.00018559686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012284718,0.0009596285,0.0010136947,0.0018577069,0.0005841035,0.0022136664,0.0008521204,0.0021093595,0.028978959],"category_scores_gemma":[0.0015612101,0.0003087634,0.0006029385,0.0011633503,0.00075221795,0.0018955339,0.001624588,0.0031418726,0.014716758],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018133564,0.00015494625,0.00027673703,0.0026593013,0.00010043553,0.0003748087,0.00012070322,0.0004022735,0.009040521,0.069840245,0.30346388,0.61338484],"study_design_scores_gemma":[0.00006642253,0.00011336966,0.00014811863,0.00032981203,0.000016896822,0.0002792935,0.00001926515,0.000119539574,0.0010456404,0.00843212,0.9894203,0.00000920032],"about_ca_topic_score_codex":0.00045537428,"about_ca_topic_score_gemma":0.0013718159,"teacher_disagreement_score":0.028978959,"about_ca_system_score_codex":0.0017517237,"about_ca_system_score_gemma":0.0013752712,"threshold_uncertainty_score":0.09694433},"labels":[],"label_agreement":null},{"id":"W4214611031","doi":"10.1517/eobt.3.7.1093.21269","title":"Peptide action in stroke therapy","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Excitotoxicity; Glutamate receptor; Glutamatergic; Neuroscience; Neurotransmission; Receptor; Biology; Excitatory postsynaptic potential; Postsynaptic potential; Pharmacology; Cell biology; Inhibitory postsynaptic potential; Biochemistry","score_opus":0.35261253727455466,"score_gpt":0.45377469932888326,"score_spread":0.1011621620543286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214611031","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003828993,0.9266086,0.0039675725,0.014106715,0.0042333873,0.00004869936,0.00009435217,0.000096451324,0.047015186],"genre_scores_gemma":[0.049642596,0.89621115,0.0060614855,0.011725706,0.0061591305,0.00012840862,0.00023880275,0.000030898293,0.029801741],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981576,0.000048975104,0.000019282419,0.000028479637,0.000063233,0.000024171966],"domain_scores_gemma":[0.99985933,0.000039381463,0.000026365035,0.000011032271,0.000039537485,0.000024292543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048286768,0.0004841254,0.000726857,0.00050942786,0.00025506233,0.0008468259,0.00050105224,0.0015550901,0.008846719],"category_scores_gemma":[0.000479033,0.000095088566,0.00022804351,0.0004196627,0.0004968127,0.00070752803,0.0004710197,0.0014760238,0.004669952],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002868194,0.00014346615,0.00026206695,0.002696797,0.000046942165,0.0014156974,0.00010735377,0.00053122226,0.015447345,0.023499642,0.05232701,0.9032357],"study_design_scores_gemma":[0.00014498274,0.0005742847,0.001121657,0.0009623395,0.00006052431,0.0047686063,0.00006422946,0.00029306373,0.0029644861,0.015493553,0.9735335,0.000018809124],"about_ca_topic_score_codex":0.0004190177,"about_ca_topic_score_gemma":0.00080185203,"teacher_disagreement_score":0.008846719,"about_ca_system_score_codex":0.00053874817,"about_ca_system_score_gemma":0.0005222293,"threshold_uncertainty_score":0.029595256},"labels":[],"label_agreement":null},{"id":"W4224219978","doi":"10.1080/14712598.2022.2066471","title":"Onasemnogene abeparvovec for the treatment of spinal muscular atrophy","year":2022,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital","funders":"","keywords":"Spinal muscular atrophy; Medicine; Physical medicine and rehabilitation; Pathology; Disease","score_opus":0.1591708778901365,"score_gpt":0.40619282643085386,"score_spread":0.24702194854071735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224219978","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010355175,0.94081557,0.0055888086,0.007356397,0.0025204686,0.00010729755,0.00042934614,0.00019868457,0.03262826],"genre_scores_gemma":[0.102657475,0.85782826,0.0050089047,0.0065372805,0.002189745,0.0001604726,0.0011263127,0.00005849628,0.024433102],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998622,0.000030257164,0.000009205166,0.000024706815,0.000055004763,0.000018644205],"domain_scores_gemma":[0.9999007,0.00003358984,0.0000238281,0.000003241405,0.00002633554,0.000012221251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028399922,0.00023577317,0.00033924033,0.00034480914,0.00011181259,0.0004552148,0.00029456368,0.00071524916,0.005656644],"category_scores_gemma":[0.00030042985,0.000059698275,0.0003004198,0.00018236956,0.00022592112,0.00033506315,0.00019180987,0.0009127063,0.0017102072],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076428987,0.00015672811,0.00053194765,0.0104683945,0.000181231,0.0010291464,0.000112537244,0.0006670302,0.068329155,0.010107685,0.09415984,0.81349206],"study_design_scores_gemma":[0.00018787743,0.00080696767,0.001121799,0.0018631158,0.00014777147,0.00304635,0.000047959235,0.00045963674,0.019840265,0.0026510877,0.9698036,0.00002352275],"about_ca_topic_score_codex":0.0005168092,"about_ca_topic_score_gemma":0.0011318572,"teacher_disagreement_score":0.005656644,"about_ca_system_score_codex":0.00037147253,"about_ca_system_score_gemma":0.0003115456,"threshold_uncertainty_score":0.018923283},"labels":[],"label_agreement":null},{"id":"W4229749993","doi":"10.1517/eobt.3.2.319.21151","title":"Biotherapeutic approaches to pancreatic cancer","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital","funders":"","keywords":"Pancreatic cancer; Cancer; Medicine; Computational biology; Cancer research; Biology; Internal medicine","score_opus":0.45762131177354465,"score_gpt":0.4377060633269027,"score_spread":0.019915248446641942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229749993","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014060205,0.14628465,0.0026777503,0.57275194,0.26454666,0.000037151007,0.000116101604,0.00013354002,0.0120461825],"genre_scores_gemma":[0.027652133,0.12527502,0.0070332643,0.58323115,0.18679422,0.000107893335,0.00024368503,0.00014466458,0.069517955],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983334,0.00042161028,0.0002656655,0.00015964886,0.00059570634,0.00022408857],"domain_scores_gemma":[0.9935055,0.0026012915,0.00034468513,0.00048531845,0.0024926143,0.00057065295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052095093,0.00060564926,0.0009941615,0.0009433343,0.0013315026,0.0018842268,0.0020694153,0.0080004465,0.0057929396],"category_scores_gemma":[0.01025935,0.00036309927,0.0008192862,0.0010775524,0.0029221005,0.00293868,0.0015206409,0.011845606,0.004380506],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015194343,0.000052599808,0.00021745804,0.00086886465,0.00004999512,0.0012801846,0.00019268636,0.00020835853,0.0012573395,0.020883936,0.7738186,0.20101807],"study_design_scores_gemma":[0.000033872766,0.000032938366,0.00014918423,0.000244398,0.000023098622,0.000718413,0.000055685177,0.00010145402,0.00035327903,0.0035667857,0.99471056,0.000010316432],"about_ca_topic_score_codex":0.0032459914,"about_ca_topic_score_gemma":0.006598399,"teacher_disagreement_score":0.0080004465,"about_ca_system_score_codex":0.0022620503,"about_ca_system_score_gemma":0.0029999288,"threshold_uncertainty_score":0.027550817},"labels":[],"label_agreement":null},{"id":"W4238774925","doi":"10.1517/eobt.3.8.1291.21293","title":"6th World Congress on Inflammation","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Inflammasome and immune disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Inflammation; Medicine; Immunology","score_opus":0.04287538238884352,"score_gpt":0.3101675836512783,"score_spread":0.26729220126243475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4238774925","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014393722,0.31373048,0.0018568278,0.067765966,0.29133388,0.00039065824,0.001590513,0.00038734043,0.32150495],"genre_scores_gemma":[0.008808059,0.14297053,0.0015811186,0.020712378,0.074008115,0.0005406597,0.002462781,0.00027695665,0.7486394],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980944,0.00028495627,0.00013239078,0.00028875773,0.0008610065,0.00033856326],"domain_scores_gemma":[0.99858475,0.00009252394,0.00013174178,0.000076744036,0.0005088404,0.0006053369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018864062,0.0021082798,0.0014347901,0.0023421382,0.0014003223,0.006557974,0.001464527,0.0046917144,0.11043466],"category_scores_gemma":[0.0022261876,0.00034075536,0.0012290113,0.0012599323,0.0011217255,0.0022360426,0.0031189658,0.0055949474,0.08265415],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102445614,0.000033944518,0.00017277851,0.0004699172,0.000019029641,0.00017325224,0.000051229377,0.00006274744,0.00065993745,0.004850608,0.90874314,0.08466094],"study_design_scores_gemma":[0.0000044033513,0.000014638417,0.00021496149,0.0001838998,0.0000038204803,0.00008676239,0.000015617714,0.00001061018,0.00007246469,0.00055630016,0.998833,0.0000035033497],"about_ca_topic_score_codex":0.0019028861,"about_ca_topic_score_gemma":0.0045424015,"teacher_disagreement_score":0.11043466,"about_ca_system_score_codex":0.0027911097,"about_ca_system_score_gemma":0.0042151697,"threshold_uncertainty_score":0.36944073},"labels":[],"label_agreement":null},{"id":"W4249444689","doi":"10.1517/eobt.3.2.215.21149","title":"Adult stem cell therapy for heart failure","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital","funders":"","keywords":"Heart failure; Stem-cell therapy; Stem cell; Medicine; Cell therapy; Intensive care medicine; Internal medicine; Biology; Cell biology","score_opus":0.05079476180649813,"score_gpt":0.32692137217583367,"score_spread":0.27612661036933556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249444689","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029151058,0.89539295,0.0280931,0.010241806,0.0035812638,0.00016265752,0.00018888734,0.00021135986,0.03297694],"genre_scores_gemma":[0.23053196,0.702112,0.024037601,0.005823488,0.003527415,0.0003251378,0.00064179103,0.000044333527,0.032956257],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99992144,0.000020796222,0.000006023072,0.000008689799,0.000034367444,0.000008704322],"domain_scores_gemma":[0.99995553,0.000014643105,0.00000918398,0.0000036232477,0.000009057251,0.000007979545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003965321,0.00027593525,0.00040678843,0.00036128084,0.0001327134,0.00024383004,0.00023225106,0.0005200724,0.006591417],"category_scores_gemma":[0.0001694854,0.000050304985,0.00024409268,0.00024692735,0.0002711068,0.00020547931,0.00022972323,0.0005800674,0.0015160757],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048191403,0.00023743871,0.0005199678,0.0021350072,0.000077791294,0.0010815423,0.0001260502,0.0005886803,0.08074526,0.017246274,0.024412917,0.87234706],"study_design_scores_gemma":[0.0005636802,0.0015898852,0.0030040229,0.00075819495,0.00015224873,0.0073969434,0.000064550084,0.0010579315,0.029515373,0.017921653,0.93794346,0.00003209742],"about_ca_topic_score_codex":0.00013137548,"about_ca_topic_score_gemma":0.00030545288,"teacher_disagreement_score":0.006591417,"about_ca_system_score_codex":0.00016744649,"about_ca_system_score_gemma":0.00027131752,"threshold_uncertainty_score":0.02205044},"labels":[],"label_agreement":null},{"id":"W4255248734","doi":"10.1517/eobt.4.1.107.25251","title":"18th Annual Scientific Meeting of the International Society for Biological Therapy of Cancer","year":2004,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Government (linguistics); Library science; Gerontology; Medicine; Political science; Environmental ethics; Family medicine; Philosophy","score_opus":0.0865523282519976,"score_gpt":0.39436392432464834,"score_spread":0.30781159607265074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255248734","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062913727,0.36415496,0.0092047015,0.08162593,0.2291519,0.00085648545,0.0026353044,0.0007156221,0.30536383],"genre_scores_gemma":[0.018435283,0.14477827,0.004526154,0.012135227,0.04742286,0.0005753405,0.0041204817,0.0002481125,0.76775825],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991391,0.00013940231,0.000051157807,0.00014702491,0.0003987175,0.00012443546],"domain_scores_gemma":[0.99890053,0.00004419407,0.00008208944,0.000042109878,0.0005651618,0.00036594432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001254573,0.0010334353,0.0009551771,0.0014044405,0.0006534144,0.0022883508,0.0009797753,0.0023016152,0.057170823],"category_scores_gemma":[0.0013078725,0.000221439,0.0006462141,0.00069596065,0.00047915702,0.0009479112,0.001368845,0.0028303985,0.03402551],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018985345,0.00008166453,0.00041016858,0.00045163592,0.00003580646,0.00012914646,0.00004342336,0.00013350256,0.004250748,0.0031555851,0.79833984,0.19277863],"study_design_scores_gemma":[0.000010435693,0.000041078685,0.00044894128,0.00008213813,0.000007773379,0.00015858775,0.000011634154,0.000054703272,0.0004098655,0.00038153437,0.9983889,0.0000043633404],"about_ca_topic_score_codex":0.0012220435,"about_ca_topic_score_gemma":0.002332721,"teacher_disagreement_score":0.057170823,"about_ca_system_score_codex":0.0018362008,"about_ca_system_score_gemma":0.0023642876,"threshold_uncertainty_score":0.19125545},"labels":[],"label_agreement":null},{"id":"W4307840943","doi":"10.1080/14712598.2022.2142039","title":"Hypersensitivity reactions to biologics in children","year":2022,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Drug-Induced Adverse Reactions","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Desensitization (medicine); Intensive care medicine; Population; Premedication; MEDLINE; Multidisciplinary approach; Pediatrics; Psychiatry; Internal medicine","score_opus":0.28195861148547285,"score_gpt":0.43985698454054195,"score_spread":0.1578983730550691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307840943","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016218972,0.9975635,0.00007460652,0.00041192188,0.0002458884,0.0000071884992,0.00003994161,0.0000052170767,0.0014896039],"genre_scores_gemma":[0.0023802053,0.99616915,0.0001383822,0.00046015845,0.00023868175,0.00000800488,0.000055906774,0.0000014228693,0.0005480837],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994073,0.00015062775,0.00009625055,0.000081627746,0.0002246017,0.000039646788],"domain_scores_gemma":[0.9989925,0.00052082184,0.00025279314,0.000017600902,0.0001804274,0.000035777728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063960033,0.00055407337,0.00094700034,0.0011556003,0.00018541995,0.00081166637,0.00044871747,0.0008687365,0.0062973276],"category_scores_gemma":[0.0017277349,0.00013834811,0.0007637576,0.0009458758,0.0003225423,0.00057757215,0.00041872464,0.0012374853,0.00113423],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013316744,0.000041413074,0.0007772231,0.055086285,0.00026513476,0.00041358962,0.000102918355,0.00026190173,0.0011636041,0.002381831,0.044525266,0.89484763],"study_design_scores_gemma":[0.00005011178,0.00012640125,0.0026694837,0.0347587,0.0004568331,0.005319172,0.00010831011,0.0000843368,0.00065426057,0.0015493631,0.9541997,0.000023476863],"about_ca_topic_score_codex":0.0013140748,"about_ca_topic_score_gemma":0.0019292864,"teacher_disagreement_score":0.0062973276,"about_ca_system_score_codex":0.00043183277,"about_ca_system_score_gemma":0.0009799877,"threshold_uncertainty_score":0.021066606},"labels":[],"label_agreement":null},{"id":"W4362506413","doi":"10.1080/14712598.2023.2199123","title":"Stem cell therapy for salivary gland regeneration after radiation injury","year":2023,"lang":"en","type":"editorial","venue":"Expert Opinion on Biological Therapy","topic":"Salivary Gland Disorders and Functions","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Regeneration (biology); Salivary gland; Stem cell; Medicine; Stem-cell therapy; Pathology; Radiation therapy; Cell therapy; Cell biology; Biology; Internal medicine","score_opus":0.057802180412068624,"score_gpt":0.34222793755110653,"score_spread":0.2844257571390379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362506413","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011974334,0.07125372,0.0002658485,0.039345197,0.8858116,0.00006028819,0.00006181261,0.000053574044,0.0030281998],"genre_scores_gemma":[0.0010042996,0.042905554,0.0002690829,0.045261014,0.89646554,0.00007172639,0.00005212223,0.000032469867,0.013938167],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980956,0.00040376707,0.0002906617,0.00018020989,0.00087131135,0.00015852452],"domain_scores_gemma":[0.9958923,0.0018939677,0.0003594301,0.000102271086,0.0012722024,0.0004797671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042510047,0.0022638321,0.0024370004,0.0019431646,0.0013901985,0.003134271,0.0019644306,0.012680581,0.01133271],"category_scores_gemma":[0.0075028716,0.00070097524,0.002320571,0.0007668684,0.0013711368,0.002221865,0.0012876703,0.011986359,0.0052025765],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015781188,0.000027827862,0.000019267178,0.0013438811,0.00005925931,0.00017943363,0.000013930508,0.000030586227,0.000307235,0.0004832621,0.9663441,0.031033458],"study_design_scores_gemma":[0.0003012323,0.000087757864,0.00018852776,0.0009749085,0.00015133311,0.00038765612,0.00001894877,0.00010798408,0.00033148009,0.0008824594,0.9965509,0.000016669383],"about_ca_topic_score_codex":0.0009033427,"about_ca_topic_score_gemma":0.002560295,"teacher_disagreement_score":0.012680581,"about_ca_system_score_codex":0.002207691,"about_ca_system_score_gemma":0.0018824734,"threshold_uncertainty_score":0.037911713},"labels":[],"label_agreement":null},{"id":"W4385619728","doi":"10.1080/14712598.2023.2245321","title":"How can clinical safety and efficacy concerns in stem cell therapy for spinal cord injury be overcome?","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Stem cell; Spinal cord injury; Neural stem cell; Mesenchymal stem cell; Stem-cell therapy; Medicine; Induced pluripotent stem cell; Embryonic stem cell; Regenerative medicine; Neuroscience; Cell therapy; Biology; Pathology; Spinal cord; Cell biology","score_opus":0.3079596881650936,"score_gpt":0.4851213653748526,"score_spread":0.177161677209759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385619728","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011280399,0.98849505,0.00042258916,0.0068872264,0.0013804523,0.000013599928,0.00003051972,0.0000136166955,0.0026442988],"genre_scores_gemma":[0.0012032508,0.99155444,0.00060389726,0.003981444,0.0010823802,0.000030357493,0.000040454866,0.000006241532,0.0014974778],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993782,0.00017348237,0.0000666048,0.00007662014,0.00025856093,0.00004652914],"domain_scores_gemma":[0.9983109,0.0009948233,0.00012117058,0.00003349747,0.0004636897,0.00007590635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002759136,0.00052674935,0.0011379794,0.0009830844,0.00031872283,0.0016181283,0.0011706589,0.0027929128,0.005244598],"category_scores_gemma":[0.0034129526,0.00018544223,0.00054608023,0.00081126584,0.0010516203,0.0023005633,0.0007450723,0.0040245918,0.0031806023],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007714622,0.00004875956,0.00006631028,0.0121776275,0.00005710778,0.00016825508,0.000081029095,0.00033744305,0.0014811883,0.020279756,0.07786343,0.88736194],"study_design_scores_gemma":[0.000023427168,0.00009219588,0.00019117408,0.0061384398,0.00004594987,0.0004296116,0.000056028097,0.00007432795,0.00031767818,0.0067035053,0.9859137,0.000013916576],"about_ca_topic_score_codex":0.0011237581,"about_ca_topic_score_gemma":0.002043889,"teacher_disagreement_score":0.005244598,"about_ca_system_score_codex":0.0010357605,"about_ca_system_score_gemma":0.0022853056,"threshold_uncertainty_score":0.017544866},"labels":[],"label_agreement":null},{"id":"W4388796117","doi":"10.1080/14712598.2023.2285996","title":"The endosomal-lysosomal system in ADC design and cancer therapy","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Endosome; Rab; Transferrin receptor; Epidermal growth factor receptor; Computational biology; Cancer; Cancer research; Medicine; GTPase; Biology; Transferrin; Cell biology; Biochemistry; Internal medicine; Intracellular","score_opus":0.4938790619789927,"score_gpt":0.5135073950707947,"score_spread":0.019628333091802008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388796117","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010781318,0.9947613,0.00034858595,0.0019963006,0.00076985464,0.0000071907302,0.000020202377,0.000009190806,0.001979501],"genre_scores_gemma":[0.0012870444,0.99570787,0.00029903225,0.0009779596,0.0005139529,0.000010602402,0.000026258469,0.0000030505576,0.0011742339],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99950695,0.00012586481,0.000041897703,0.00007650544,0.00020172345,0.000046992973],"domain_scores_gemma":[0.9995098,0.00023613186,0.000061418126,0.000016226064,0.00014724312,0.000029198058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011750897,0.0007023441,0.0010454108,0.0012229605,0.00028491914,0.0015213615,0.0008994203,0.002103591,0.005660096],"category_scores_gemma":[0.0011778033,0.00022809439,0.0005087613,0.0011595374,0.00092764344,0.0023128781,0.0009137178,0.0026244386,0.0032725967],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103767365,0.000047196256,0.00010738381,0.02490544,0.00008404925,0.00023391609,0.00016947597,0.0008185789,0.0034475818,0.0392736,0.081755675,0.84905326],"study_design_scores_gemma":[0.000009154524,0.000047932346,0.00010877183,0.0029902686,0.00002662809,0.00040886473,0.00004881121,0.00010361685,0.00056920666,0.00432577,0.9913504,0.000010619434],"about_ca_topic_score_codex":0.0010880459,"about_ca_topic_score_gemma":0.0016456282,"teacher_disagreement_score":0.005660096,"about_ca_system_score_codex":0.0012172096,"about_ca_system_score_gemma":0.0013639221,"threshold_uncertainty_score":0.018934906},"labels":[],"label_agreement":null},{"id":"W4389792976","doi":"10.1080/14712598.2023.2296126","title":"An evaluation of rozanolixizumab-noli for the treatment of anti-AChR and anti-MuSK antibody-positive generalized myasthenia gravis","year":2023,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Myasthenia gravis; Antibody; Medicine; Immunology; Acetylcholine receptor; Internal medicine; Receptor","score_opus":0.1486298224363761,"score_gpt":0.4292359436668372,"score_spread":0.28060612123046114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389792976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9244316,0.06174077,0.0011201848,0.002792886,0.00055376085,0.0020925463,0.001134107,0.00012112778,0.0060129613],"genre_scores_gemma":[0.9729182,0.01737809,0.0021510688,0.0022863531,0.00023067006,0.0009894128,0.0011361284,0.000016743374,0.002893274],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99973315,0.00010602503,0.000024427418,0.00005179537,0.000043620654,0.000040954954],"domain_scores_gemma":[0.99964356,0.00009055155,0.000071890245,0.000020218276,0.000045864534,0.00012796611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009711494,0.000440864,0.0013670842,0.00024862066,0.00021078697,0.00064973196,0.0005283686,0.000922755,0.0041249087],"category_scores_gemma":[0.0007211899,0.00017654976,0.0014273816,0.00017054105,0.00037984707,0.000481275,0.00019486366,0.0013532548,0.0005974486],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29876298,0.025003115,0.0037182176,0.008470375,0.003012582,0.0010479206,0.0004392014,0.0017954594,0.092525385,0.0012088496,0.0053601135,0.5586558],"study_design_scores_gemma":[0.30839795,0.6175068,0.023817422,0.0010102472,0.0034495124,0.0014833354,0.00017879228,0.0021284465,0.010490943,0.00046023488,0.030997243,0.00007904556],"about_ca_topic_score_codex":0.00057644193,"about_ca_topic_score_gemma":0.0018433383,"teacher_disagreement_score":0.0041249087,"about_ca_system_score_codex":0.00056499476,"about_ca_system_score_gemma":0.00070140563,"threshold_uncertainty_score":0.0137991905},"labels":[],"label_agreement":null},{"id":"W4397047590","doi":"10.1080/14712598.2024.2357382","title":"Anti-CD38 monoclonal antibodies in multiple myeloma with gain/amplification of chromosome arm 1q: a review of the literature","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia","keywords":"Daratumumab; CD38; Monoclonal antibody; Multiple myeloma; Antibody; Cancer research; Medicine; Immunology; Biology; Genetics; Stem cell","score_opus":0.16356094872052226,"score_gpt":0.4215744358332648,"score_spread":0.2580134871127425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397047590","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011863598,0.99942505,0.000023957984,0.00022092515,0.00006124634,0.0000032578519,0.000026104519,0.0000015702315,0.00011919939],"genre_scores_gemma":[0.001166536,0.99824286,0.00007881205,0.00025403046,0.00017810114,0.000006763636,0.000029595813,6.72238e-7,0.00004267564],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9993074,0.00014106017,0.0002304685,0.00011676367,0.00016983897,0.00003445253],"domain_scores_gemma":[0.995765,0.0028617508,0.00079757074,0.000047856567,0.0004493945,0.00007847635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016014469,0.0007179152,0.0020493045,0.004760095,0.00028917796,0.00118166,0.0011005658,0.0012411282,0.003229157],"category_scores_gemma":[0.0040975213,0.0003281219,0.0013843476,0.005314138,0.00044569356,0.0012712495,0.0005789936,0.00093858276,0.0005027367],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029396647,0.00007996726,0.0017284522,0.25399074,0.0014283814,0.0004686724,0.00019197387,0.00035105506,0.0006339372,0.0012742552,0.028611822,0.7109467],"study_design_scores_gemma":[0.00014986677,0.00045962274,0.016927065,0.29832223,0.01215581,0.008242138,0.00050567766,0.00035452005,0.0005714217,0.003134905,0.6590772,0.00009954471],"about_ca_topic_score_codex":0.0013113243,"about_ca_topic_score_gemma":0.0026012978,"teacher_disagreement_score":0.004760095,"about_ca_system_score_codex":0.0006137275,"about_ca_system_score_gemma":0.002003481,"threshold_uncertainty_score":0.010802627},"labels":[],"label_agreement":null},{"id":"W4399883248","doi":"10.1080/14712598.2024.2321360","title":"Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 administered by auto-injector or pre-filled syringe: a randomized, open‑label, single-dose phase I study","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Celltrion","keywords":"Pharmacokinetics; Medicine; Biosimilar; Bioequivalence; Syringe; Immunogenicity; Pharmacology; Open label; Safety profile; Adverse effect; Anesthesia; Internal medicine; Antibody; Immunology","score_opus":0.12781426508065188,"score_gpt":0.4271629290048784,"score_spread":0.29934866392422654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399883248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969207,0.0005218767,0.00071536563,0.00005764959,0.00003163815,0.0012170033,0.00018430037,0.000021274825,0.00033024352],"genre_scores_gemma":[0.99613476,0.000422005,0.0012118518,0.00018611558,0.00011915543,0.0013023324,0.00020679162,0.000007803639,0.00040923175],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999273,0.0003611911,0.000049420156,0.000117636475,0.00011736307,0.000081386395],"domain_scores_gemma":[0.9988176,0.0003181272,0.00043846449,0.00010281516,0.000079317215,0.0002436985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018801455,0.0006380034,0.0013170827,0.0002400942,0.00029343914,0.00046060898,0.00042878644,0.00073451374,0.0027032],"category_scores_gemma":[0.001669433,0.0003641477,0.0008288338,0.0003156237,0.00090984756,0.00067455333,0.000147168,0.0015166836,0.00042586104],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80779684,0.045332983,0.008102046,0.0007760756,0.00081923493,0.00014889313,0.00025948635,0.0015033259,0.075556874,0.00022604932,0.00085108966,0.05862723],"study_design_scores_gemma":[0.21093151,0.7557122,0.014798502,0.000036495578,0.00084431167,0.0002775861,0.00007043594,0.0019077369,0.01389144,0.00016149633,0.0013346479,0.000033656845],"about_ca_topic_score_codex":0.00035413558,"about_ca_topic_score_gemma":0.00047518933,"teacher_disagreement_score":0.0027032,"about_ca_system_score_codex":0.0007225561,"about_ca_system_score_gemma":0.0012401035,"threshold_uncertainty_score":0.009943247},"labels":[],"label_agreement":null},{"id":"W4399896975","doi":"10.1080/14712598.2024.2371049","title":"How close are we to a success stratification tool for improving biological therapy in ulcerative colitis?","year":2024,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Ulcerative colitis; Medicine; Intensive care medicine; Clinical trial; Colitis; Internal medicine; Disease","score_opus":0.06058328736767934,"score_gpt":0.34182203433071473,"score_spread":0.2812387469630354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399896975","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0042436593,0.5161985,0.022242887,0.43293157,0.012448394,0.00022316547,0.0009796463,0.00040140757,0.01033069],"genre_scores_gemma":[0.12561092,0.5740411,0.09341305,0.15351216,0.042468894,0.00106542,0.0018026485,0.0002984537,0.0077873934],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9903723,0.0052134874,0.0010139055,0.00086403254,0.0022385344,0.00029773268],"domain_scores_gemma":[0.95209736,0.027461229,0.004579593,0.0008314899,0.013154381,0.001875987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018164614,0.0010830346,0.0030387407,0.0018346214,0.0007602832,0.0045543127,0.0017289312,0.0038740733,0.009126253],"category_scores_gemma":[0.079946354,0.00030491024,0.0016537061,0.0011058779,0.0017582404,0.004985121,0.001526987,0.004986413,0.0049284254],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000583608,0.00011423264,0.008198562,0.0075168377,0.0006389719,0.00023973768,0.0003396138,0.00065104035,0.00052545837,0.010617624,0.16699503,0.8035793],"study_design_scores_gemma":[0.00054264854,0.0010304694,0.019740006,0.04805145,0.0025604926,0.0017123201,0.0017877336,0.005276697,0.0011010652,0.10171736,0.8160957,0.00038395196],"about_ca_topic_score_codex":0.0018718694,"about_ca_topic_score_gemma":0.003392299,"teacher_disagreement_score":0.018164614,"about_ca_system_score_codex":0.001966769,"about_ca_system_score_gemma":0.0035454084,"threshold_uncertainty_score":0.096064866},"labels":[],"label_agreement":null},{"id":"W4400462617","doi":"10.1080/14712598.2024.2378090","title":"Systematic review: effectiveness and safety of switching between originator infliximab and biosimilar infliximab in patients with inflammatory bowel disease","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"Pfizer","keywords":"Biosimilar; Infliximab; Medicine; Inflammatory bowel disease; Adverse effect; Intensive care medicine; Ulcerative colitis; Disease; Internal medicine; Pharmacology","score_opus":0.03492524527650228,"score_gpt":0.34824673445929305,"score_spread":0.3133214891827908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400462617","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0068817153,0.98431605,0.00035479042,0.0005776371,0.00028994842,0.003943517,0.0027177457,0.000035683366,0.0008829276],"genre_scores_gemma":[0.08485457,0.90231705,0.0018064306,0.0015719346,0.00022685781,0.007022782,0.001666529,0.000022037006,0.00051178585],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9856397,0.005914929,0.0052117836,0.0009391342,0.0019983675,0.00029600714],"domain_scores_gemma":[0.96345884,0.021756854,0.010554112,0.0005777186,0.0032553594,0.00039709694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010602734,0.001521163,0.0118062375,0.0073803505,0.0006965814,0.00286155,0.0020005142,0.0019938156,0.0071562603],"category_scores_gemma":[0.053904213,0.0009755289,0.009944842,0.00786909,0.0011545396,0.0022384888,0.0013762644,0.0014246879,0.00042359976],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055477157,0.000014452399,0.00087113876,0.9679469,0.018864347,0.000055036766,0.00009599444,0.00006301529,0.00008264385,0.00006321151,0.00084127946,0.010547321],"study_design_scores_gemma":[0.0020365554,0.0004908847,0.008291224,0.77231514,0.20792477,0.0003431979,0.00023666961,0.00014786048,0.0002367308,0.00025426783,0.007668268,0.000054539956],"about_ca_topic_score_codex":0.008538071,"about_ca_topic_score_gemma":0.020382434,"teacher_disagreement_score":0.0118062375,"about_ca_system_score_codex":0.0054677366,"about_ca_system_score_gemma":0.0108299,"threshold_uncertainty_score":0.05607325},"labels":[],"label_agreement":null},{"id":"W4400958298","doi":"10.1080/14712598.2024.2383882","title":"The potential for medical therapies to address fistulizing Crohn’s disease: a state-of-the-art review","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Crohn's disease; Disease; Intensive care medicine; Internal medicine","score_opus":0.054839421885677274,"score_gpt":0.38407368583395946,"score_spread":0.3292342639482822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400958298","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000081520906,0.99802303,0.000075931,0.0009564093,0.00035716037,0.0000042171196,0.00002097495,0.0000048662087,0.00047598113],"genre_scores_gemma":[0.00064358296,0.998128,0.00011256713,0.00055320864,0.00035430415,0.0000073046976,0.00002805614,0.0000012644293,0.00017181077],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9995691,0.00010363021,0.00007071962,0.00007382036,0.00014560699,0.000037208523],"domain_scores_gemma":[0.9985511,0.0009359924,0.00017955482,0.00001977607,0.00026346953,0.000050168837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000868998,0.00061700563,0.0014115867,0.001340831,0.00024051555,0.0012866259,0.00084543467,0.0015442815,0.0051526157],"category_scores_gemma":[0.0021462445,0.00018777254,0.00089626224,0.0011671904,0.00041741642,0.0014002636,0.0005757526,0.0016684209,0.0013623766],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012380208,0.00005165176,0.0001819127,0.05855075,0.00020001107,0.00017448554,0.00008783496,0.00027318517,0.00097452797,0.0031576997,0.045944564,0.8902796],"study_design_scores_gemma":[0.00004260295,0.00013453429,0.0006596257,0.030303953,0.0005223655,0.0010019316,0.00011128264,0.00014254225,0.0002794331,0.0024833772,0.9642972,0.000021243524],"about_ca_topic_score_codex":0.0006315825,"about_ca_topic_score_gemma":0.001272401,"teacher_disagreement_score":0.0051526157,"about_ca_system_score_codex":0.0005184816,"about_ca_system_score_gemma":0.0013720767,"threshold_uncertainty_score":0.017237186},"labels":[],"label_agreement":null},{"id":"W4402455324","doi":"10.1080/14712598.2024.2404079","title":"Mosunetuzumab for the treatment of follicular lymphoma","year":2024,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia","keywords":"Follicular lymphoma; Medicine; Cancer research; Lymphoma; Oncology; Internal medicine; Rituximab; Biology; Immunology","score_opus":0.23548741695875694,"score_gpt":0.44401641511800954,"score_spread":0.2085289981592526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402455324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000146824,0.9991372,0.00003568497,0.00013008692,0.00008282821,0.000005983952,0.000018335497,0.0000025654858,0.00044047937],"genre_scores_gemma":[0.0023206947,0.9966875,0.00013152872,0.00028201778,0.00011715399,0.000010500079,0.000052364136,0.0000011279575,0.00039715736],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9998448,0.000037415837,0.000028203202,0.000027352171,0.00004713316,0.000015142097],"domain_scores_gemma":[0.9998196,0.00008597932,0.000047013724,0.0000031464117,0.00003291095,0.00001144716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035991037,0.00042230758,0.00087930035,0.0015583371,0.00014062258,0.000493697,0.0004199008,0.00059189985,0.0038280261],"category_scores_gemma":[0.00066722033,0.000111784124,0.0006297076,0.0011854904,0.00017383645,0.00048312068,0.0002866627,0.0007927223,0.0008967731],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024469878,0.000038936727,0.00016428111,0.06749918,0.00033031186,0.0002573292,0.000058828547,0.00020002534,0.0019779534,0.0011633321,0.022491075,0.90557396],"study_design_scores_gemma":[0.00021488832,0.00028307966,0.0020329924,0.028500745,0.0012776734,0.003242632,0.000074001975,0.00015777048,0.0012480179,0.0011400194,0.9618031,0.000025110283],"about_ca_topic_score_codex":0.0009469827,"about_ca_topic_score_gemma":0.0018582164,"teacher_disagreement_score":0.0038280261,"about_ca_system_score_codex":0.0004979204,"about_ca_system_score_gemma":0.00067081803,"threshold_uncertainty_score":0.012805998},"labels":[],"label_agreement":null},{"id":"W4403791186","doi":"10.1080/14712598.2024.2422998","title":"Recent developments and industry interest in gene therapy for Duchenne muscular dystrophy","year":2024,"lang":"en","type":"editorial","venue":"Expert Opinion on Biological Therapy","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Duchenne muscular dystrophy; Muscular dystrophy; Genetic enhancement; Medicine; Adverse effect; Intensive care medicine; Bioinformatics; Gene; Internal medicine; Biology; Genetics","score_opus":0.07155911960616099,"score_gpt":0.34584290525654365,"score_spread":0.2742837856503827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403791186","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000829648,0.16001582,0.00033044623,0.06365151,0.7712556,0.000022431974,0.0000881984,0.00007982064,0.0044732895],"genre_scores_gemma":[0.0009794732,0.13825367,0.00035069344,0.06834499,0.77343416,0.000038141035,0.00013234073,0.00006401875,0.018402485],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982503,0.00031230072,0.00017693081,0.00023882506,0.0008798238,0.00014179079],"domain_scores_gemma":[0.9945532,0.0021757234,0.000293173,0.00009543812,0.0020910464,0.0007913641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034280415,0.0016381465,0.0014970659,0.0014233225,0.00097306067,0.002895255,0.0017492515,0.008180219,0.012762875],"category_scores_gemma":[0.008748646,0.0005097667,0.0013520495,0.0008459694,0.0011647885,0.003189439,0.0012359027,0.010544348,0.010286825],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004066372,0.00000812558,0.000011545122,0.00052371813,0.000014516931,0.000083605875,0.0000114226805,0.000025039102,0.00012457703,0.000694257,0.9752508,0.023211772],"study_design_scores_gemma":[0.00004108106,0.000030955453,0.00007739007,0.00037247592,0.000033148015,0.00021420643,0.0000143038515,0.000041361825,0.00006921335,0.0009490774,0.9981487,0.000008182081],"about_ca_topic_score_codex":0.0008774775,"about_ca_topic_score_gemma":0.002930004,"teacher_disagreement_score":0.012762875,"about_ca_system_score_codex":0.0017952567,"about_ca_system_score_gemma":0.001654944,"threshold_uncertainty_score":0.04269606},"labels":[],"label_agreement":null},{"id":"W4407086441","doi":"10.1080/14712598.2025.2456485","title":"Navigating the landscape of immune checkpoint inhibitors and novel immunotherapies in melanoma: long-term outcomes, progress, and challenges","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Melanoma; Immunotherapy; Nivolumab; Immune checkpoint; Immune system; Medicine; Ipilimumab; Term (time); Cancer research; Pembrolizumab; Immunology","score_opus":0.11995718681064713,"score_gpt":0.39524859417414226,"score_spread":0.2752914073634951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407086441","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011425945,0.99763393,0.000094963296,0.0013509626,0.00023300192,0.0000037686907,0.000020682382,0.000005608974,0.0005427621],"genre_scores_gemma":[0.0010250119,0.99738365,0.00016494552,0.00078096235,0.00025584007,0.000006779749,0.000033933196,0.0000018640097,0.00034700005],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960595,0.00012045893,0.000049350416,0.0000519437,0.00013150314,0.0000408113],"domain_scores_gemma":[0.9992173,0.00039741353,0.00010993747,0.000014127597,0.00022161032,0.0000396349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012621231,0.00043643528,0.0011678621,0.0010263342,0.0002060695,0.0010809432,0.0006442475,0.0010693836,0.0037673677],"category_scores_gemma":[0.0016522448,0.00015625179,0.00073941477,0.0008528539,0.00031033525,0.0013439064,0.0005781934,0.0018885578,0.0012487426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011964187,0.0000427832,0.00018185191,0.021066502,0.00015969154,0.000104025596,0.00006114235,0.0003705207,0.0009941023,0.0037318394,0.03999867,0.9331691],"study_design_scores_gemma":[0.00004895615,0.00020117879,0.0010068187,0.017614031,0.00031126483,0.0008229308,0.00012300652,0.00023900346,0.0003766619,0.0043883985,0.9748452,0.000022620465],"about_ca_topic_score_codex":0.0009201316,"about_ca_topic_score_gemma":0.0027271423,"teacher_disagreement_score":0.0037673677,"about_ca_system_score_codex":0.0005974723,"about_ca_system_score_gemma":0.0014187787,"threshold_uncertainty_score":0.012603104},"labels":[],"label_agreement":null},{"id":"W4408341556","doi":"10.1080/14712598.2025.2477192","title":"State of the art of the molecular hyperselection to guide treatment with anti-EGFR antibodies in RAS WT mCRC: implications for clinical practice and future perspectives","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pivotal (Canada)","funders":"","keywords":"Antibody; Clinical Practice; Medicine; Cancer research; Immunology; Family medicine","score_opus":0.12063140703017454,"score_gpt":0.48610959772964424,"score_spread":0.3654781906994697,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408341556","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006760367,0.9981444,0.000081589074,0.0011279702,0.00014671628,0.000005177333,0.000029832818,0.00000310139,0.00039350358],"genre_scores_gemma":[0.0013516495,0.9973225,0.0002678844,0.0006694706,0.00020244496,0.000012781073,0.00003333826,0.0000017658859,0.00013808589],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99912614,0.00028210453,0.00021420977,0.00011551112,0.00021677677,0.0000453047],"domain_scores_gemma":[0.9950918,0.0031939282,0.00064551743,0.000072341245,0.0009269168,0.000069431364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027079026,0.00056757504,0.0020821027,0.0018951243,0.00018604864,0.0014863195,0.0012253853,0.0015244386,0.003975903],"category_scores_gemma":[0.006803783,0.00026927164,0.001372683,0.0020148896,0.0005427082,0.0016502135,0.00045494147,0.0015381814,0.0011617506],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014603804,0.000037220685,0.00040287012,0.106408276,0.00043685682,0.00013895011,0.00011227835,0.00038898637,0.0005766301,0.0043267068,0.031539794,0.85548544],"study_design_scores_gemma":[0.00010110216,0.00018541736,0.002995385,0.16779304,0.0017253879,0.0013256824,0.00029544198,0.0004269696,0.00045206607,0.0067189266,0.8179185,0.000062068015],"about_ca_topic_score_codex":0.0018742329,"about_ca_topic_score_gemma":0.003390884,"teacher_disagreement_score":0.003975903,"about_ca_system_score_codex":0.0010566944,"about_ca_system_score_gemma":0.002570857,"threshold_uncertainty_score":0.01432091},"labels":[],"label_agreement":null},{"id":"W4408393364","doi":"10.1080/14712598.2025.2480258","title":"IL23p19 therapies for moderately-to-severely active ulcerative colitis","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Ulcerative colitis; Medicine; Vedolizumab; Internal medicine; Tofacitinib; Gastroenterology; Disease; Rheumatoid arthritis","score_opus":0.09232761844520763,"score_gpt":0.39198695492837554,"score_spread":0.2996593364831679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408393364","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00080913614,0.98682225,0.0006365769,0.0049224896,0.0014049727,0.00003583288,0.00014234216,0.00002456933,0.005201757],"genre_scores_gemma":[0.016506223,0.97041196,0.0010244139,0.004817722,0.003558981,0.000064760105,0.00035941586,0.000009640226,0.003246832],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963164,0.00011941634,0.000036117763,0.00004845006,0.00013387293,0.00003059924],"domain_scores_gemma":[0.999534,0.00019419553,0.00010431838,0.000007795338,0.00012860721,0.000031164793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057944545,0.00037661777,0.0007393482,0.00065447454,0.00013260383,0.00077401457,0.0005165046,0.0009418493,0.008492162],"category_scores_gemma":[0.0011425697,0.000090182475,0.00048585373,0.0004838666,0.00024215663,0.00054990884,0.00029174227,0.0010909177,0.0025853638],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004080374,0.000059078124,0.0002746232,0.021172376,0.00025014888,0.0004396695,0.00005408141,0.00034299624,0.0034273253,0.0025399837,0.100576356,0.8704554],"study_design_scores_gemma":[0.00029040972,0.0003286925,0.0010160403,0.00904898,0.00041364756,0.0014850277,0.00006241488,0.00024160245,0.001086885,0.0025701898,0.98343486,0.000021247792],"about_ca_topic_score_codex":0.00039433065,"about_ca_topic_score_gemma":0.0011704972,"teacher_disagreement_score":0.008492162,"about_ca_system_score_codex":0.0004068239,"about_ca_system_score_gemma":0.0005124376,"threshold_uncertainty_score":0.028409123},"labels":[],"label_agreement":null},{"id":"W4410261758","doi":"10.1080/14712598.2025.2500962","title":"Second-line strategies after anti-TNF failure in chronically active, moderate-to-severe ulcerative colitis: a retrospective, multicentre cohort study","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Ministry of Innovation; National Research, Development and Innovation Office; Nemzeti Kutatási, Fejlesztési és Innovaciós Alap; Innovation Fund; Szegedi Tudományegyetem; United European Gastroenterology; European Crohn's and Colitis Organisation","keywords":"Ulcerative colitis; Medicine; Retrospective cohort study; Cohort; Internal medicine; Cohort study; Infliximab; Inflammatory bowel disease; Tumor necrosis factor alpha; Gastroenterology; Disease","score_opus":0.015234076884882413,"score_gpt":0.3058804994429039,"score_spread":0.2906464225580215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410261758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99892634,0.0006480951,0.00008752346,0.000012915955,0.0000043550694,0.000012797209,0.00019133808,0.0000016499046,0.00011496254],"genre_scores_gemma":[0.99937445,0.00016526389,0.00006164663,0.000019671097,0.000010408139,0.000011440766,0.00029848496,0.0000016871156,0.00005692053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911684,0.00020434626,0.00012419725,0.00030162337,0.00011488,0.00013804979],"domain_scores_gemma":[0.9972843,0.00031004645,0.0014449231,0.0004209765,0.00020182364,0.00033785065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010680651,0.00033872374,0.0005211249,0.00067667617,0.00055878854,0.000790442,0.0003778304,0.00057689403,0.000955829],"category_scores_gemma":[0.0021164445,0.00031653047,0.00084526517,0.00087334233,0.0002978988,0.0004755915,0.0004398488,0.0005241253,0.00022157711],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003973026,0.000032501273,0.99841547,0.000014060891,0.00008007953,0.0001634456,0.00005203515,0.000016109318,0.0001519915,0.000009152145,0.000043375614,0.00062454306],"study_design_scores_gemma":[0.0000331164,0.000772982,0.99677354,0.000012786372,0.00012661143,0.0014958874,0.00018896989,0.000102682374,0.000095467,0.000016690034,0.0003741811,0.0000070995106],"about_ca_topic_score_codex":0.0019704143,"about_ca_topic_score_gemma":0.0019023899,"teacher_disagreement_score":0.0019704143,"about_ca_system_score_codex":0.00031623605,"about_ca_system_score_gemma":0.00035811064,"threshold_uncertainty_score":0.0056485534},"labels":[],"label_agreement":null},{"id":"W4414026299","doi":"10.1080/14712598.2025.2557626","title":"Efficacy and safety of biosimilars in gastroenterology: a focus on inflammatory bowel disease management","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Biosimilar; Inflammatory bowel disease; Medicine; Gastroenterology; Internal medicine; Disease; Inflammatory Bowel Diseases; Intensive care medicine","score_opus":0.06055974414817065,"score_gpt":0.3647163946971899,"score_spread":0.30415665054901925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414026299","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005736482,0.998555,0.000058655616,0.0007156438,0.00019699374,0.000002310028,0.000007145989,0.0000019881504,0.00040487704],"genre_scores_gemma":[0.0008845634,0.99784243,0.00010880496,0.0005803131,0.0003467591,0.000004594528,0.000013465038,0.0000010847322,0.00021787063],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993154,0.00019260687,0.00009485358,0.00010927298,0.00024582222,0.000042057996],"domain_scores_gemma":[0.99765307,0.0014762124,0.00031144396,0.00003376402,0.0004443637,0.000081170816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016040739,0.0006017909,0.0012850699,0.0014929852,0.00019640873,0.0010912472,0.00064998586,0.0019430417,0.004614736],"category_scores_gemma":[0.0031901044,0.00018114137,0.0007268833,0.0016836493,0.00061041483,0.0014548635,0.0006429097,0.0021973304,0.0013577536],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010421447,0.00004392762,0.00012229901,0.031998016,0.00012358767,0.00009604643,0.0000672625,0.00021914681,0.0009444102,0.0051320605,0.022673251,0.9384758],"study_design_scores_gemma":[0.00007438311,0.00023925536,0.001184262,0.031397726,0.00032222574,0.0013817779,0.00011736082,0.00013355917,0.0005180491,0.004277869,0.9603262,0.000027292579],"about_ca_topic_score_codex":0.00079490384,"about_ca_topic_score_gemma":0.0011294155,"teacher_disagreement_score":0.004614736,"about_ca_system_score_codex":0.00063306716,"about_ca_system_score_gemma":0.0015252996,"threshold_uncertainty_score":0.015437841},"labels":[],"label_agreement":null},{"id":"W4415325193","doi":"10.1080/14712598.2025.2577752","title":"Improving care for children with juvenile idiopathic arthritis: the role of IL-6 inhibitors in a patient-centered approach","year":2025,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children’s Health Research Institute; London Health Sciences Centre; Western University","funders":"Fresenius Kabi","keywords":"Oligoarthritis; Tocilizumab; Disease; Refractory (planetary science); Bridging (networking); Complex disease; Arthritis","score_opus":0.04256535268733067,"score_gpt":0.32880076810499925,"score_spread":0.28623541541766856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415325193","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026850759,0.83885634,0.0012351666,0.14793137,0.0022874342,0.0001008004,0.00030666913,0.00007176663,0.0065253535],"genre_scores_gemma":[0.06386456,0.8808597,0.008752796,0.040031984,0.004470081,0.00031739473,0.00038120363,0.000028711438,0.0012935947],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99570763,0.0025588665,0.0004742107,0.00032560804,0.000680734,0.00025291095],"domain_scores_gemma":[0.9883857,0.0064942236,0.002132236,0.000160554,0.0016345162,0.0011927783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045870286,0.0004922061,0.0011376337,0.0011167061,0.0008311733,0.0022504923,0.0010364155,0.0017731756,0.0063805343],"category_scores_gemma":[0.020470284,0.00023063333,0.0014565047,0.0010246837,0.00075893546,0.0030196486,0.0025239799,0.0042658984,0.00070886506],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002478885,0.0001366217,0.007153269,0.05239991,0.0005750278,0.00063916895,0.002276942,0.00039442573,0.00027595292,0.010583265,0.21042292,0.71489465],"study_design_scores_gemma":[0.0004619206,0.0004317201,0.023849268,0.24580802,0.0013607879,0.002987929,0.0055739754,0.00046164688,0.0003291741,0.012146553,0.70645624,0.00013266773],"about_ca_topic_score_codex":0.0056851576,"about_ca_topic_score_gemma":0.01147692,"teacher_disagreement_score":0.0063805343,"about_ca_system_score_codex":0.0028765697,"about_ca_system_score_gemma":0.008839176,"threshold_uncertainty_score":0.024258792},"labels":[],"label_agreement":null},{"id":"W4416866620","doi":"10.1080/14712598.2025.2597848","title":"An evaluation of guselkumab for the treatment of ulcerative colitis","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Golimumab; Ulcerative colitis; Clinical trial; Clinical efficacy; Combination therapy; Clinical endpoint","score_opus":0.07990704056397012,"score_gpt":0.3965135112182138,"score_spread":0.3166064706542437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416866620","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08837914,0.8527936,0.0018488447,0.021394607,0.003696607,0.0008167823,0.001723373,0.00011410809,0.029232966],"genre_scores_gemma":[0.531882,0.41526222,0.0059216265,0.026743477,0.0029733146,0.00088368694,0.0029483745,0.000058155434,0.013327167],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999332,0.0003378398,0.000056687182,0.0000694185,0.00015320406,0.000050828312],"domain_scores_gemma":[0.99911696,0.00033005633,0.0001588777,0.00003390032,0.00022596476,0.00013422294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017603859,0.00036380487,0.0010167573,0.00025936094,0.00019729146,0.0008319764,0.00034705305,0.0010057047,0.0059149424],"category_scores_gemma":[0.0019517804,0.00009256878,0.0011383828,0.00024910163,0.00023316409,0.00046054088,0.00023076113,0.0016475165,0.001067763],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02677183,0.0009772626,0.0016980426,0.010318316,0.0014997197,0.0006019131,0.0001444851,0.00078395667,0.016826125,0.0029543513,0.033095412,0.9043287],"study_design_scores_gemma":[0.03672802,0.08123342,0.023187794,0.01212493,0.0063526393,0.0033327884,0.00028615858,0.0019851439,0.015776096,0.004202205,0.8146728,0.000118037606],"about_ca_topic_score_codex":0.00046229654,"about_ca_topic_score_gemma":0.001366917,"teacher_disagreement_score":0.0059149424,"about_ca_system_score_codex":0.0007356496,"about_ca_system_score_gemma":0.00074021844,"threshold_uncertainty_score":0.01978749},"labels":[],"label_agreement":null},{"id":"W4417073551","doi":"10.1080/14712598.2025.2601053","title":"Natural killer cell therapies in cancer: innovations, challenges, and future directions","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University College of the North","funders":"","keywords":"Immunotherapy; Cancer immunotherapy; Natural killer cell; Cancer; Cell; Chimeric antigen receptor; Cancer treatment; Cell therapy","score_opus":0.04228165378890512,"score_gpt":0.3129518251061232,"score_spread":0.27067017131721804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417073551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000624035,0.9692221,0.0019459993,0.023789812,0.002103876,0.000018786106,0.00003560451,0.000039825067,0.0022198907],"genre_scores_gemma":[0.006722302,0.9745359,0.0027461734,0.009963298,0.0039851693,0.000052686843,0.00007683082,0.000013506245,0.0019041863],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991997,0.00027667166,0.00005444508,0.00010860139,0.00025325292,0.000107398504],"domain_scores_gemma":[0.9984042,0.0008268866,0.00012092976,0.000047089175,0.00042138092,0.0001795796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035837356,0.00055185024,0.00095250976,0.0006680399,0.00033733947,0.0017605267,0.00094772433,0.0026535075,0.0044497102],"category_scores_gemma":[0.0019799336,0.00019518407,0.0006042949,0.0005010391,0.0015744834,0.0031055226,0.0010644632,0.004128828,0.0021581303],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023241644,0.0001171758,0.00032261517,0.0059661795,0.00007597331,0.00031263658,0.00014127698,0.0009970296,0.006349596,0.02452125,0.09121387,0.8697501],"study_design_scores_gemma":[0.00007312182,0.00032289638,0.00041589956,0.0030234826,0.00006802787,0.0009156704,0.00021473996,0.000556804,0.0015227685,0.022378469,0.97047305,0.00003502419],"about_ca_topic_score_codex":0.0006429103,"about_ca_topic_score_gemma":0.0019363104,"teacher_disagreement_score":0.0044497102,"about_ca_system_score_codex":0.0011243728,"about_ca_system_score_gemma":0.0016681055,"threshold_uncertainty_score":0.018952787},"labels":[],"label_agreement":null},{"id":"W4417314564","doi":"10.1080/14712598.2025.2604057","title":"Cell population data as predictive biomarkers for biologic therapy response in psoriasis","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"National Key Research and Development Program of China; Natural Science Foundation of Hunan Province; National Natural Science Foundation of China","keywords":"Psoriasis; Population; Biological response modifiers; Biologic Agents; Biomarker; Clinical trial; Cell; Cell therapy","score_opus":0.0950750619438016,"score_gpt":0.3562980083849614,"score_spread":0.2612229464411598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417314564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848636,0.0034481885,0.0061231568,0.00012562032,0.00004679754,0.0001234125,0.0031902501,0.000090115274,0.0019888005],"genre_scores_gemma":[0.99669576,0.00028488197,0.0015328089,0.000057183304,0.00003913556,0.000069849695,0.0011061671,0.0000088639945,0.00020547106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858487,0.000591764,0.00013892034,0.00024875646,0.0003618143,0.0000739168],"domain_scores_gemma":[0.9954158,0.0019416698,0.0014749,0.00061210117,0.00034385637,0.0002116279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026484823,0.00030523541,0.00053494645,0.0015930801,0.00020051852,0.00084951194,0.00043918955,0.00045496144,0.0015521167],"category_scores_gemma":[0.0053037507,0.00016645792,0.00026330585,0.0012135503,0.00024677813,0.00035634195,0.0003974468,0.00072890293,0.00035096533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082036917,0.0000652486,0.9829647,0.00004382627,0.00012393514,0.000045210996,0.000046223682,0.00045617225,0.0022058384,0.00010643575,0.00031199664,0.012810094],"study_design_scores_gemma":[0.000044195574,0.0006575225,0.98891836,0.000017667973,0.0001489899,0.00056059484,0.00009088438,0.0036125204,0.0034147317,0.0007034188,0.0018155759,0.000015405183],"about_ca_topic_score_codex":0.0004944446,"about_ca_topic_score_gemma":0.0004896678,"teacher_disagreement_score":0.0026484823,"about_ca_system_score_codex":0.00027148443,"about_ca_system_score_gemma":0.00018844943,"threshold_uncertainty_score":0.014006734},"labels":[],"label_agreement":null},{"id":"W4417497569","doi":"10.1080/14712598.2025.2606897","title":"Ranibizumab biosimilar (Oceva) – real-world experience from India (RORE study)","year":2025,"lang":"en","type":"article","venue":"Expert Opinion on Biological Therapy","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Electrovaya (Canada)","funders":"","keywords":"Biosimilar; Ranibizumab; Population; Clinical trial; Pharmacogenetics; MEDLINE","score_opus":0.09086108873478276,"score_gpt":0.39661812815289293,"score_spread":0.30575703941811017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417497569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961314,0.0015584016,0.00025592954,0.00015873623,0.00001435523,0.00012924576,0.00037861106,0.000009143024,0.0013640402],"genre_scores_gemma":[0.99730384,0.00079033355,0.00039115077,0.00027937547,0.00006601771,0.000060532,0.0008888311,0.0000063932666,0.00021354457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99537474,0.0024003894,0.00039867984,0.00052769424,0.0009260245,0.0003724673],"domain_scores_gemma":[0.98585874,0.0030149352,0.00703781,0.0019562666,0.0011601623,0.0009720429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069537554,0.0003370889,0.00048022787,0.0004761885,0.00031908494,0.0011059927,0.0006327897,0.0005158033,0.001376522],"category_scores_gemma":[0.0061001084,0.00024227302,0.00054691994,0.00086003524,0.00085355464,0.0005982116,0.00049477915,0.0007655746,0.0006166944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013570308,0.004659407,0.9217498,0.0006946887,0.0009384096,0.0011289485,0.0018863311,0.0003337525,0.008852882,0.0003264321,0.001823395,0.044035632],"study_design_scores_gemma":[0.003501441,0.03360388,0.9404269,0.00021380254,0.0012453124,0.00544914,0.0014670456,0.00061971816,0.0061997,0.0001593141,0.006987958,0.00012579343],"about_ca_topic_score_codex":0.0011602837,"about_ca_topic_score_gemma":0.0013203281,"teacher_disagreement_score":0.0069537554,"about_ca_system_score_codex":0.0006310985,"about_ca_system_score_gemma":0.0011211433,"threshold_uncertainty_score":0.03677547},"labels":[],"label_agreement":null}]}